WO2016143650A1 - 3-aminooxalylaminobenzamide compound and use for controlling harmful arthropod - Google Patents

3-aminooxalylaminobenzamide compound and use for controlling harmful arthropod Download PDF

Info

Publication number
WO2016143650A1
WO2016143650A1 PCT/JP2016/056540 JP2016056540W WO2016143650A1 WO 2016143650 A1 WO2016143650 A1 WO 2016143650A1 JP 2016056540 W JP2016056540 W JP 2016056540W WO 2016143650 A1 WO2016143650 A1 WO 2016143650A1
Authority
WO
WIPO (PCT)
Prior art keywords
group
compound
haloalkyl
present
alkyl
Prior art date
Application number
PCT/JP2016/056540
Other languages
French (fr)
Japanese (ja)
Inventor
政樹 ▲高▼橋
Original Assignee
住友化学株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 住友化学株式会社 filed Critical 住友化学株式会社
Publication of WO2016143650A1 publication Critical patent/WO2016143650A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/84Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms six-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/4261,3-Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/101,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/121,4-Thiazines; Hydrogenated 1,4-thiazines not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D281/00Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02Seven-membered rings
    • C07D281/04Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/06Seven-membered rings having the hetero atoms in positions 1 and 4 not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms

Definitions

  • the present invention relates to certain 3-aminooxalylaminobenzamide compounds and their use for harmful arthropods.
  • Patent Document 1 International Publication No. 2012/164698
  • An object of the present invention is to provide a compound having an excellent controlling effect on harmful arthropods and a method for controlling harmful arthropods using the compound.
  • G 1 and G 5 each independently represent —CR 6 R 7 — or —C (O) —
  • G 2 , G 3 and G 4 each independently represent —CR 6 R 7 — or a single bond
  • Q represents an oxygen atom
  • R 1 and R 3 are each independently a hydrogen atom, a C1-C6 alkyl group, a C1-C6 alkoxy group, a —S (O) p- (C1-C6 alkyl) group, a C1-C6 haloalkyl group, a C1-C6 A haloalkoxy group, a —S (O) p — (C1-C6 haloalkyl) group, a halogen atom, a nitro group or a cyano group;
  • R 2 represents a C1-C6 haloalkyl group, a C1-C6 haloalkoxy group or
  • R 8 represents a hydrogen atom, a C1-C6 alkyl group, a C1-C6 haloalkyl group or a cyano group
  • R 9 represents a C1-C6 alkyl group or a C1-C6 haloalkyl group
  • Each X a independently represents a C1-C6 alkyl group, a C1-C6 alkoxy group, a C1-C6 haloalkyl group, a C1-C6 haloalkoxy group, a halogen atom or a cyano group
  • Each Xb independently represents a C1-C6 alkyl group, a C1-C6 alkoxy group, a C1-C6 haloalkyl group, a C1-C6 haloalk
  • R 1 and R 3 are each independently a hydrogen atom, a C1-C6 alkyl group, a C1-C6 alkoxy group, a —S (O) p — (C1-C6 alkyl) group, a C1-C6 haloalkyl group, A C1-C6 haloalkoxy group, —S (O) p — (C1-C6 haloalkyl) group or a halogen atom
  • R 4 and R 5 are each independently a hydrogen atom, a C1-C6 alkyl group, a (C1-C6 alkyl) carbonyl group, a C1-C6 haloalkyl group or a (C1-C6 haloalkyl) carbonyl group
  • R 6 and R 7 are each independently a hydrogen atom, a
  • G 1 and G 5 are each independently —CR 6 R 7 —
  • R 1 and R 3 are each independently a hydrogen atom, a C1-C3 alkyl group, a C1-C3 alkoxy group, a —S (O) p — (C1-C3 alkyl) group, a C1-C3 haloalkyl group, a C1-C3 A haloalkoxy group, a —S (O) p — (C1-C3 haloalkyl) group or a halogen atom
  • R 4 and R 5 are each independently a hydrogen atom or a C1-C3 alkyl group
  • R 6 and R 7 are each independently a hydrogen atom, a C1-C3 alkyl group or a C1-C3 haloalkyl group
  • R 8 is a hydrogen atom, a methyl group, an ethyl group or a cyano group
  • R 9 is a methyl
  • [6] The compound according to any one of [1] to [5], wherein R 2 is a C1-C6 haloalkyl group.
  • R 2 is a C1-C6 haloalkoxy group.
  • R 2 is a —S (O) p — (C1-C6 haloalkyl) group.
  • a harmful arthropod control composition comprising the compound according to any one of [1] to [8] and an inert carrier.
  • a method for controlling harmful arthropods which comprises applying an effective amount of the compound according to any one of [1] to [8] to harmful arthropods or harmful arthropod habitats.
  • the compound of the present invention Since the compound of the present invention has an excellent control activity against harmful arthropods, it is useful as an active ingredient of a harmful arthropod control agent.
  • C1-C6 alkyl group includes, for example, methyl group, ethyl group, propyl group, isopropyl group, butyl group, isobutyl group, sec-butyl group and tert-butyl group.
  • the “C1-C6 alkyl group” includes a “C1-C4 alkyl group” and further a “C1-C3 alkyl group”.
  • examples of the “C1-C6 alkoxy group” include a methoxy group, an ethoxy group, a propoxy group, an isopropoxy group, a butoxy group, an isobutoxy group, a sec-butoxy group, and a tert-butoxy group.
  • the “C1-C6 alkoxy group” includes a “C1-C4 alkoxy group” and further a “C1-C3 alkoxy group”.
  • the “—S (O) p — (C1-C6 alkyl) group” is a group in which the “C1-C6 alkyl group” is bonded to the sulfur atom of S (O) p , for example, a methylsulfanyl group.
  • the “C1-C6 haloalkyl group” is a group in which one or more hydrogen atoms of the “C1-C6 alkyl group” are substituted with a halogen atom, such as a fluoromethyl group, a difluoromethyl group, a trifluoromethyl group.
  • the “C1-C6 haloalkoxy group” is a group in which one or more hydrogen atoms of the “C1-C6 alkoxy group” are substituted with a halogen atom, such as a fluoromethoxy group, a difluoromethoxy group, a trifluoro group.
  • Methoxy group chlorodifluoromethoxy group, 2,2,2-trifluoroethoxy group, pentafluoroethoxy group, heptafluoropropoxy group, heptafluoroisopropoxy group, 1,1,2,2,3,3-hexafluoropropoxy group And the groups 2,2,2-trifluoro-1- (trifluoromethyl) ethoxy and trichloromethoxy.
  • the “—S (O) p — (C1-C6 haloalkyl) group” is a group in which the “C1-C6 haloalkyl group” is bonded to the sulfur atom of S (O) p.
  • Methyl) sulfanyl group (trifluoromethane) sulfinyl group, (trifluoromethane) sulfonyl group, (pentafluoroethyl) sulfanyl group, (pentafluoroethane) sulfinyl group, (pentafluoroethane) sulfonyl group, (heptafluoroisopropyl) sulfanyl group , (Heptafluoroisopropane) sulfinyl group and (heptafluoroisopropane) sulfonyl group.
  • halogen atom represents a fluorine atom, a chlorine atom, a bromine atom and an iodine atom.
  • the compound of the present invention may contain one or more asymmetric carbon atoms or asymmetric centers in its structural formula, and there may be two or more optical isomers. All of the optical isomers and a mixture containing them in an arbitrary ratio are also contained.
  • the compound of the present invention may contain two or more geometric isomers derived from a carbon-carbon double bond, sulfur-nitrogen double bond, or cyclic structure in the structure. It also contains all geometric isomers and mixtures containing them in any proportion.
  • Examples of the compound of the present invention include the following compounds.
  • a compound wherein G 1 is —CR 6 R 7 —;
  • G 1 is —CR 6 R 7 —, and R 6 and R 7 are each independently a hydrogen atom, a C1-C6 alkyl group, or a C1-C6 haloalkyl group;
  • a compound wherein G 1 is —CH 2 —;
  • a compound wherein G 1 is —CH (CH 3 ) —;
  • a compound wherein G 2 is —CR 6 R 7 —;
  • G 2 is —CR 6 R 7 —, and R 6 and R 7 are each independently a hydrogen atom, a C1-C6 alkyl group, or a C1-C6 haloalkyl group;
  • a compound wherein G 2 is —CH 2 —;
  • a compound wherein G 2 is —CH (CH 3 ) —;
  • a compound in which G 2 is a single bond;
  • a compound wherein G 3 is —CR 6 R 7 —;
  • G 3 is —CR 6 R 7 —, and R 6 and R 7 are each independently a hydrogen atom, a C1-C6 alkyl group, or a C1-C6 haloalkyl group;
  • a compound wherein G 3 is —CH 2 —;
  • a compound wherein G 3 is —CH (CH 3 ) —;
  • a compound in which G 3 is a single bond;
  • a compound wherein G 4 is —CR 6 R 7 —;
  • G 4 is —CR 6 R 7 —, and R 6 and R 7 are each independently a hydrogen atom, a C1-C6 alkyl group, or a C1-C6 haloalkyl group;
  • a compound wherein G 4 is —CH 2 —;
  • a compound wherein G 4 is —CH (CH 3 ) —;
  • a compound in which G 4 is a single bond;
  • G 1 and G 5 each independently represent —CHR 6 —
  • G 2 , G 3 and G 4 each independently represent —CHR 6 — or a single bond, and at least one of G 2 , G 3 and G 4 is —CHR 6 —
  • G 1 , G 2 and G 5 are —CHR 6 —
  • G 3 and G 4 are each independently —CHR 6 — or a single bond
  • R 6 is independently a hydrogen atom or a C1-C6 alkyl group
  • a compound wherein G 5 is —CR 6 R 7 —;
  • G 5 is —CR 6 R 7 —, and R 6 and R 7 are each independently a hydrogen atom, a C1-C6 alkyl group, or a C1-C6 haloalkyl group;
  • a compound wherein G 5 is —CH 2 —;
  • a compound wherein G 5 is —CH (CH 3 ) —;
  • a compound in which Q is an oxygen atom;
  • Q is NR 8 and R 8 is a hydrogen atom, a C1-C6 alkyl group, a C1-C6 haloalkyl group or a cyano group;
  • Q is NR 8 and R 8 is a hydrogen atom, a C1-C6 alkyl group, or a cyano group;
  • a compound wherein Q is NH;
  • a compound wherein Q is NCN;
  • Q is NC (O) R 9 and R 9 is a C1-C6 alkyl group or a C1-C6 haloalkyl group;
  • a compound in which Q is NC (O) CH 3 or NC (O) CF 3 ;
  • a compound in which Q is unsubstituted
  • a compound wherein R 1 is a hydrogen atom; In the compounds of the present invention, a compound wherein R 1 is a C1-C6 alkyl group; In the compounds of the present invention, a compound wherein R 1 is a C1-C6 haloalkyl group; In the compound of the present invention, R 1 is a C1-C6 haloalkoxy group, —S— (C1-C6 haloalkyl) group, —S (O) — (C1-C6 haloalkyl) group, or —S (O) 2 — ( A compound which is a C1-C6 haloalkyl) group; In the compounds of the present invention, a compound wherein R 1 is a halogen atom; In the compounds of the present invention, a compound wherein R 1 is a methyl group, an ethyl group, a propyl group, or an isopropyl group; In the compounds of the present invention,
  • a compound wherein R 2 is a C1-C6 haloalkyl group; In the compounds of the present invention, a compound wherein R 2 is a C1-C6 haloalkoxy group; In the compounds of the present invention, a compound wherein R 2 is a trifluoromethyl group, a pentafluoroethyl group, a heptafluoropropyl group, or a heptafluoroisopropyl group; In the compound of the present invention, a compound wherein R 2 is a trifluoromethoxy group, a pentafluoroethoxy group, a heptafluoropropoxy group, or a heptafluoroisopropoxy group;
  • a compound wherein R 3 is a hydrogen atom; In the compounds of the present invention, a compound wherein R 3 is a C1-C6 alkyl group; In the compounds of the present invention, a compound wherein R 3 is a C1-C6 haloalkyl group; In the compounds of the present invention, a compound wherein R 3 is a C1-C6 haloalkoxy group; In the compounds of the present invention, a compound wherein R 3 is a —S— (C1-C6 haloalkyl) group; In the compounds of the present invention, a compound wherein R 3 is a —S (O) — (C1-C6 haloalkyl) group; In the compounds of the present invention, a compound wherein R 3 is a —S (O) 2 — (C1-C6 haloalkyl) group; In the compounds of the present invention, a compound wherein R 3 is a halogen atom;
  • either one of R 1 and R 3 is a halogen atom or a C1-C6 alkyl group, and the other is a C1-C6 alkyl group, a C1-C6 alkoxy group, —S (O) p —
  • R 1 or R 3 is a bromine atom, an iodine atom or a C1-C3 alkyl group, and the other is a C1-C3 alkyl group, a C1-C3 haloalkyl group, a C1-C3 haloalkoxy group.
  • X a is each independently a C1-C6 alkyl group or a C1-C6 haloalkyl group, and m is an integer of 0-4;
  • compounds wherein X a is each independently a C1-C6 alkoxy group or a C1-C6 haloalkoxy group, and m is an integer of 0-4;
  • X a is independently a halogen atom, and m is an integer of 0 to 4;
  • G 1 , G 2 and G 5 are —CR 6 R 7 —, G 3 and G 4 are each independently —CR 6 R 7 — or a single bond, Q is absent or is an oxygen atom, NR 8 , or NC (O) R 9 ;
  • R 6 and R 7 are each independently a hydrogen atom, a C1-C6 alkyl group or a C1-C6 haloalkyl group,
  • R 1 is a hydrogen atom, a C1-C6 alkyl group or a halogen atom
  • R 3 is a C1-C6 alkyl group, a C1-C6 haloalkyl group, a C1-C6 haloalkoxy group, or a —S (O) p — (C1-C6 haloalkyl) group
  • R 4 and R 5 are each independently a hydrogen atom, a C1-C6 alkyl group or a (C1-C6 alkyl) carbon
  • G 1 , G 2 and G 5 are —CHR 6 —, G 3 and G 4 are each independently —CHR 6 — or a single bond, Q is absent or is an oxygen atom, NR 8 , or NC (O) R 9 ;
  • Each R 6 is independently a hydrogen atom or a C1-C6 alkyl group;
  • R 1 is a hydrogen atom, a C1-C6 alkyl group or a halogen atom,
  • R 2 is a C1-C6 haloalkyl group or a C1-C6 haloalkoxy group,
  • R 3 is a C1-C6 alkyl group, a C1-C6 haloalkyl group, a C1-C6 haloalkoxy group, or a C1-C6 haloalkylsulfanyl group
  • R 4 and R 5 are each independently a hydrogen atom or a C1-C6 alkyl group
  • R 8 is
  • the compound of the present invention and the intermediate compound can be produced, for example, according to the following production methods 1 to 10.
  • Manufacturing method 1 The compound of the present invention can be produced according to the following method.
  • Compound (M2) can be produced by reacting compound (M1) with a compound represented by formula (R1) (hereinafter referred to as compound (R1)) in the presence of a base.
  • Compound (M1) can be produced according to the method described in International Publication No. 2005/073165.
  • Compound (R1) is a commercially available compound.
  • the reaction is usually performed in the presence of a solvent.
  • a solvent examples include aliphatic halogenated hydrocarbons such as dichloromethane and chloroform (hereinafter referred to as aliphatic halogenated hydrocarbons); nitriles such as acetonitrile (hereinafter referred to as nitriles).
  • Ethers such as tetrahydrofuran (hereinafter referred to as THF), ethylene glycol dimethyl ether, methyl tert-butyl ether (hereinafter referred to as MTBE), 1,4-dioxane (hereinafter referred to as ethers); acetone, ethyl Ketones such as methyl ketone and isobutyl methyl ketone (hereinafter referred to as ketones); esters such as methyl acetate and ethyl acetate (hereinafter referred to as esters); aromatic hydrocarbons such as toluene and xylene ( Hereinafter referred to as aromatic hydrocarbons); dimethylformamide (hereinafter referred to as DMF) Be), N- methylpyrrolidone, aprotic polar solvents such as dimethyl sulfoxide (hereinafter, referred to as aprotic polar solvent);.. And mixtures thereof.
  • THF tetrahydro
  • Examples of the base used in the reaction include organic bases such as triethylamine, diisopropylethylamine, pyridine, 1,8-diazabicyclo [5.4.0] undec-7-ene (hereinafter referred to as organic bases); Alkali metal carbonates such as sodium and potassium carbonate (hereinafter referred to as alkali metal carbonates); alkaline earth metal carbonates such as calcium carbonate (hereinafter referred to as alkaline earth metal carbonates); sodium hydrogen carbonate and the like Alkali metal hydrogen carbonates (hereinafter referred to as alkali metal hydrogen carbonates); alkali metal hydroxides such as sodium hydroxide and potassium hydroxide (hereinafter referred to as alkali metal hydroxides); Alkaline earth metal hydroxides such as calcium (hereinafter referred to as alkaline earth metal hydroxides); sodium metho Metal alkoxides such as Sid and sodium ethoxide (hereinafter, referred to as metal alkoxides.); Alkali
  • the reaction can be performed by adding a catalyst as necessary.
  • the catalyst used in the reaction include dimethylaminopyridine.
  • the ratio of the compound (R1) is usually 1 to 2 moles
  • the base is usually 1 to 2 moles
  • the catalyst is usually 0.01 to 0.5 moles Used in
  • the reaction temperature is usually in the range of ⁇ 30 to 150 ° C.
  • the reaction time is usually in the range of 0.1 to 12 hours.
  • compound (M2) can be obtained by performing post-treatment operations such as adding water to the reaction mixture, extracting with an organic solvent, and drying and concentrating the organic layer.
  • the compound of the present invention can be produced by reacting the compound (M2) with a compound represented by the formula (R2) (hereinafter referred to as compound (R2)).
  • the reaction is usually performed in the presence of a solvent.
  • a solvent examples include aliphatic halogenated hydrocarbons, nitriles, ethers, ketones, esters, aromatic hydrocarbons, aprotic polar solvents, alcohols such as methanol, ethanol, and isopropanol. (Hereinafter referred to as alcohols), water and mixtures thereof.
  • the reaction can be performed by adding a base as necessary.
  • the base used in the reaction include organic bases, alkali metal carbonates, alkaline earth metal carbonates, alkali metal hydrogen carbonates, alkali metal hydroxides, alkaline earth metal hydroxides, metal alkoxides. And alkali metal hydrides.
  • the compound (R2) is usually used in a proportion of 1 to 10 mol and the base is usually used in a proportion of 1 to 10 mol with respect to 1 mol of the compound (M2).
  • the reaction temperature is usually in the range of ⁇ 30 to 150 ° C.
  • the reaction time is usually in the range of 0.1 to 12 hours.
  • the compound of the present invention can be obtained by post-treatment operations such as extraction of the reaction mixture with an organic solvent, drying and concentration of the organic layer.
  • Manufacturing method 2 The compound of the present invention can also be produced according to the following method.
  • Compound (M3) can be produced by reacting compound (M2) in the presence of a base.
  • the reaction is usually performed in the presence of a solvent.
  • a solvent examples include water and a mixture of alcohols and water.
  • Examples of the base used in the reaction include alkali metal hydroxides and alkaline earth metal hydroxides.
  • the base is usually used at a ratio of 1 to 10 mol per 1 mol of the compound (M2).
  • the reaction temperature is usually in the range of 0 to 150 ° C.
  • the reaction time is usually in the range of 0.1 to 12 hours.
  • compound (M3) can be obtained by performing post-treatment operations such as adding water to the reaction mixture, extracting with an organic solvent, and drying and concentrating the organic layer.
  • the compound of the present invention can be produced by reacting the compound (M3) and the compound (R2) in the presence of a condensing agent.
  • the reaction is usually performed in the presence of a solvent.
  • a solvent examples include aliphatic halogenated hydrocarbons, nitriles, ethers, ketones, esters, aromatic hydrocarbons, aprotic polar solvents, nitrogen-containing aromatics such as pyridine and quinoline. Examples thereof include compounds (hereinafter referred to as nitrogen-containing aromatic compounds), water, and mixtures thereof.
  • the condensing agent examples include carbodiimides such as 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride and 1,3-dicyclohexylcarbodiimide (hereinafter referred to as carbodiimides), N, N′-carbonyldi- Imidazoles such as imidazole (hereinafter referred to as imidazoles), 4- (4,6-dimethoxy-1,3,5-triazin-2-yl) -4-methylmorphonium chloride n hydrate, trifluoro Triazines such as romethanesulfonic acid (4,6-dimethoxy-1,3,5-triazin-2-yl)-(2-octoxy-2-oxoethyl) dimethylammonium (hereinafter referred to as triazines), 1H— Benzotriazol-1-yloxytris (dimethylamino) phosphonium hexafluorophosphat
  • the reaction can be performed by adding a catalyst as necessary.
  • a catalyst include 1-hydroxybenzotriazole (hereinafter referred to as HOBt) and 1-hydroxyazabenzotriol (hereinafter referred to as HOAt).
  • the compound (R2) is usually 0.5 to 2 mol
  • the condensing agent is usually 1 to 5 mol
  • the catalyst is usually 0.01 to 1 mol. Used in proportions.
  • the reaction temperature is usually in the range of 0 to 120 ° C.
  • the reaction time is usually in the range of 0.1 to 24 hours.
  • the compound of the present invention can be obtained by post-treatment operations such as extraction of the reaction mixture with an organic solvent, drying and concentration of the organic layer.
  • Production method 3 The compound of the present invention can also be produced according to the following method.
  • Compound (M5) can be produced by reacting compound (R2) with compound (R1) in the presence of a base.
  • the reaction is usually performed in the presence of a solvent.
  • a solvent examples include aliphatic halogenated hydrocarbons, nitriles, ethers, ketones, esters, aromatic hydrocarbons, aprotic polar solvents, and mixtures thereof.
  • Examples of the base used in the reaction include organic bases, alkali metal carbonates, alkaline earth metal carbonates, alkali metal hydrogen carbonates, alkali metal hydroxides, alkaline earth metal hydroxides, metal alkoxides. And alkali metal hydrides.
  • the reaction can be performed by adding a catalyst as necessary.
  • the catalyst used in the reaction include dimethylaminopyridine.
  • compound (R1) is usually in a proportion of 1 to 2 mol
  • base is usually in a proportion of 1 to 2 mol
  • catalyst is usually in a proportion of 0.01 to 0.5 mol.
  • the reaction temperature is usually in the range of ⁇ 30 to 150 ° C.
  • the reaction time is usually in the range of 0.1 to 12 hours.
  • compound (M5) can be obtained by performing post-treatment operations such as adding water to the reaction mixture, extracting with an organic solvent, and drying and concentrating the organic layer.
  • compound (M6) a method for producing a compound represented by formula (M6) from compound (M5) (hereinafter referred to as compound (M6)) will be described.
  • Compound (M6) can be produced by reacting compound (M5) in the presence of a base.
  • the reaction is usually performed in the presence of a solvent.
  • a solvent examples include water and a mixture of alcohols and water.
  • Examples of the base used in the reaction include alkali metal hydroxides and alkaline earth metal hydroxides.
  • the base is usually used at a ratio of 1 to 10 mol per 1 mol of the compound (M5).
  • the reaction temperature is usually in the range of 0 to 150 ° C.
  • the reaction time is usually in the range of 0.1 to 12 hours.
  • the compound (M6) can be obtained by performing post-treatment operations such as extraction of the reaction mixture with an organic solvent and drying and concentration of the organic layer.
  • the compound of the present invention can be produced by reacting the compound (M6) and the compound (M1) in the presence of a condensing agent.
  • the reaction is usually performed in the presence of a solvent.
  • a solvent examples include aliphatic halogenated hydrocarbons, nitriles, ethers, ketones, esters, aromatic hydrocarbons, aprotic polar solvents, nitrogen-containing aromatics such as pyridine and quinoline. Examples thereof include compounds (hereinafter referred to as nitrogen-containing aromatic compounds), water, and mixtures thereof.
  • condensing agent examples include carbodiimides, imidazoles, triazines, phosphoniums, and uroniums.
  • the reaction can be performed by adding a catalyst as necessary.
  • a catalyst examples include HOBt and HOAt.
  • the compound (M1) is usually 0.5 to 2 mol
  • the condensing agent is usually 1 to 5 mol
  • the catalyst is usually 0.01 to 1 mol. Used in proportions.
  • the reaction temperature is usually in the range of 0 to 120 ° C.
  • the reaction time is usually in the range of 0.1 to 24 hours.
  • the compound of the present invention can be obtained by post-treatment operations such as adding water to the reaction mixture, extracting with an organic solvent, and drying and concentrating the organic layer.
  • Manufacturing method 4 The compound of the present invention can also be produced according to the following method.
  • the compound of the present invention can be produced by reacting compound (M1) with compound (M7) in the presence of a base.
  • the reaction is usually performed in the presence of a solvent.
  • a solvent examples include aliphatic halogenated hydrocarbons, nitriles, ethers, ketones, esters, aromatic hydrocarbons, aprotic polar solvents, and mixtures thereof.
  • Examples of the base used in the reaction include organic bases, alkali metal carbonates, alkaline earth metal carbonates, alkali metal hydrogen carbonates, alkali metal hydroxides, alkaline earth metal hydroxides, metal alkoxides. And alkali metal hydrides.
  • the reaction can be performed by adding a catalyst as necessary.
  • the catalyst used in the reaction include dimethylaminopyridine.
  • compound (M7) is usually in a proportion of 0.5 to 2 mol
  • base is usually in a proportion of 1 to 2 mol
  • catalyst is usually in a proportion of 0.01 to 0.5 mol. It is used in the ratio.
  • the reaction temperature is usually in the range of ⁇ 30 to 150 ° C.
  • the reaction time is usually in the range of 0.1 to 12 hours.
  • the compound of the present invention can be obtained by post-treatment operations such as adding water to the reaction mixture, extracting with an organic solvent, and drying and concentrating the organic layer.
  • Compound (M7) can be produced by reacting compound (M6) with a chlorinating agent.
  • the reaction is performed in the presence or absence of a solvent.
  • a solvent used in the reaction include aliphatic halogenated hydrocarbons, nitriles, ethers, ketones, esters, aromatic hydrocarbons, aprotic polar solvents, and mixtures thereof.
  • chlorinating agent used in the reaction examples include thionyl chloride, oxalyl chloride, phosphoryl chloride, sulfuryl chloride, phosphorus trichloride, and phosphorus pentachloride.
  • the chlorinating agent is usually used at a ratio of 1 to 100 mol per 1 mol of the compound (M6).
  • the reaction temperature is usually in the range of ⁇ 30 to 150 ° C.
  • the reaction time is usually in the range of 0.1 to 12 hours.
  • the compound (M7) can be obtained by post-treatment such as adding water to the reaction mixture and concentrating.
  • a compound represented by formula (1b) (hereinafter referred to as compound (1b)) and a compound represented by formula (1c) (hereinafter referred to as compound (1c)) can be produced by the following scheme. .
  • Compound (1b) can be produced by reacting compound (1a) with an oxidizing agent.
  • the reaction is usually performed in the presence of a solvent.
  • a solvent examples include aliphatic halogenated hydrocarbons, nitriles, alcohols, acetic acid, water, and mixtures thereof.
  • oxidizing agent used in the reaction examples include sodium periodate, m-chloroperbenzoic acid (hereinafter referred to as mCPBA), and hydrogen peroxide.
  • a base or a catalyst may be added as necessary.
  • sodium carbonate As the base used in the reaction, sodium carbonate can be mentioned.
  • Examples of the catalyst used in the reaction include tungstic acid and sodium tungstate.
  • the oxidizing agent is usually in a proportion of 1 to 1.2 mol
  • the base is usually in a proportion of 0.01 to 1 mol
  • the catalyst is usually in a proportion of 0.01 to 0.5 mol. It is used in the ratio.
  • the reaction temperature is usually in the range of ⁇ 20 to 80 ° C.
  • the reaction time is usually in the range of 0.1 to 12 hours.
  • Compound (1c) can be produced by reacting compound (1b) with an oxidizing agent.
  • the reaction is usually performed in the presence of a solvent.
  • a solvent examples include aliphatic halogenated hydrocarbons, nitriles, alcohols, acetic acid, water, and mixtures thereof.
  • oxidizing agent used in the reaction examples include mCPBA and hydrogen peroxide.
  • hydrogen peroxide a base or a catalyst may be added as necessary.
  • sodium carbonate As the base used in the reaction, sodium carbonate can be mentioned.
  • Examples of the catalyst used in the reaction include sodium tungstate.
  • the oxidizing agent is usually in a proportion of 1 to 4 mol
  • the base is usually in a proportion of 0.01 to 1 mol
  • the catalyst is usually in a proportion of 0.01 to 0.5 mol.
  • the reaction temperature is usually in the range of ⁇ 20 to 120 ° C.
  • the reaction time is usually in the range of 0.1 to 12 hours.
  • the compound (1c) can be produced in a one-step reaction (one pot) by reacting the compound (1a) with an oxidizing agent.
  • the reaction is usually performed in the presence of a solvent.
  • a solvent examples include aliphatic halogenated hydrocarbons, nitriles, alcohols, acetic acid, water, and mixtures thereof.
  • oxidizing agent used in the reaction examples include mCPBA and hydrogen peroxide.
  • a base or a catalyst may be added as necessary.
  • sodium carbonate As the base used in the reaction, sodium carbonate can be mentioned.
  • Examples of the catalyst used for the reaction include tungstic acid and sodium tungstate.
  • the oxidizing agent is usually in a proportion of 2 to 5 mol
  • the base is usually in a proportion of 0.01 to 1 mol
  • the catalyst is usually in a proportion of 0.01 to 0.5 mol.
  • the reaction temperature is usually in the range of 0 to 120 ° C.
  • the reaction time is usually in the range of 0.1 to 12 hours.
  • a compound represented by formula (1e) (hereinafter referred to as compound (1e)) is produced by reacting a compound represented by formula (1d) (hereinafter referred to as compound (1d)) with an oxidizing agent. can do.
  • the reaction is usually performed in the presence of a solvent.
  • the solvent used in the reaction include aliphatic halogenated hydrocarbons, nitriles, alcohols, acetic acid, water, and mixtures thereof.
  • Examples of the oxidizing agent used in the reaction include sodium periodate, mCPBA, and hydrogen peroxide.
  • a base or a catalyst may be added as necessary.
  • sodium carbonate As the base used in the reaction, sodium carbonate can be mentioned.
  • Examples of the catalyst used for the reaction include tungstic acid and sodium tungstate.
  • the oxidizing agent is usually in a proportion of 1 to 1.2 mol
  • the base is usually in a proportion of 0.01 to 1 mol
  • the catalyst is usually in a proportion of 0.01 to 0.5 mol. It is used in the ratio.
  • the reaction temperature is usually in the range of ⁇ 20 to 80 ° C.
  • the reaction time is usually in the range of 0.1 to 12 hours.
  • the compound represented by the formula (1f) (hereinafter referred to as the compound (1f)) can be produced by the following scheme.
  • the compound represented by the formula (1g) (hereinafter referred to as the compound (1g)) can be produced by the following scheme.
  • R 1a and E each independently represent a chlorine atom, a bromine atom or an iodine atom
  • R 2a represents a C1-C6 perfluoroalkyl group
  • R 4a and R 5a each independently represent C1 —C6 alkyl group or C1-C6 haloalkyl group, and other symbols have the same meanings as described above.
  • the compound represented by the formula (M8) (hereinafter referred to as the compound (M8)) is described in Journal of the American Chemical Society, 1931, vol. 53, p. It can be produced according to the method described in 3143-3146.
  • a compound represented by formula (M9) (hereinafter referred to as compound (M9)) can be produced by reacting compound (M8) with a compound represented by formula (R3) in the presence of a base. It can.
  • the reaction can be carried out according to the method described in, for example, International Publication No. 2003/024961.
  • the compound represented by the formula (M10) (hereinafter referred to as the compound (M10)) can be produced using the compound (M9) according to the method described in International Publication No. 2005/073165.
  • a compound represented by the formula (M11) (hereinafter referred to as compound (M11)) can be produced according to the method described in International Publication No. 2003/024961.
  • the compound represented by the formula (M12) (hereinafter referred to as the compound (M12)) is prepared according to the method for producing the compound (M2) from the compound (M1) described in the production method 1 using the compound (M11). Can be manufactured.
  • compound (M14) The compound represented by formula (M14) (hereinafter referred to as compound (M14)) can be produced according to the method described in production method 2 using compound (M12).
  • Compound (1g) can be produced by reacting compound (M14) with a compound represented by formula (R5) (hereinafter referred to as compound (R5)) in the presence of an additive.
  • the reaction is usually performed in the presence of a solvent.
  • a solvent examples include aprotic polar solvents.
  • Examples of the additive used in the reaction include copper powder activated by the method described in Journal of Fluorine Chemistry, 102 (2000) 293-300.
  • the compound (R5) is usually used at a ratio of 1 to 10 moles, and the additive is usually used at a ratio of 1 to 10 moles.
  • the reaction temperature is usually in the range of 0 to 150 ° C.
  • the reaction time is usually in the range of 0.1 to 48 hours.
  • the additive is removed by filtration, water is added to the reaction mixture, extraction is performed with an organic solvent, and post-treatment operations such as drying and concentration of the organic layer are performed to obtain the compound (1 g). be able to.
  • Manufacturing method 10 Compound (1g) can be produced according to the following scheme.
  • the compound represented by the formula (M15) (hereinafter referred to as the compound (M15)) is obtained from the compound (M3) described in the production method 2 using the compound (M6) and the compound represented by the formula (R6). It can be produced according to the method for producing the inventive compound.
  • compound (M16) The compound represented by formula (M16) (hereinafter referred to as compound (M16)) was prepared according to the method for producing compound (M3) from compound (M2) described in production method 2 using compound (M15). Can be manufactured.
  • the compound represented by the formula (M17) (hereinafter referred to as the compound (M17)) is obtained from the compound (M3) described in the production method 2 using the compound (M16) and the compound represented by the formula (R7). It can be produced according to the method for producing the inventive compound.
  • the compound represented by the formula (R6) and the compound represented by the formula (R7) are commercially available compounds or can be produced according to known methods.
  • Compound (M18) can be produced by reacting compound (M17) and compound (R5) in the presence of an additive.
  • the reaction is usually performed in the presence of a solvent.
  • a solvent examples include aliphatic halogenated hydrocarbons, nitriles, ethers, ketones, esters, aromatic hydrocarbons, aprotic polar solvents, and mixtures thereof.
  • Examples of the additive used in the reaction include dithionite such as sodium dithionite or zinc-sulfite water.
  • Examples of the base used in the reaction include organic bases, alkali metal carbonates, and alkali metal hydroxides.
  • phase transfer catalyst In the reaction, a phase transfer catalyst can be used as necessary.
  • the phase transfer catalyst used in the reaction include quaternary ammonium salts such as tetrabutylammonium hydrogen sulfate, organic phosphorus salts such as tetrabutylphosphonium bromide, and alkyl polyether alkylamine compounds such as tris (methoxyethoxyethyl) amine. Is mentioned.
  • compound (M17) is usually in a proportion of 1 to 10 mol
  • additive is usually in a proportion of 0.1 to 2 mol
  • base is usually in a proportion of 1 to 10 mol
  • a phase transfer catalyst is usually used at a ratio of 0.01 to 2 mol.
  • the reaction temperature is usually in the range of 0 to 150 ° C.
  • the reaction time is usually in the range of 0.1 to 48 hours.
  • the compound (M18) can be obtained by performing post-treatment operations such as adding water to the reaction mixture, extracting with an organic solvent, and drying and concentrating the organic layer.
  • Compound (1g) can be produced by reacting compound (M18) with a halogenating agent.
  • the reaction is usually performed in the presence of a solvent.
  • a solvent examples include aliphatic halogenated hydrocarbons, nitriles, ethers, ketones, esters, aromatic hydrocarbons, aprotic polar solvents, and mixtures thereof.
  • halogenating agent used in the reaction examples include N-chlorosuccinimide (hereinafter referred to as NCS), chlorine, N-bromosuccinimide (hereinafter referred to as NBS), bromine, and N-iodosuccinic acid.
  • NCS N-chlorosuccinimide
  • NBS N-bromosuccinimide
  • bromine N-iodosuccinic acid
  • examples include imide (hereinafter referred to as NIS), iodine and the like.
  • the halogenating agent is usually used at a ratio of 1 to 10 mol per 1 mol of the compound (M18).
  • the reaction temperature is usually in the range of 0 to 100 ° C.
  • the reaction time is usually in the range of 0.1 to 12 hours.
  • the compound (1 g) can be obtained by adding water to the reaction mixture, extracting with an organic solvent, and drying and concentrating the organic layer.
  • Compound (R9) can be produced according to the method described in production method 8 using the compound represented by formula (R8) (hereinafter referred to as compound (R8)).
  • Compound (R10) can be produced according to the method described in Production Method 7 using Compound (R9).
  • Compound (R11) and Compound (R12) can be produced according to the method described in Production Method 6 using Compound (R8).
  • Compound (R8) is a commercially available compound or can be produced according to a known method.
  • R 1 , R 2 , R 3 , R 4 , R 5 , R 6a , R 7a , R 6b , R 7b , R 6c , R 7c , R 6d , R 7d , Q and k are [Table 1] to The compound of the present invention which is a combination described in [Table 10].
  • R 6c , R 7c , R 6d and R 7d are hydrogen atoms
  • R 1 , R 2 , R 3 , R 4 , R 5 , R 6a , R 7a , R 6b , R 7b , Q and k are The compounds of the present invention which are combinations described in [Table 11] to [Table 18].
  • harmful arthropods for which the compounds of the present invention are effective include harmful insects and harmful mites. Specific examples of such harmful arthropods include the following.
  • Hemiptera pests Japanese brown planthoppers (Laodelphax striatellus), brown planthoppers (Nilaparvata lugens), white planthoppers (Sogatella furcifera), corn planters (Peregrinus maidis), etc.
  • Stinkbugs (Leptocorisa chinensis), Helicoptera helicopters (Leptocorisa acuta), Leptocorisa genus, etc. , Chinchi Bugs (Blissus leucopterus leucopterus) and other turtles, whitefly (Trialeurodes vaporariorum), tobacco whitefly (Bemisia tabaci), citrus whitefly (Dialeurodes citri), citrus whitefly (Aleurocanthus spiniferus San Jose scale insect (Comstockaspis perniciosa), citrus snow scale (Unaspis citri), ruby rot beetle (Ceroplastes rubens), Icerya scale insect (Icerya purchasi), Fujicona scale insect (Planococcus kraunhiae), staghorn beetle (Pseuocis) Pseudaulacaspis pentagona), scale insects such as Brevennia ⁇
  • Lepidoptera Chilo suppressalis, Darkheaded stm borer (Chilo polychrysus), Sunpikeza (Tryporyza incertulas), Netloi (Chilo polychrysus), White-meicho (Scirpophaga innotata), Yellow stem borer (Scirpophaga incertulas) Sesamia inferens, Rupela albinella, Cnaphalocrocis medinalis, Marasmia patnalis, Marasmia exigna, Notarcha derogata, Plodia interpunctella, Odalian Hula isla teterrellus), rice case worm (Nymphula depunctalis), Marasmia spp., Hop vine borer (Hydraecia immanis), European corn borer (Ostrinia nubilalis), Lesser cornstalk borer (Elasmopalpus lignosellus), Bean Shoot Borane (
  • Goats such as Velvetbean caterpillar (Anticarsia gammatalis) and Cotton leafworm (Alabama argillacea), white butterflies such as Pieris rapae, genus Adoxofies, Grapholita molesta, Leguminivora glycinivorella , Azukisayamushiga (Matsumuraeses azukivora), apple Coca summer fruit tortrix (Adoxophyes orana fasciata), smaller tea tortrix (Adoxophyes honmai.
  • Citrus thrips (Frankliniella occidentalis), Thrips peri, Scirtothrips dorsalis, Thrips tabaci Thrips such as Kapida thrips (Haplothrips aculeatus), Rice thrips (Stenchaetothrips biformis).
  • Diptera Culex pipiens pallens, Culex tritaeniorhynchus, Culex quinquefasciatus and other mosquitoes, Aedes ophegos Genus Anopheles, Chironomid, Musca domestica, Muscina stabulans, etc.
  • Agromyza oryzae rice leaflet (Hydrellia griseola), tomato leaffly (Liriomyza sativae), beetle leaflet (Liriomyza trifolii), leafhopper (Chromatomyia horticola) and other leafhoppers (Chromatomyia horticola), ryzae and other fruit fly, Dacus cucurbitae, fruit fly such as Ceratitis capitata, Hydrellia philippina, and Fleas such as fleas (Megaselia spiracularis), butterflies such as Clogmia albipunctata, and black fly flies.
  • Crane fly such as Hessian fly (Mayetiola destructor), Oreseolia oryzae, Crane fly such as Diopsis macrophthalma, Common cranefly (Tipula oleracea), European gantry such as Europeanopecranefly (Tipula paludosa).
  • Coleoptera Western corn root worm (Diabrotica virgifera virgifera), Southern corn root worm (Diabrotica undecimpunctata howardi), Northern corn root worm (Diabrotica virgifera zeae), Banded cucumber beetle (Diabrotica virgifera zeae) , San Antonio beetle (Diabrotica speciosa), Cucurbit Beetle (Diabrotica speciosa), bean leaf beetle (Cerotoma trifurcata), cereal leaf beetle (Oulema melanopus), cucumber horn beetle (Aulacophora) femoralis), pheasant potato beetle (Phylolsa ⁇ decor) , Rice beetle (Oulema oryzae), grape colaspis (Colaspis brunnea), corn flare beetle (Chaetocnema pulicaria), potato flare beetle (Epitrix
  • Insect pests Tosama locust (Locusta migratoria), Kera (Gryllotalpa africana),ixie flying grasshopper (Dociostaurus maroccanus), Australian flying grasshopper (Chortoicetes terminifera), Red-spotted grasshopper (Nomadacris septemfa ciaustal Locna, Loc) melanorhodon), Italian Locust (Calliptamus italicus), Differential grasshopper (Melanoplus differentialis), Twostriped grasshopper (Melanoplus bivittatus), Migratory grasshopper (Melanoplus sanguinipes), Red-Legged grasshopper (Melanoplus sanguinipes), Red-Legged grasshopper (Melanoplus sanguinipes) (Schistocerca gregaria), Yellow-winged locust (Gastrimargus musicus), Spur-throated locust (Austracris guttulosa), Coxenago (Oxya yezo
  • Hymenopteran pests bees such as Athalia rosae and Japanese bee (Athalia japonica). Fire Ants. Hachiriari such as Brown leaf-cutting ant (Atta capiguara).
  • Cockroach eye insects German cockroach (Blattella germanica), Black cockroach (Periplaneta fliginosa), American cockroach (Periplaneta americana), Great cockroach (Periplaneta brunnea), Great cockroach (Blatta orientalis).
  • Termite insect pests Yamato termite (Reticulitermes speratus), termite (Coptotermes formosanus), American ant termite (Incisitermes minor), daiko termite (Cryptotermes domesticus), ant-white termite (Odontotermes formosaterm), ants Glyptotermes satsumensis), long term termite (Glyptotermes miyatakei), white termite (Reticulitermes flaviceps amamianus), common termite (Reticulitermes sp.), white termite (Nasutitermes takasagoensis), nitobeshi Lori (Pericapritermes nitobei), Mushy termite (Sinocapritermes mushae), Cornitermes cumulans, etc.
  • Yamato termite Reticulitermes speratus
  • termite Coptotermes formosanus
  • American ant termite Inc
  • Nite spider mite (Tetranychus urticae), Kanzawa spider mite (Tetranychus kanzawai), Scarlet spider mite (Panonychus citri), Apple spider mite (Panonychus ulmi), Oligonicus spp.
  • the harmful arthropod control agent of the present invention contains the compound of the present invention and an inert carrier.
  • the harmful arthropod control agent of the present invention is usually a mixture of the compound of the present invention and an inert carrier such as a solid carrier, a liquid carrier, a gaseous carrier, etc., and if necessary, a surfactant and other adjuvants for formulation.
  • the harmful arthropod control agent of the present invention can be mixed with other insecticides, acaricides, nematicides, fungicides, plant growth regulators, herbicides and synergists.
  • the harmful arthropod control agent of the present invention usually contains 0.01 to 95% by weight of the compound of the present invention.
  • solid carriers used for formulation include clays (kaolin clay, diatomaceous earth, bentonite, fusami clay, acidic clay), synthetic hydrous silicon oxide, talc, ceramics, and other inorganic minerals (sericite, quartz, sulfur).
  • Polyester resins such as polyethylene terephthalate, nylon resins such as nylon-6, nylon-11, and nylon-66, polyamide resins, polyvinyl chloride, polyvinylidene chloride, and vinyl chloride-propylene copolymers).
  • liquid carrier examples include water, alcohols (methanol, ethanol, isopropyl alcohol, butanol, hexanol, benzyl alcohol, ethylene glycol, propylene glycol, phenoxyethanol, etc.), ketones (acetone, methyl ethyl ketone, cyclohexanone, etc.), aromatic hydrocarbons (Toluene, xylene, ethylbenzene, dodecylbenzene, phenylxylylethane, methylnaphthalene, etc.), aliphatic hydrocarbons (hexane, cyclohexane, kerosene, light oil, etc.), esters (ethyl acetate, butyl acetate, isopropyl myristate, Ethyl oleate, diisopropyl adipate, diisobutyl adipate, propylene glycol monomethyl ether acetate, etc.), n
  • Acid amides (DMF, N, N-dimethylacetamide, etc.), halogenated hydrocarbons (dichloromethane, trichloroethane, carbon tetrachloride, etc.), sulfoxides (dimethylsulfoxide, etc.), propylene carbonate and vegetable oils (soybean oil, cottonseed oil) Etc.).
  • gaseous carrier examples include fluorocarbon, butane gas, LPG (liquefied petroleum gas), dimethyl ether, and carbon dioxide gas.
  • surfactant examples include nonionic surfactants such as polyoxyethylene alkyl ether, polyoxyethylene alkyl aryl ether, and polyethylene glycol fatty acid ester, and anions such as alkyl sulfonate, alkyl benzene sulfonate, and alkyl sulfate. Surfactant is mentioned.
  • adjuvants for preparation include fixing agents, dispersants, colorants and stabilizers, such as casein, gelatin, saccharides (starch, gum arabic, cellulose derivatives, alginic acid, etc.), lignin derivatives, bentonite, Synthetic water-soluble polymers (polyvinyl alcohol, polyvinylpyrrolidone, polyacrylic acids, etc.), PAP (isopropyl acid phosphate), BHT (2,6-di-tert-butyl-4-methylphenol), BHA (2-tert- And a mixture of butyl-4-methoxyphenol and 3-tert-butyl-4-methoxyphenol).
  • fixing agents such as casein, gelatin, saccharides (starch, gum arabic, cellulose derivatives, alginic acid, etc.), lignin derivatives, bentonite, Synthetic water-soluble polymers (polyvinyl alcohol, polyvinylpyrrolidone, polyacrylic acids, etc.), PAP (is
  • the base material of the resin preparation examples include vinyl chloride polymers, polyurethanes, etc., and these base materials include phthalic acid esters (dimethyl phthalate, dioctyl phthalate, etc.) and adipic acid esters as necessary. Further, a plasticizer such as stearic acid may be added.
  • the resin formulation is obtained by kneading the compound in the base material using a normal kneading apparatus, and then molding by injection molding, extrusion molding, press molding, etc., and if necessary, through steps such as molding, cutting, It can be processed into resin preparations such as plate, film, tape, net, and string. These resin preparations are processed, for example, as animal collars, animal ear tags, sheet preparations, attracting strings, or gardening supports.
  • Examples of the bait base include cereal flour, vegetable oil, sugar, crystalline cellulose and the like, and if necessary, antioxidants such as dibutylhydroxytoluene and nordihydroguaiaretic acid, and preservatives such as dehydroacetic acid. Additives for preventing accidental eating by children and pets such as pepper powder, pests such as cheese flavor, onion flavor and peanut oil are added.
  • an effective amount of the compound of the present invention is applied directly to harmful arthropods and / or to the place where the harmful arthropods live (plants, soil, households, animal bodies, etc.). Is done.
  • the harmful arthropod control method of the present invention is usually used in the form of the harmful arthropod control agent of the present invention.
  • the application amount is usually 1 to 10,000 g in the amount of the compound of the present invention per 10,000 m 2 .
  • the harmful arthropod control agent of the present invention is formulated into an emulsion, a wettable powder, a flowable agent, etc., it is usually applied by diluting with water so that the active ingredient concentration becomes 0.01 to 10,000 ppm. Granules, powders and the like are usually applied as they are.
  • These preparations and water dilutions of these preparations may be sprayed directly on harmful arthropods or plants such as crops to be protected from harmful arthropods, and harmful arthropods that inhabit the soil of cultivated land. You may treat to this soil in order to control.
  • it can be treated by methods such as wrapping a resin preparation processed into a sheet or string around the crop, stretching it around the crop, or laying it on the stock soil.
  • the amount applied is usually the amount of the compound of the present invention per 1 m 2 when treated on the surface. 0.01 to 1000 mg, and when processing in a space, the amount of the compound of the present invention per 1 m 3 of the processing space is usually 0.01 to 500 mg.
  • the harmful arthropod control agent of the present invention is formulated into an emulsion, a wettable powder, a flowable agent, etc., it is usually diluted with water so that the active ingredient concentration is 0.1 to 10,000 ppm. Apply oils, aerosols, smoke, poison baits, etc. as they are.
  • the harmful arthropod control agent of the present invention When used to control ectoparasites of cattle, horses, pigs, sheep, goats, chickens, small animals such as dogs, cats, rats, mice, etc., it is well known in veterinary medicine. Can be used on animals.
  • systemic suppression for example, administration by tablet, feed mixing, suppository, injection (intramuscular, subcutaneous, intravenous, intraperitoneal, etc.) is intended for non-systemic suppression.
  • an oil agent or an aqueous liquid is sprayed, a pour-on treatment or a spot-on treatment is performed, the animal is washed with a shampoo preparation, or a resin preparation is attached to the animal with a collar or ear tag.
  • the amount of the compound of the present invention when administered to an animal body is usually in the range of 0.1 to 1000 mg per 1 kg body weight of the animal.
  • Reference production example 4 1.37 mL of oxalyl chloride was added dropwise to a mixture of 2.74 g of 4-fluoro-3-nitrobenzoic acid, 0.1 mL of DMF and 30 mL of THF, and the mixture was stirred for 1 hour under reflux. The reaction mixture allowed to cool to room temperature was concentrated to give 4-fluoro-3-nitrobenzoyl chloride.
  • Reference production example 11 2.39 g of N-bromosuccinimide was added to a mixture of 3.0 g of 4- (trifluoromethoxy) -2- (trifluoromethyl) aniline, 25 mL of ethyl acetate and 5 mL of DMF, and the mixture was stirred at room temperature for 2.5 hours. To this reaction mixture was added 20% aqueous sodium thiosulfate solution, and the mixture was extracted with ethyl acetate. The organic layer was washed successively with water and saturated brine. The organic layer was dried over anhydrous magnesium sulfate and concentrated under reduced pressure. The obtained residue was subjected to silica gel column chromatography to give 2-bromo-4- (trifluoromethoxy) -6- (trifluoromethyl) aniline 3 0.2 g was obtained.
  • R 1 , R 3 and X a are represented by [Table 28].
  • R 1 , R 3 and X a are represented by [Table 29].
  • R 1 , R 3 and X a are represented by [Table 30] and [Table 31].
  • R 1 , R 3 and X a are represented by [Table 32] and [Table 33].
  • N-bromosuccinimide (59 mg) was added to a mixture of the compound of the present invention 1-1 (0.15 g), cyanamide (12 mg), tert-butoxypotassium (29 mg) and methanol (7 mL), and the mixture was stirred at room temperature for 5 hours.
  • a saturated aqueous sodium thiosulfate solution was added to the reaction mixture, extracted with ethyl acetate, and dried over anhydrous magnesium sulfate.
  • the obtained residue was subjected to silica gel column chromatography to obtain 0.13 g of the present compound 1-10 shown below.
  • Compound 1-10 of the present invention 60 mg was added to a mixture of the compound of the present invention 1-1 (0.15 g), cyanamide (12 mg), tert-butoxypotassium (29 mg) and methanol (7 mL), and the mixture was stirred at room temperature for 5 hours.
  • a saturated aqueous sodium thiosulfate solution was added to the reaction mixture, extracted
  • Production Example 8 The present compound 1-19 shown below was obtained according to the method described in Production Example 7 using the present compound 1-2 instead of the present compound 1-1.
  • T in the formula represents a substituent described in [Table 34] to [Table 36] below.
  • R 1 , R 3 , X 1 and n in the formula represent the combinations described in the following [Table 37] to [Table 40].
  • R 4 , R 5 and n in the formula represent the combinations described in [Table 41] below.
  • X a in the formula represents a combination described in [Table 42].
  • Formulation Example 1 10 parts of any one of compounds 1-1 to 1-20, 2-1 to 2-31, 3-1 to 3-7, 4-1 to 4-4, 5-1, and 6-1 of the present invention In a mixture of 35 parts of xylene and 35 parts of DMF, 14 parts of polyoxyethylene styryl phenyl ether and 6 parts of calcium dodecylbenzenesulfonate are added and mixed to obtain each preparation.
  • Formulation Example 2 4 parts of sodium lauryl sulfate, 2 parts of calcium lignin sulfonate, 20 parts of a synthetic silicon hydroxide fine powder and 54 parts of diatomaceous earth are mixed, and the compounds of the present invention 1-1 to 1-20, 2-1 to 2-31, 3 20 parts of any one of -1 to 3-7, 4-1 to 4-4, 5-1, and 6-1 are added and mixed to obtain each wettable powder.
  • Formulation Example 3 Compounds of the present invention 1-1 to 1-20, 2-1 to 2-31, 3-1 to 3-7, 4-1 to 4-4, 5-1, and 6-1 Then, 1 part of synthetic silicon hydrous fine powder, 2 parts of calcium lignin sulfonate, 30 parts of bentonite and 65 parts of kaolin clay are added and mixed. Next, an appropriate amount of water is added to the mixture, and the mixture is further stirred, granulated by a granulator, and dried by ventilation to obtain each granule.
  • Formulation Example 4 One part of any one of the compounds of the present invention 1-1 to 1-20, 2-1 to 2-31, 3-1 to 3-7, 4-1 to 4-4, 5-1, and 6-1 Dissolve in an appropriate amount of acetone, add 5 parts of synthetic hydrous hydroxide fine powder, 0.3 part of isopropyl acid phosphate and 93.7 parts of fusami clay, stir and mix thoroughly, and evaporate and remove acetone to remove each powder. Get.
  • Formulation Example 5 35 parts of a mixture of polyoxyethylene alkyl ether sulfate ammonium salt and white carbon (weight ratio 1: 1), and the compounds of the present invention 1-1 to 1-20, 2-1 to 2-31, 3-1 to 3-7 Each flowable agent is obtained by mixing 10 parts of any one of 4-1 to 4-4, 5-1, and 6-1 and 55 parts of water and finely pulverizing them by a wet pulverization method.
  • Formulation Example 7 10 mg of any one of the compounds of the present invention 1-1 to 1-20, 2-1 to 2-31, 3-1 to 3-7, 4-1 to 4-4, 5-1, and 6-1 in acetone Dissolve in 0.5 mL and drop this solution into 5 g of animal solid feed powder (solid feed powder CE-2 for breeding, product of Nippon Claire Co., Ltd.) and mix uniformly. Then acetone is evaporated to dryness to obtain each poisonous bait.
  • animal solid feed powder solid feed powder CE-2 for breeding, product of Nippon Claire Co., Ltd.
  • Formulation Example 8 Compounds of the present invention 1-1 to 1-20, 2-1 to 2-31, 3-1 to 3-7, 4-1 to 4-4, 5-1, and 6-1 0.1 Part, neothiozole (manufactured by Chuo Kasei Co., Ltd.) 49.9 parts in an aerosol can, and after mounting an aerosol valve, 25 parts of dimethyl ether and 25 parts of LPG are added, shaken, and an actuator aerosol is attached by attaching an actuator. obtain.
  • neothiozole manufactured by Chuo Kasei Co., Ltd.
  • Formulation Example 9 Compounds of the present invention 1-1 to 1-20, 2-1 to 2-31, 3-1 to 3-7, 4-1 to 4-4, 5-1, and 6-1 0.6 Parts, BHT (2,6-di-tert-butyl-4-methylphenol) 0.01 part, xylene 5 parts, kerosene 3.39 parts and emulsifier ⁇ Rheodor MO-60 (manufactured by Kao Corporation) ⁇ 1 part After the mixture and 50 parts of distilled water are filled in an aerosol container and a valve is mounted, 40 parts of propellant (LPG) is pressurized and filled through the valve to obtain an aqueous aerosol.
  • LPG propellant
  • Formulation Example 10 Compounds of the present invention 1-1 to 1-20, 2-1 to 2-31, 3-1 to 3-7, 4-1 to 4-4, 5-1, and 6-1 0.1 g Is mixed with 2 mL of propylene glycol and impregnated into a porous ceramic plate of 4.0 ⁇ 4.0 cm and a thickness of 1.2 cm to obtain a heating smoke.
  • Formulation Example 11 Compounds of the present invention 1-1 to 1-20, 2-1 to 2-31, 3-1 to 3-7, 4-1 to 4-4, 5-1, and 6-1 5 parts Melt 95 parts of ethylene-methyl methacrylate copolymer (ratio of methyl methacrylate in the copolymer: 10% by weight, ACLIFT (registered trademark) WD301, manufactured by Sumitomo Chemical Co., Ltd.) with a closed pressure kneader (Moriyama Seisakusho) The resulting kneaded product is extruded from an extruder through a molding die to obtain a rod-shaped molded body having a length of 15 cm and a diameter of 3 mm.
  • ACLIFT registered trademark
  • WD301 manufactured by Sumitomo Chemical Co., Ltd.
  • the resulting kneaded product is extruded from an extruder through a molding die to obtain a rod-shaped molded body having a length of 15 cm and a diameter of 3 mm.
  • Formulation Example 12 Compounds of the present invention 1-1 to 1-20, 2-1 to 2-31, 3-1 to 3-7, 4-1 to 4-4, 5-1, and 6-1 5 parts 95 parts of a soft vinyl chloride resin is melt-kneaded with a closed pressure kneader (manufactured by Moriyama Seisakusho), and the resulting kneaded product is extruded from an extrusion molding machine through a molding die to obtain a rod-shaped molded body having a length of 15 cm and a diameter of 3 mm. obtain.
  • a closed pressure kneader manufactured by Moriyama Seisakusho
  • Formulation Example 13 Compounds of the present invention 1-1 to 1-20, 2-1 to 2-31, 3-1 to 3-7, 4-1 to 4-4, 5-1, and 6-1 100 mg, lactose 68.75 mg, corn starch 237.5 mg, microcrystalline cellulose 43.75 mg, polyvinylpyrrolidone 18.75 mg, sodium carboxymethyl starch 28.75 mg, and magnesium stearate 2.5 mg are mixed and the resulting mixture is Compress to size to obtain tablets.
  • Formulation Example 14 Compounds of the present invention 1-1 to 1-20, 2-1 to 2-31, 3-1 to 3-7, 4-1 to 4-4, 5-1, and 6-1 25 mg, lactose 60 mg, corn starch 25 mg, carmellose calcium 6 mg, and 5% hydroxypropylmethylcellulose are mixed in an appropriate amount, and the resulting mixture is filled into a hard shell gelatin capsule or hydroxypropylmethylcellulose capsule to obtain a capsule.
  • Formulation Example 15 Compounds of the present invention 1-1 to 1-20, 2-1 to 2-31, 3-1 to 3-7, 4-1 to 4-4, 5-1, and 6-1 100 mg, fumar Distilled to 500 mL of acid, 2000 mg of sodium chloride, 150 mg of methylparaben, 50 mg of propylparaben, 25000 mg of granular sugar, 13000 mg of sorbitol (70% solution), 100 mg of VeegumK (VanderbiltCo.), 35 mg of fragrance, and 500 mg of colorant to a final volume of 100 mL Add water and mix to obtain a suspension for oral administration.
  • Formulation Example 16 Compounds of the present invention 1-1 to 1-20, 2-1 to 2-31, 3-1 to 3-7, 4-1 to 4-4, 5-1, and 6-1 5% by weight Is dissolved in 5% by weight of polysorbate 85, 3% by weight of benzyl alcohol and 30% by weight of propylene glycol, and a phosphate buffer solution is added so that the pH of this solution is 6.0 to 6.5. Water is added as the balance to obtain a solution for oral administration.
  • Formulation Example 17 5% by weight of aluminum distearate in 57% by weight of fractionated coconut oil and 3% by weight of polysorbate 85 is added and dispersed by heating. This is cooled to room temperature and 25% by weight of saccharin is dispersed in the oily vehicle.
  • any one of the compounds of the present invention 1-1 to 1-20, 2-1 to 2-31, 3-1 to 3-7, 4-1 to 4-4, 5-1, and 6-1 10 Distribute the weight percentage to obtain a paste preparation for oral administration.
  • Formulation Example 18 Compounds of the present invention 1-1 to 1-20, 2-1 to 2-31, 3-1 to 3-7, 4-1 to 4-4, 5-1, and 6-1 5% by weight Is mixed with 95% by weight of limestone powder to obtain granules for oral administration using the wet granulation method.
  • Formulation Example 19 5 parts of any one of compounds 1-1 to 1-20, 2-1 to 2-31, 3-1 to 3-7, 4-1 to 4-4, 5-1, and 6-1 of the present invention Dissolve in 80 parts of diethylene glycol monoethyl ether and mix with 15 parts of propylene carbonate to obtain a spot-on solution.
  • Formulation Example 20 10 parts of any one of compounds 1-1 to 1-20, 2-1 to 2-31, 3-1 to 3-7, 4-1 to 4-4, 5-1, and 6-1 of the present invention Dissolve in 70 parts of diethylene glycol monoethyl ether and mix with 20 parts of 2-octyldodecanol to obtain a pour-on solution.
  • Formulation Example 21 Compounds of the present invention 1-1 to 1-20, 2-1 to 2-31, 3-1 to 3-7, 4-1 to 4-4, 5-1, and 6-1 0.5 60 parts of Nikkor (registered trademark) TEALS-42 (42% aqueous solution of Nikko Chemicals lauryl sulfate triethanolamine) and 20 parts of propylene glycol were added to the resulting mixture, and the mixture was stirred and mixed until a homogeneous solution was obtained. Add 5 parts and further stir and mix to obtain a shampoo of a uniform solution.
  • Nikkor registered trademark
  • TEALS-42 42% aqueous solution of Nikko Chemicals lauryl sulfate triethanolamine
  • Formulation Example 22 Compounds of the present invention 1-1 to 1-20, 2-1 to 2-31, 3-1 to 3-7, 4-1 to 4-4, 5-1, and 6-1 0.15
  • the animal feed premix is obtained by sufficiently stirring and mixing 4.85% by weight of a mixture consisting of dilute calcium phosphate, diatomaceous earth, Aerosil, and carbonate (or chalk).
  • Formulation Example 23 Compounds of the present invention 1-1 to 1-20, 2-1 to 2-31, 3-1 to 3-7, 4-1 to 4-4, 5-1, and 6-1 7.2 g , And 92.8 g of Fosco (registered trademark) S-55 (manufactured by Maruishi Pharmaceutical Co., Ltd.) are dissolved and mixed at 100 ° C., poured into a suppository form, cooled and solidified to obtain a suppository.
  • Fosco registered trademark
  • S-55 manufactured by Maruishi Pharmaceutical Co., Ltd.
  • Test example 1 Compounds of the present invention 1-1 to 1-20, 2-1 to 2-3, 2-7 to 2-9, 2-11 to 2-31, 3-1 to 3-7 obtained by Formulation Example 5
  • Formulations 4-1 to 4-3, 5-1, and 6-1 were each diluted with water so that the concentration of the compound of the present invention was 500 ppm to obtain a diluted solution.
  • Control value (%) ⁇ 1 ⁇ (Cb ⁇ Tai) / (Cai ⁇ Tb) ⁇ ⁇ 100
  • the character in a formula represents the following meaning.
  • the group refers to a group in which a preparation diluted with the same amount of water as the treatment group was sprayed on the preparation not containing the compound of the present invention in Preparation Example 5.
  • Test example 2 Compounds of the present invention 1-1 to 1-3, 1-5 to 1-8, 1-10, 1-12 to 1-14, 1-16, 1-20, 2-1 to 2-3, 2-7 to 2-9, 2-11, 2-12, 2-14, 2-15, 2-17 to 2-19, 2-21 to 2-25, 2-27 to 2-
  • the preparations of 29, 3-1 to 3-7, 4-2, 5-1 and 6-1 were diluted with water so that the concentration of the compound of the present invention was 200 ppm, respectively, to obtain a diluted solution.
  • Control value (%) ⁇ 1 ⁇ (Cb ⁇ Tai) / (Cai ⁇ Tb) ⁇ ⁇ 100
  • the character in a formula represents the following meaning.
  • the group refers to a group in which a preparation diluted with the same amount of water as the treatment group was sprayed on the preparation not containing the compound of the present invention in Preparation Example 5.
  • Test example 3 Compounds of the present invention 1-1 to 1-20, 2-1 to 2-4, 2-7 to 2-11 to 2-31, 3-1 to 3-7, 4-1 to 4
  • the preparations 4-3 and 5-1 were each diluted with water so that the concentration of the compound of the present invention was 500 ppm to obtain a diluted solution.
  • the diluted solution was sprayed at a rate of 20 mL / cup on a three-leaf cabbage planted in a polyethylene cup. After spraying, the plants were air-dried, the stems and leaves were cut out and accommodated in a 50 mL cup, and 5 second-instar larvae (Plutella xylostella) were released and capped. After storing at 25 ° C., the number of dead insects was counted after 5 days, and the death rate was calculated from the following formula.
  • Death rate (%) (Number of dead insects / number of test insects) ⁇ 100 As a result, the death rate was 80% or more in all the treatment areas where the compounds of the present invention were tested.
  • Test example 4 Compounds of the present invention 1-1 to 1-10, 1-12 to 1-15, 1-18, 1-20, 2-1 to 2-4, 2-7 to 2-9 obtained by Formulation Example 5
  • Formulations 2-11 to 2-19, 2-21 to 2-23, 2-25 to 2-29, 3-1 to 3-7, 4-1 to 4-3, and 5-1 are respectively represented in the present invention. It diluted with water so that the density
  • the diluted solution was sprayed at a rate of 20 mL / cup on a three-leaf cabbage planted in a polyethylene cup. After spraying, the plants were air-dried, the stems and leaves were cut out and accommodated in a 50 mL cup, and 5 second-instar larvae (Plutella xylostella) were released and capped. After storing at 25 ° C., the number of dead insects was counted after 5 days, and the death rate was calculated from the following formula.
  • Death rate (%) (Number of dead insects / number of test insects) ⁇ 100 As a result, the death rate was 80% or more in all the treatment areas where the compounds of the present invention were tested.
  • Test Example 5 Compounds of the present invention 1-1 to 1-18, 2-20, 2-1 to 2-4, 2-7 to 2-9, 2-11 to 2-19, 2-21 to Formulations 2-29, 3-1 to 3-7, 4-1, 4-2 and 5-1 were each diluted with water so that the concentration of the compound of the present invention was 500 ppm to obtain a diluted solution.
  • a filter paper of the same size was laid on the bottom of a polyethylene cup having a diameter of 5.5 cm, in-sector LF (Nihon Nosan Co., Ltd.) sliced into 6 mm thickness and cut in half was placed, and 2 mL of the diluted solution was irrigated. After air drying, 5 third instar larvae of Spodoptera litura were released and covered. Six days later, the number of dead insects was counted, and the death rate was obtained from the following formula.
  • Death rate (%) (Number of dead insects / number of test insects) ⁇ 100 As a result, the death rate was 80% or more in all the treatment areas where the compounds of the present invention were tested.
  • Test Example 6 Compounds of the present invention 1-1 to 1-18, 1-20, 2-1 to 2-3, 2-7 to 2-9, 2-11 to 2-29, 2-31 obtained by Formulation Example 5
  • the preparations of 3-1 to 3-7, 4-1 to 4-3, and 5-1 were each diluted with water so that the concentration of the compound of the present invention was 200 ppm to obtain a diluted solution.
  • the diluted solution was sprayed at a rate of 20 mL / cup on 5-6 leaf cabbage (Brassicae oleracea) planted in a polyethylene cup. After spraying, the plants were air-dried, covered with a polyethylene cup (capacity 400 mL), 10 4th instars of Spodoptera litura were released, and capped with Tetorongose. After storing at 25 ° C., the number of surviving insects was counted after 6 days, and the death rate was determined from the following formula.
  • Death rate (%) (Number of dead insects / number of test insects) ⁇ 100 As a result, the death rate was 80% or more in all the treatment areas where the compounds of the present invention were tested.
  • Test Example 7 Compounds of the present invention 1-1 to 1-3, 1-5 to 1-10, 1-13, 1-14, 1-16, 1-17, 2-1, 2-2 obtained by Formulation Example 5 2-7 to 2-9, 2-11, 2-12, 2-17 to 2-19, 2-21, 2-23, 2-24, 2-26, 2-27 and 3-1 to 3- Each of the preparations 7 was diluted with water so that the concentration of the compound of the present invention was 500 ppm to obtain a diluted solution.
  • Control rate (%) 100 ⁇ ⁇ 1 ⁇ (number of surviving ticks in treated area) / (number of surviving ticks in untreated area) ⁇ As a result, a control rate of 90% or more was exhibited in all the treatment sections where the compounds of the present invention were tested.
  • Test Example 8 Compounds of the present invention 1-1 to 1-18, 2-1 to 2-3, 2-7 to 2-31, 3-1 to 3-3, 3-5, 3-6 obtained by Formulation Example 5 Formulations 4-1 to 4-3 and 5-1 were each diluted with water so that the concentration of the compound of the present invention was 500 ppm to obtain a diluted solution.
  • a filter paper of the same size was laid on the bottom of a polyethylene cup having a diameter of 5.5 cm, 0.7 mL of the diluted solution was dropped on the filter paper, and 30 mg of sucrose was uniformly added as food.
  • Ten female fly (Musca domestica) females were released into the polyethylene cup and covered. One day later, the life and death of the house fly was investigated, the number of dead insects was counted, and the death rate was calculated by the following formula.
  • Death rate (%) (Number of dead insects / number of test insects) ⁇ 100 As a result, the death rate was 100% in all the treatment sections where the compound of the present invention was tested.
  • Test Example 9 Compounds of the present invention 1-1 to 1-20, 2-1 to 2-31, 3-1 to 3-7, 4-1 to 4-4, 5-1 and 6-1 obtained by Formulation Example 5 Each preparation was diluted with water so that the concentration of the compound of the present invention was 500 ppm to obtain a diluted solution.
  • the diluted solution (0.7 mL) was added to ion-exchanged water (100 mL) (active ingredient concentration: 3.5 ppm). Twenty instar larvae of Culex pipiens pallens were released into the solution, and the number of dead insects was counted one day later, and the death rate was determined.
  • Death rate (%) (Number of dead insects / number of test insects) ⁇ 100 As a result, the mortality rate of 91% or more was shown in all the treatment sections where the compounds of the present invention were tested.
  • Test Example 10 Compound 1-2 of the present invention obtained by Formulation Example 5, 1-4 to 1-7, 1-9, 1-12 to 1-14, 1-18, 1-20, 2-1 to 2-3, 2-7 to 2-9, 2-11, 2-12, 2-14 to 2-16, 2-18, 2-19, 2-21, 2-22, 2-24 to 2-27, 3-
  • the preparations 1 to 3-3, 3-5 to 3-7, 4-1, and 5-1 were each diluted with water so that the concentration of the compound of the present invention was 500 ppm to obtain a diluted solution.
  • a filter paper of the same size was laid on the bottom of a polyethylene cup having a diameter of 5.5 cm, 0.7 mL of the diluted solution was dropped on the filter paper, and 30 mg of sucrose was uniformly added as food.
  • Two adult male cockroaches (Blattalla germanica) were released into the polyethylene cup and covered. One day later, the number of dead insects was counted to determine the death rate.
  • Death rate (%) (Number of dead insects / number of test insects) ⁇ 100 As a result, the death rate was 100% in all the treatment sections where the compound of the present invention was tested.
  • Comparative Test Example 1 The compound 1-4 of the present invention and the compound 1-22 described in International Publication No. 2012/164698 were tested in accordance with the method described in Test Example 1 above, and control when the compound 1-4 of the present invention was used was tested. The control value when using compound 1-22 was 29% or less, whereas the value was 100%.
  • Compound 1-4 of the present invention was tested in accordance with the method described in Test Example 1 above, and control when the compound 1-4 of the present invention was used was tested. The control value when using compound 1-22 was 29% or less, whereas the value was 100%.
  • Comparative test example 2 The compound 1-7 of the present invention and the compound 1-25 described in International Publication No. 2012/164698 were tested according to the method described in Test Example 1 except that the concentration of the active compound was 50 ppm. The control value when using the inventive compound 1-7 was 90% or more, whereas the control value when using the compound 1-25 was 29% or less. Compound 1-7 of the present invention
  • the compound of the present invention exhibits an excellent control effect against harmful arthropods.

Abstract

Provided is a compound that exhibits an excellent controlling effect against harmful arthropods. A 3-aminooxalylaminobenzamide compound represented by formula (1) has an excellent controlling effect against harmful arthropods.

Description

3-アミノオキサリルアミノベンズアミド化合物及びその有害節足動物防除用途3-Aminooxalylaminobenzamide compounds and their use for controlling harmful arthropods
 本発明は、ある種の3-アミノオキサリルアミノベンズアミド化合物及びその有害節足動物用途に関する。 The present invention relates to certain 3-aminooxalylaminobenzamide compounds and their use for harmful arthropods.
 これまでに有害節足動物の防除を目的として、様々な化合物が検討されており、実用に供されている。 So far, various compounds have been studied and put to practical use for the purpose of controlling harmful arthropods.
 また、ある種の化合物(例えば、特許文献1参照)が知られている。 Also, certain compounds (for example, see Patent Document 1) are known.
 特許文献1:国際公開第2012/164698号公報 Patent Document 1: International Publication No. 2012/164698
 本発明は、有害節足動物に対して優れた防除効力を有する化合物及びその化合物を用いた有害節足動物の防除方法を提供することを課題とする。 An object of the present invention is to provide a compound having an excellent controlling effect on harmful arthropods and a method for controlling harmful arthropods using the compound.
[1] 式(1) [1] Formula (1)
Figure JPOXMLDOC01-appb-I000002
Figure JPOXMLDOC01-appb-I000002
[式中、
 G及びGはそれぞれ独立して、-CR-又は-C(O)-を表し、
 G、G及びGはそれぞれ独立して、-CR-又は単結合を表し、
 Qは酸素原子、NR、NC(O)R又は無置換を表し、
 R及びRはそれぞれ独立して、水素原子、C1-C6アルキル基、C1-C6アルコキシ基、-S(O)-(C1-C6アルキル)基、C1-C6ハロアルキル基、C1-C6ハロアルコキシ基、-S(O)-(C1-C6ハロアルキル)基、ハロゲン原子、ニトロ基又はシアノ基を表し、
 RはC1-C6ハロアルキル基、C1-C6ハロアルコキシ基又は-S(O)-(C1-C6ハロアルキル)基を表し、
 R及びRはそれぞれ独立して水素原子、C1-C6アルキル基、(C1-C4アルコキシ)C1-C4アルキル基、(C1-C6アルキル)カルボニル基、(C1-C4アルコキシ)カルボニル基、C1-C6ハロアルキル基、(C1-C6ハロアルキル)カルボニル基又は(C1-C4ハロアルコキシ)カルボニル基を表し、
 R及びRはそれぞれ独立して水素原子、C1-C6アルキル基、C1-C6アルコキシ基、-S(O)-(C1-C6アルキル)基、C1-C6ハロアルキル基、C1-C6ハロアルコキシ基、-S(O)-(C1-C6ハロアルキル)基、ハロゲン原子又はシアノ基を表し、
 Rは水素原子、C1-C6アルキル基、C1-C6ハロアルキル基又はシアノ基を表し、
 RはC1-C6アルキル基、又はC1-C6ハロアルキル基を表し、
 Xはそれぞれ独立して、C1-C6アルキル基、C1-C6アルコキシ基、C1-C6ハロアルキル基、C1-C6ハロアルコキシ基、ハロゲン原子又はシアノ基を表し、
 Xはそれぞれ独立して、C1-C6アルキル基、C1-C6アルコキシ基、C1-C6ハロアルキル基、C1-C6ハロアルコキシ基、ハロゲン原子又はシアノ基を表し、
 kは0又は1を表し、
 mは0~4の整数を表し、
 nは0~2の整数を表し、
 pは0~2の整数を表す。]
で示される3-アミノオキサリルアミノベンズアミド化合物(以下、本発明化合物とも記載する)。
[2] R及びRがそれぞれ独立して、水素原子、C1-C6アルキル基、C1-C6アルコキシ基、-S(O)-(C1-C6アルキル)基、C1-C6ハロアルキル基、C1-C6ハロアルコキシ基、-S(O)-(C1-C6ハロアルキル)基又はハロゲン原子であり、
 R及びRがそれぞれ独立して水素原子、C1-C6アルキル基、(C1-C6アルキル)カルボニル基、C1-C6ハロアルキル基又は(C1-C6ハロアルキル)カルボニル基であり、
 R及びRがそれぞれ独立して水素原子、C1-C6アルキル基、C1-C6ハロアルキル基、ハロゲン原子又はシアノ基であり、
 Xがそれぞれ独立して、C1-C6アルキル基、C1-C6アルコキシ基、C1-C6ハロアルキル基、C1-C6ハロアルコキシ基又はハロゲン原子であり、
 Xがそれぞれ独立して、C1-C6アルキル基、C1-C6アルコキシ基、C1-C6ハロアルキル基、C1-C6ハロアルコキシ基又はハロゲン原子である[1]記載の化合物。[3] G及びGがそれぞれ独立して、-CR-であり、
 R及びRがそれぞれ独立して、水素原子、C1-C3アルキル基、C1-C3アルコキシ基、-S(O)-(C1-C3アルキル)基、C1-C3ハロアルキル基、C1-C3ハロアルコキシ基、-S(O)-(C1-C3ハロアルキル)基又はハロゲン原子であり、
 R及びRがそれぞれ独立して水素原子又はC1-C3アルキル基であり、
 R及びRがそれぞれ独立して水素原子、C1-C3アルキル基又はC1-C3ハロアルキル基であり、
 Rが水素原子、メチル基、エチル基又はシアノ基であり、
 Rがメチル基、エチル基又はトリフルオロメチル基であり、
 Xがそれぞれ独立して、C1-C3アルキル基、C1-C3アルコキシ基、C1-C3ハロアルキル基、C1-C3ハロアルコキシ基又はハロゲン原子であり、
 Xがそれぞれ独立して、C1-C3アルキル基、C1-C3アルコキシ基、C1-C3ハロアルキル基、C1-C3ハロアルコキシ基又はハロゲン原子である[1]又は[2]記載の化合物。
[4] G、G及びGのうち少なくとも1つが-CR-である[1]~[3]のいずれかに記載の化合物。
[5] R及びRのいずれか一方が、臭素原子、ヨウ素原子又はC1-C3アルキル基であり、他方が、C1-C3アルキル基、C1-C3ハロアルキル基、C1-C3ハロアルコキシ基、又は-S(O)-(C1-C3ハロアルキル)基である[1]~[4]のいずれかに記載の化合物。
[6] RがC1-C6ハロアルキル基である[1]~[5]のいずれかに記載の化合物。
[7] RがC1-C6ハロアルコキシ基である[1]~[5]のいずれかに記載の化合物。
[8] Rが-S(O)-(C1-C6ハロアルキル)基である[1]~[5]のいずれかに記載の化合物。
[9] [1]~[8]のいずれかに記載の化合物と、不活性担体とを含有する有害節足動物防除組成物。
[10] [1]~[8]のいずれかに記載の化合物の有効量を有害節足動物又は有害節足動物生息場所に施用する有害節足動物の防除方法。
[Where:
G 1 and G 5 each independently represent —CR 6 R 7 — or —C (O) —,
G 2 , G 3 and G 4 each independently represent —CR 6 R 7 — or a single bond,
Q represents an oxygen atom, NR 8 , NC (O) R 9 or unsubstituted,
R 1 and R 3 are each independently a hydrogen atom, a C1-C6 alkyl group, a C1-C6 alkoxy group, a —S (O) p- (C1-C6 alkyl) group, a C1-C6 haloalkyl group, a C1-C6 A haloalkoxy group, a —S (O) p — (C1-C6 haloalkyl) group, a halogen atom, a nitro group or a cyano group;
R 2 represents a C1-C6 haloalkyl group, a C1-C6 haloalkoxy group or a —S (O) p — (C1-C6 haloalkyl) group,
R 4 and R 5 are each independently a hydrogen atom, a C1-C6 alkyl group, a (C1-C4 alkoxy) C1-C4 alkyl group, a (C1-C6 alkyl) carbonyl group, a (C1-C4 alkoxy) carbonyl group, C1 A —C6 haloalkyl group, a (C1-C6 haloalkyl) carbonyl group or a (C1-C4 haloalkoxy) carbonyl group,
R 6 and R 7 are each independently a hydrogen atom, a C1-C6 alkyl group, a C1-C6 alkoxy group, a —S (O) p- (C1-C6 alkyl) group, a C1-C6 haloalkyl group, a C1-C6 halo. Represents an alkoxy group, —S (O) p — (C1-C6 haloalkyl) group, halogen atom or cyano group,
R 8 represents a hydrogen atom, a C1-C6 alkyl group, a C1-C6 haloalkyl group or a cyano group,
R 9 represents a C1-C6 alkyl group or a C1-C6 haloalkyl group,
Each X a independently represents a C1-C6 alkyl group, a C1-C6 alkoxy group, a C1-C6 haloalkyl group, a C1-C6 haloalkoxy group, a halogen atom or a cyano group;
Each Xb independently represents a C1-C6 alkyl group, a C1-C6 alkoxy group, a C1-C6 haloalkyl group, a C1-C6 haloalkoxy group, a halogen atom or a cyano group;
k represents 0 or 1,
m represents an integer of 0 to 4,
n represents an integer of 0 to 2,
p represents an integer of 0-2. ]
A 3-aminooxalylaminobenzamide compound represented by the following (hereinafter also referred to as the present compound).
[2] R 1 and R 3 are each independently a hydrogen atom, a C1-C6 alkyl group, a C1-C6 alkoxy group, a —S (O) p — (C1-C6 alkyl) group, a C1-C6 haloalkyl group, A C1-C6 haloalkoxy group, —S (O) p — (C1-C6 haloalkyl) group or a halogen atom,
R 4 and R 5 are each independently a hydrogen atom, a C1-C6 alkyl group, a (C1-C6 alkyl) carbonyl group, a C1-C6 haloalkyl group or a (C1-C6 haloalkyl) carbonyl group,
R 6 and R 7 are each independently a hydrogen atom, a C1-C6 alkyl group, a C1-C6 haloalkyl group, a halogen atom or a cyano group,
Each X a is independently a C1-C6 alkyl group, a C1-C6 alkoxy group, a C1-C6 haloalkyl group, a C1-C6 haloalkoxy group or a halogen atom;
[1] The compound according to [1], wherein each X b is independently a C1-C6 alkyl group, a C1-C6 alkoxy group, a C1-C6 haloalkyl group, a C1-C6 haloalkoxy group or a halogen atom. [3] G 1 and G 5 are each independently —CR 6 R 7 —,
R 1 and R 3 are each independently a hydrogen atom, a C1-C3 alkyl group, a C1-C3 alkoxy group, a —S (O) p — (C1-C3 alkyl) group, a C1-C3 haloalkyl group, a C1-C3 A haloalkoxy group, a —S (O) p — (C1-C3 haloalkyl) group or a halogen atom,
R 4 and R 5 are each independently a hydrogen atom or a C1-C3 alkyl group,
R 6 and R 7 are each independently a hydrogen atom, a C1-C3 alkyl group or a C1-C3 haloalkyl group,
R 8 is a hydrogen atom, a methyl group, an ethyl group or a cyano group,
R 9 is a methyl group, an ethyl group or a trifluoromethyl group,
Each X a is independently a C1-C3 alkyl group, a C1-C3 alkoxy group, a C1-C3 haloalkyl group, a C1-C3 haloalkoxy group or a halogen atom;
The compound according to [1] or [2], wherein X b is each independently a C1-C3 alkyl group, a C1-C3 alkoxy group, a C1-C3 haloalkyl group, a C1-C3 haloalkoxy group or a halogen atom.
[4] The compound according to any one of [1] to [3], wherein at least one of G 2 , G 3 and G 4 is —CR 6 R 7 —.
[5] Either one of R 1 and R 3 is a bromine atom, an iodine atom or a C1-C3 alkyl group, and the other is a C1-C3 alkyl group, a C1-C3 haloalkyl group, a C1-C3 haloalkoxy group, Or the compound according to any one of [1] to [4], which is a —S (O) p — (C1-C3 haloalkyl) group.
[6] The compound according to any one of [1] to [5], wherein R 2 is a C1-C6 haloalkyl group.
[7] The compound according to any one of [1] to [5], wherein R 2 is a C1-C6 haloalkoxy group.
[8] The compound according to any one of [1] to [5], wherein R 2 is a —S (O) p — (C1-C6 haloalkyl) group.
[9] A harmful arthropod control composition comprising the compound according to any one of [1] to [8] and an inert carrier.
[10] A method for controlling harmful arthropods, which comprises applying an effective amount of the compound according to any one of [1] to [8] to harmful arthropods or harmful arthropod habitats.
 本発明化合物は、有害節足動物に対して優れた防除活性を有することから、有害節足動物防除剤の有効成分として有用である。 Since the compound of the present invention has an excellent control activity against harmful arthropods, it is useful as an active ingredient of a harmful arthropod control agent.
 本明細書の記載において用いられる基について、例を挙げて以下に説明する。 Examples of groups used in the description of the present specification will be described below.
 本発明において「C1-C6アルキル基」とは、例えばメチル基、エチル基、プロピル基、イソプロピル基、ブチル基、イソブチル基、sec-ブチル基及びtert-ブチル基が挙げられる。「C1-C6アルキル基」には、「C1-C4アルキル基」、さらに「C1-C3アルキル基」が包含される。 In the present invention, “C1-C6 alkyl group” includes, for example, methyl group, ethyl group, propyl group, isopropyl group, butyl group, isobutyl group, sec-butyl group and tert-butyl group. The “C1-C6 alkyl group” includes a “C1-C4 alkyl group” and further a “C1-C3 alkyl group”.
 本発明において「C1-C6アルコキシ基」とは、例えばメトキシ基、エトキシ基、プロポキシ基、イソプロポキシ基、ブトキシ基、イソブトキシ基、sec-ブトキシ基及びtert-ブトキシ基が挙げられる。「C1-C6アルコキシ基」には、「C1-C4アルコキシ基」、さらに「C1-C3アルコキシ基」が包含される。 In the present invention, examples of the “C1-C6 alkoxy group” include a methoxy group, an ethoxy group, a propoxy group, an isopropoxy group, a butoxy group, an isobutoxy group, a sec-butoxy group, and a tert-butoxy group. The “C1-C6 alkoxy group” includes a “C1-C4 alkoxy group” and further a “C1-C3 alkoxy group”.
 本発明において「-S(O)-(C1-C6アルキル)基」とは、前記「C1-C6アルキル基」がS(O)の硫黄原子に結合した基であり、例えばメチルスルファニル基、メタンスルフィニル基、メタンスルホニル基、エチルスルファニル基、エタンスルフィニル基及びエタンスルホニル基が挙げられる。 In the present invention, the “—S (O) p — (C1-C6 alkyl) group” is a group in which the “C1-C6 alkyl group” is bonded to the sulfur atom of S (O) p , for example, a methylsulfanyl group. Methanesulfinyl group, methanesulfonyl group, ethylsulfanyl group, ethanesulfinyl group, and ethanesulfonyl group.
 本発明において「C1-C6ハロアルキル基」とは、前記「C1-C6アルキル基」の1以上の水素原子がハロゲン原子で置換された基であり、例えばフルオロメチル基、ジフルオロメチル基、トリフルオロメチル基、クロロジフルオロメチル基、2,2,2-トリフルオロエチル基、ペンタフルオロエチル基、ヘプタフルオロプロピル基、ヘプタフルオロイソプロピル基、1,1,2,2,3,3-ヘキサフルオロプロピル基、2,2,2-トリフルオロ-1-(トリフルオロメチル)エチル基及びトリクロロメチル基が挙げられる。 In the present invention, the “C1-C6 haloalkyl group” is a group in which one or more hydrogen atoms of the “C1-C6 alkyl group” are substituted with a halogen atom, such as a fluoromethyl group, a difluoromethyl group, a trifluoromethyl group. Group, chlorodifluoromethyl group, 2,2,2-trifluoroethyl group, pentafluoroethyl group, heptafluoropropyl group, heptafluoroisopropyl group, 1,1,2,2,3,3-hexafluoropropyl group, Examples include 2,2,2-trifluoro-1- (trifluoromethyl) ethyl group and trichloromethyl group.
 本発明において「C1-C6ハロアルコキシ基」とは、前記「C1-C6アルコキシ基」の1以上の水素原子がハロゲン原子で置換された基であり、例えばフルオロメトキシ基、ジフルオロメトキシ基、トリフルオロメトキシ基、クロロジフルオロメトキシ基、2,2,2-トリフルオロエトキシ基、ペンタフルオロエトキシ基、ヘプタフルオロプロポキシ基、ヘプタフルオロイソプロポキシ基、1,1,2,2,3,3-ヘキサフルオロプロポキシ基、2,2,2-トリフルオロ-1-(トリフルオロメチル)エトキシ基及びトリクロロメトキシ基が挙げられる。 In the present invention, the “C1-C6 haloalkoxy group” is a group in which one or more hydrogen atoms of the “C1-C6 alkoxy group” are substituted with a halogen atom, such as a fluoromethoxy group, a difluoromethoxy group, a trifluoro group. Methoxy group, chlorodifluoromethoxy group, 2,2,2-trifluoroethoxy group, pentafluoroethoxy group, heptafluoropropoxy group, heptafluoroisopropoxy group, 1,1,2,2,3,3-hexafluoropropoxy group And the groups 2,2,2-trifluoro-1- (trifluoromethyl) ethoxy and trichloromethoxy.
 本発明において「-S(O)-(C1-C6ハロアルキル)基」とは、前記「C1-C6ハロアルキル基」がS(O)の硫黄原子に結合した基であり、例えば(トリフルオロメチル)スルファニル基、(トリフルオロメタン)スルフィニル基、(トリフルオロメタン)スルホニル基、(ペンタフルオロエチル)スルファニル基、(ペンタフルオロエタン)スルフィニル基、(ペンタフルオロエタン)スルホニル基、(ヘプタフルオロイソプロピル)スルファニル基、(ヘプタフルオロイソプロパン)スルフィニル基及び(ヘプタフルオロイソプロパン)スルホニル基が挙げられる。 In the present invention, the “—S (O) p — (C1-C6 haloalkyl) group” is a group in which the “C1-C6 haloalkyl group” is bonded to the sulfur atom of S (O) p. Methyl) sulfanyl group, (trifluoromethane) sulfinyl group, (trifluoromethane) sulfonyl group, (pentafluoroethyl) sulfanyl group, (pentafluoroethane) sulfinyl group, (pentafluoroethane) sulfonyl group, (heptafluoroisopropyl) sulfanyl group , (Heptafluoroisopropane) sulfinyl group and (heptafluoroisopropane) sulfonyl group.
 本発明において「Qは無置換を表す」とは、Qが存在しないことを意味する。 In the present invention, “Q represents no substitution” means that Q does not exist.
 本発明において、「ハロゲン原子」とは、フッ素原子、塩素原子、臭素原子及びヨウ素原子を表す。 In the present invention, “halogen atom” represents a fluorine atom, a chlorine atom, a bromine atom and an iodine atom.
 本発明化合物は、その構造式中に1個又は複数個の不斉炭素原子又は不斉中心を含む場合があり、2種以上の光学異性体が存在する場合もあるが、本発明は各々の光学異性体及びそれらが任意の割合で含まれる混合物をも全て含有するものである。また、本発明化合物は、その構造中に炭素-炭素二重結合、硫黄-窒素二重結合、環状構造に由来する2種以上の幾何異性体が存在する場合もあるが、本発明は各々の幾何異性体及びそれらが任意の割合で含まれる混合物をも全て含有するものである。 The compound of the present invention may contain one or more asymmetric carbon atoms or asymmetric centers in its structural formula, and there may be two or more optical isomers. All of the optical isomers and a mixture containing them in an arbitrary ratio are also contained. The compound of the present invention may contain two or more geometric isomers derived from a carbon-carbon double bond, sulfur-nitrogen double bond, or cyclic structure in the structure. It also contains all geometric isomers and mixtures containing them in any proportion.
 本発明化合物としては、例えば、以下の化合物が挙げられる。 Examples of the compound of the present invention include the following compounds.
 本発明化合物において、Gが、-CR-である化合物;
 本発明化合物において、Gが、-CR-であり、R及びRが、それぞれ独立して水素原子、C1-C6アルキル基、又はC1-C6ハロアルキル基である化合物;
 本発明化合物において、Gが、-CH-である化合物;
 本発明化合物において、Gが、-CH(CH)-である化合物;
In the compounds of the present invention, a compound wherein G 1 is —CR 6 R 7 —;
In the compounds of the present invention, G 1 is —CR 6 R 7 —, and R 6 and R 7 are each independently a hydrogen atom, a C1-C6 alkyl group, or a C1-C6 haloalkyl group;
In the compounds of the present invention, a compound wherein G 1 is —CH 2 —;
In the compounds of the present invention, a compound wherein G 1 is —CH (CH 3 ) —;
 本発明化合物において、Gが、-CR-である化合物;
 本発明化合物において、Gが、-CR-であり、R及びRが、それぞれ独立して水素原子、C1-C6アルキル基、又はC1-C6ハロアルキル基である化合物;
 本発明化合物において、Gが、-CH-である化合物;
 本発明化合物において、Gが、-CH(CH)-である化合物;
 本発明化合物において、Gが、単結合である化合物;
In the compounds of the present invention, a compound wherein G 2 is —CR 6 R 7 —;
In the compounds of the present invention, G 2 is —CR 6 R 7 —, and R 6 and R 7 are each independently a hydrogen atom, a C1-C6 alkyl group, or a C1-C6 haloalkyl group;
In the compounds of the present invention, a compound wherein G 2 is —CH 2 —;
In the compounds of the present invention, a compound wherein G 2 is —CH (CH 3 ) —;
In the compounds of the present invention, a compound in which G 2 is a single bond;
 本発明化合物において、Gが、-CR-である化合物;
 本発明化合物において、Gが、-CR-であり、R及びRが、それぞれ独立して水素原子、C1-C6アルキル基、又はC1-C6ハロアルキル基である化合物;
 本発明化合物において、Gが、-CH-である化合物;
 本発明化合物において、Gが、-CH(CH)-である化合物;
 本発明化合物において、Gが、単結合である化合物;
In the compounds of the present invention, a compound wherein G 3 is —CR 6 R 7 —;
In the compounds of the present invention, G 3 is —CR 6 R 7 —, and R 6 and R 7 are each independently a hydrogen atom, a C1-C6 alkyl group, or a C1-C6 haloalkyl group;
In the compounds of the present invention, a compound wherein G 3 is —CH 2 —;
In the compounds of the present invention, a compound wherein G 3 is —CH (CH 3 ) —;
In the compounds of the present invention, a compound in which G 3 is a single bond;
 本発明化合物において、Gが、-CR-である化合物; 
 本発明化合物において、Gが、-CR-であり、R及びRが、それぞれ独立して水素原子、C1-C6アルキル基、又はC1-C6ハロアルキル基である化合物;
 本発明化合物において、Gが、-CH-である化合物;
 本発明化合物において、Gが、-CH(CH)-である化合物;
 本発明化合物において、Gが、単結合である化合物;
In the compounds of the present invention, a compound wherein G 4 is —CR 6 R 7 —;
In the compounds of the present invention, G 4 is —CR 6 R 7 —, and R 6 and R 7 are each independently a hydrogen atom, a C1-C6 alkyl group, or a C1-C6 haloalkyl group;
In the compounds of the present invention, a compound wherein G 4 is —CH 2 —;
In the compounds of the present invention, a compound wherein G 4 is —CH (CH 3 ) —;
In the compounds of the present invention, a compound in which G 4 is a single bond;
 本発明化合物において、G、G及びGのうち少なくとも1つが-CR-である化合物;
 本発明化合物において、G、G及びGのうちいずれか1つが-CR-であり、残り2つが単結合である化合物;
 本発明化合物において、G、G及びGのうち2つがそれぞれ独立して-CR-であり、残り1つが単結合である化合物;
 本発明化合物において、G、G及びGのすべてがそれぞれ独立して-CR-である化合物;
In the compound of the present invention, a compound in which at least one of G 2 , G 3 and G 4 is —CR 6 R 7 —;
In the compound of the present invention, one of G 2 , G 3 and G 4 is —CR 6 R 7 —, and the remaining two are single bonds;
In the compounds of the present invention, two of G 2 , G 3 and G 4 are each independently —CR 6 R 7 —, and the remaining one is a single bond;
A compound of the present invention, wherein G 2 , G 3 and G 4 are each independently —CR 6 R 7 —;
 本発明化合物において、G及びGがそれぞれ独立して、-CHR-を表し、
 G、G及びGがそれぞれ独立して、-CHR-又は単結合を表し、G、G及びGの少なくとも1つが-CHR-であり、
 Rはそれぞれ独立して、水素原子、C1-C6アルキル基、C1-C6ハロアルキル基である化合物;
 本発明化合物において、G、G及びGが、-CHR-であり、
 G及びGがそれぞれ独立して、-CHR-又は単結合であり、
 Rはそれぞれ独立して、水素原子、C1-C6アルキル基である化合物;
In the compound of the present invention, G 1 and G 5 each independently represent —CHR 6 —,
G 2 , G 3 and G 4 each independently represent —CHR 6 — or a single bond, and at least one of G 2 , G 3 and G 4 is —CHR 6 —;
A compound in which each R 6 is independently a hydrogen atom, a C1-C6 alkyl group, or a C1-C6 haloalkyl group;
In the compound of the present invention, G 1 , G 2 and G 5 are —CHR 6 —,
G 3 and G 4 are each independently —CHR 6 — or a single bond,
R 6 is independently a hydrogen atom or a C1-C6 alkyl group;
 本発明化合物において、Gが、-CR-である化合物;
 本発明化合物において、Gが、-CR-であり、R及びRが、それぞれ独立して水素原子、C1-C6アルキル基、又はC1-C6ハロアルキル基である化合物;
 本発明化合物において、Gが、-CH-である化合物;
 本発明化合物において、Gが、-CH(CH)-である化合物;
In the compounds of the present invention, a compound wherein G 5 is —CR 6 R 7 —;
In the compounds of the present invention, G 5 is —CR 6 R 7 —, and R 6 and R 7 are each independently a hydrogen atom, a C1-C6 alkyl group, or a C1-C6 haloalkyl group;
In the compounds of the present invention, a compound wherein G 5 is —CH 2 —;
In the compounds of the present invention, a compound wherein G 5 is —CH (CH 3 ) —;
 本発明化合物において、Qが、酸素原子である化合物;
 本発明化合物において、Qが、NRであり、Rが、水素原子、C1-C6アルキル基、C1-C6ハロアルキル基又はシアノ基である化合物;
 本発明化合物において、Qが、NRであり、Rが、水素原子、C1-C6アルキル基、又はシアノ基である化合物;
 本発明化合物において、Qが、NHである化合物;
 本発明化合物において、Qが、NCNである化合物;
 本発明化合物において、Qが、NC(O)Rであり、Rが、C1-C6アルキル基、又はC1-C6ハロアルキル基である化合物;
 本発明化合物において、Qが、NC(O)CH又はNC(O)CFである化合物;
 本発明化合物において、Qが、無置換である化合物;
In the compounds of the present invention, a compound in which Q is an oxygen atom;
In the compounds of the present invention, Q is NR 8 and R 8 is a hydrogen atom, a C1-C6 alkyl group, a C1-C6 haloalkyl group or a cyano group;
In the compounds of the present invention, Q is NR 8 and R 8 is a hydrogen atom, a C1-C6 alkyl group, or a cyano group;
In the compounds of the present invention, a compound wherein Q is NH;
In the compounds of the present invention, a compound wherein Q is NCN;
In the compounds of the present invention, Q is NC (O) R 9 and R 9 is a C1-C6 alkyl group or a C1-C6 haloalkyl group;
In the compounds of the present invention, a compound in which Q is NC (O) CH 3 or NC (O) CF 3 ;
In the compounds of the present invention, a compound in which Q is unsubstituted;
 本発明化合物において、Rが、水素原子である化合物;
 本発明化合物において、Rが、C1-C6アルキル基である化合物;
 本発明化合物において、Rが、C1-C6ハロアルキル基である化合物;
 本発明化合物において、Rが、C1-C6ハロアルコキシ基、-S-(C1-C6ハロアルキル)基、-S(O)-(C1-C6ハロアルキル)基、又は-S(O)-(C1-C6ハロアルキル)基である化合物;
 本発明化合物において、Rが、ハロゲン原子である化合物;
 本発明化合物において、Rが、メチル基、エチル基、プロピル基、又はイソプロイル基である化合物;
 本発明化合物において、Rが、ジフルオロメトキシ基、トリフルオロメトキシ基、トリフルオロメチル基、又はトリフルオロメチルチオ基である化合物;  
 本発明化合物において、Rが、臭素原子、又はヨウ素原子である化合物;
In the compounds of the present invention, a compound wherein R 1 is a hydrogen atom;
In the compounds of the present invention, a compound wherein R 1 is a C1-C6 alkyl group;
In the compounds of the present invention, a compound wherein R 1 is a C1-C6 haloalkyl group;
In the compound of the present invention, R 1 is a C1-C6 haloalkoxy group, —S— (C1-C6 haloalkyl) group, —S (O) — (C1-C6 haloalkyl) group, or —S (O) 2 — ( A compound which is a C1-C6 haloalkyl) group;
In the compounds of the present invention, a compound wherein R 1 is a halogen atom;
In the compounds of the present invention, a compound wherein R 1 is a methyl group, an ethyl group, a propyl group, or an isopropyl group;
In the compounds of the present invention, a compound wherein R 1 is a difluoromethoxy group, a trifluoromethoxy group, a trifluoromethyl group, or a trifluoromethylthio group;
In the compounds of the present invention, a compound wherein R 1 is a bromine atom or an iodine atom;
 本発明化合物において、Rが、C1-C6ハロアルキル基である化合物;
 本発明化合物において、Rが、C1-C6ハロアルコキシ基である化合物;
 本発明化合物において、Rが、トリフルオロメチル基、ペンタフルオロエチル基、ヘプタフルオロプロピル基、又はヘプタフルオロイソプロピル基である化合物;
 本発明化合物において、Rが、トリフルオロメトキシ基、ペンタフルオロエトキシ基、ヘプタフルオロプロポキシ基、又はヘプタフルオロイソプロポキシ基である化合物;
In the compounds of the present invention, a compound wherein R 2 is a C1-C6 haloalkyl group;
In the compounds of the present invention, a compound wherein R 2 is a C1-C6 haloalkoxy group;
In the compounds of the present invention, a compound wherein R 2 is a trifluoromethyl group, a pentafluoroethyl group, a heptafluoropropyl group, or a heptafluoroisopropyl group;
In the compound of the present invention, a compound wherein R 2 is a trifluoromethoxy group, a pentafluoroethoxy group, a heptafluoropropoxy group, or a heptafluoroisopropoxy group;
 本発明化合物において、Rが、水素原子である化合物;
 本発明化合物において、Rが、C1-C6アルキル基である化合物;
 本発明化合物において、Rが、C1-C6ハロアルキル基である化合物;
 本発明化合物において、Rが、C1-C6ハロアルコキシ基である化合物;
 本発明化合物において、Rが、-S-(C1-C6ハロアルキル)基である化合物;
 本発明化合物において、Rが、-S(O)-(C1-C6ハロアルキル)基である化合物;
 本発明化合物において、Rが、-S(O)-(C1-C6ハロアルキル)基である化合物;
 本発明化合物において、Rが、ハロゲン原子である化合物;
 本発明化合物において、Rが、メチル基、エチル基、プロピル基、又はイソプロイル基である化合物;
 本発明化合物において、Rが、ジフルオロメトキシ基、トリフルオロメトキシ基、トリフルオロメチル基、又はトリフルオロメチルチオ基である化合物;
 本発明化合物において、Rが、臭素原子、又はヨウ素原子である化合物;
In the compounds of the present invention, a compound wherein R 3 is a hydrogen atom;
In the compounds of the present invention, a compound wherein R 3 is a C1-C6 alkyl group;
In the compounds of the present invention, a compound wherein R 3 is a C1-C6 haloalkyl group;
In the compounds of the present invention, a compound wherein R 3 is a C1-C6 haloalkoxy group;
In the compounds of the present invention, a compound wherein R 3 is a —S— (C1-C6 haloalkyl) group;
In the compounds of the present invention, a compound wherein R 3 is a —S (O) — (C1-C6 haloalkyl) group;
In the compounds of the present invention, a compound wherein R 3 is a —S (O) 2 — (C1-C6 haloalkyl) group;
In the compounds of the present invention, a compound wherein R 3 is a halogen atom;
In the compounds of the present invention, a compound wherein R 3 is a methyl group, an ethyl group, a propyl group, or an isopropyl group;
In the compound of the present invention, a compound wherein R 3 is a difluoromethoxy group, a trifluoromethoxy group, a trifluoromethyl group, or a trifluoromethylthio group;
In the compounds of the present invention, a compound wherein R 3 is a bromine atom or an iodine atom;
 本発明化合物において、R又はRのいずれか一方が、ハロゲン原子又はC1-C6アルキル基であり、他方が、C1-C6アルキル基、C1-C6アルコキシ基、-S(O)-(C1-C6アルキル)基、C1-C6ハロアルキル基、C1-C6ハロアルコキシ基、又は-S(O)-(C1-C6ハロアルキル)基である化合物; 
 本発明化合物において、R又はRのいずれか一方が、臭素原子、ヨウ素原子又はC1-C3アルキル基であり、他方が、C1-C3アルキル基、C1-C3ハロアルキル基、C1-C3ハロアルコキシ基、又は-S(O)-(C1-C3ハロアルキル)基である化合物; 
In the compound of the present invention, either one of R 1 and R 3 is a halogen atom or a C1-C6 alkyl group, and the other is a C1-C6 alkyl group, a C1-C6 alkoxy group, —S (O) p — ( A compound that is a C1-C6 alkyl) group, a C1-C6 haloalkyl group, a C1-C6 haloalkoxy group, or a —S (O) p — (C1-C6 haloalkyl) group;
In the compound of the present invention, either R 1 or R 3 is a bromine atom, an iodine atom or a C1-C3 alkyl group, and the other is a C1-C3 alkyl group, a C1-C3 haloalkyl group, a C1-C3 haloalkoxy group. Or a compound which is a —S (O) p — (C1-C3 haloalkyl) group;
 本発明化合物において、Rが、水素原子である化合物;
 本発明化合物において、Rが、水素原子である化合物;
In the compounds of the present invention, a compound wherein R 4 is a hydrogen atom;
In the compounds of the present invention, a compound wherein R 5 is a hydrogen atom;
 本発明化合物において、Xがそれぞれ独立して、C1-C6アルキル基、又はC1-C6ハロアルキル基であり、mが0~4の整数である化合物;
 本発明化合物において、Xがそれぞれ独立して、C1-C6アルコキシ基、又はC1-C6ハロアルコキシ基であり、mが0~4の整数である化合物;
 本発明化合物において、Xがそれぞれ独立して、ハロゲン原子であり、mが0~4の整数である化合物;
In the compounds of the present invention, compounds wherein X a is each independently a C1-C6 alkyl group or a C1-C6 haloalkyl group, and m is an integer of 0-4;
In the compounds of the present invention, compounds wherein X a is each independently a C1-C6 alkoxy group or a C1-C6 haloalkoxy group, and m is an integer of 0-4;
In the compounds of the present invention, X a is independently a halogen atom, and m is an integer of 0 to 4;
 本発明化合物において、nが0である化合物;
 本発明化合物において、nが0であり、mが0又は1である化合物;
 本発明化合物において、Xが、C1-C3アルキル基、C1-C3アルコキシ基、又はハロゲン原子であり、nが0であり、mが0又は1である化合物;
 本発明化合物において、Xが、C1-C3アルキル基、C1-C3アルコキシ基、又はハロゲン原子であり、nが0であり、mが0又は1であり、
 R及びRはそれぞれ独立して水素原子又はC1-C6アルキル基である化合物;
 本発明化合物において、Xが、C1-C3アルキル基、C1-C3アルコキシ基、又はハロゲン原子であり、nが0であり、mが0又は1であり、
 R及びRはそれぞれ独立して水素原子又はC1-C6アルキル基であり、
 Rが、水素原子、C1-C6アルキル基又はハロゲン原子であり、
 Rが、C1-C6アルキル基、C1-C6ハロアルキル基、C1-C6ハロアルコキシ基、又は-S(O)-(C1-C6ハロアルキル)基である化合物;
 本発明化合物において、Xが、C1-C3アルキル基、C1-C3アルコキシ基、又はハロゲン原子であり、nが0であり、mが0又は1であり、
 R及びRはそれぞれ独立して水素原子又はC1-C6アルキル基であり、
 Rが、水素原子、C1-C6アルキル基又はハロゲン原子であり、
 Rが、C1-C6アルキル基、C1-C6ハロアルキル基、又はC1-C6ハロアルコキシ基である化合物;
In the compounds of the present invention, a compound in which n is 0;
In the compounds of the present invention, a compound in which n is 0 and m is 0 or 1;
In the compounds of the present invention, a compound in which X a is a C1-C3 alkyl group, a C1-C3 alkoxy group, or a halogen atom, n is 0, and m is 0 or 1;
In the compound of the present invention, X a is a C1-C3 alkyl group, a C1-C3 alkoxy group, or a halogen atom, n is 0, m is 0 or 1,
Compounds wherein R 4 and R 5 are each independently a hydrogen atom or a C1-C6 alkyl group;
In the compound of the present invention, X a is a C1-C3 alkyl group, a C1-C3 alkoxy group, or a halogen atom, n is 0, m is 0 or 1,
R 4 and R 5 are each independently a hydrogen atom or a C1-C6 alkyl group,
R 1 is a hydrogen atom, a C1-C6 alkyl group or a halogen atom,
A compound wherein R 3 is a C1-C6 alkyl group, a C1-C6 haloalkyl group, a C1-C6 haloalkoxy group, or a —S (O) p — (C1-C6 haloalkyl) group;
In the compound of the present invention, X a is a C1-C3 alkyl group, a C1-C3 alkoxy group, or a halogen atom, n is 0, m is 0 or 1,
R 4 and R 5 are each independently a hydrogen atom or a C1-C6 alkyl group,
R 1 is a hydrogen atom, a C1-C6 alkyl group or a halogen atom,
A compound in which R 3 is a C1-C6 alkyl group, a C1-C6 haloalkyl group, or a C1-C6 haloalkoxy group;
 本発明化合物において、G、G及びGが、-CR-であり、
 G及びGが、それぞれ独立して、-CR-又は単結合であり、
 Qが、存在しないか、酸素原子、NR、又はNC(O)Rであり、
 R及びRがそれぞれ独立して、水素原子、C1-C6アルキル基又はC1-C6ハロアルキル基であり、
 Rが、水素原子、C1-C6アルキル基又はハロゲン原子であり、
 Rが、C1-C6アルキル基、C1-C6ハロアルキル基、C1-C6ハロアルコキシ基、又は-S(O)-(C1-C6ハロアルキル)基であり、
 R及びRはそれぞれ独立して水素原子、C1-C6アルキル基又は(C1-C6アルキル)カルボニル基であり、
 Rが、水素原子、又はシアノ基であり、
 Rが、C1-C6ハロアルキル基であり、
 Xが、C1-C3アルキル基、C1-C3アルコキシ基、又はハロゲン原子であり、nが0であり、mが0又は1である化合物;
In the compound of the present invention, G 1 , G 2 and G 5 are —CR 6 R 7 —,
G 3 and G 4 are each independently —CR 6 R 7 — or a single bond,
Q is absent or is an oxygen atom, NR 8 , or NC (O) R 9 ;
R 6 and R 7 are each independently a hydrogen atom, a C1-C6 alkyl group or a C1-C6 haloalkyl group,
R 1 is a hydrogen atom, a C1-C6 alkyl group or a halogen atom,
R 3 is a C1-C6 alkyl group, a C1-C6 haloalkyl group, a C1-C6 haloalkoxy group, or a —S (O) p — (C1-C6 haloalkyl) group,
R 4 and R 5 are each independently a hydrogen atom, a C1-C6 alkyl group or a (C1-C6 alkyl) carbonyl group,
R 8 is a hydrogen atom or a cyano group,
R 9 is a C1-C6 haloalkyl group,
A compound in which X a is a C1-C3 alkyl group, a C1-C3 alkoxy group, or a halogen atom, n is 0, and m is 0 or 1;
 本発明化合物において、G、G及びGが、-CHR-であり、
 G及びGが、それぞれ独立して、-CHR-又は単結合であり、
 Qが、存在しないか、酸素原子、NR、又はNC(O)Rであり、
 Rがそれぞれ独立して、水素原子又はC1-C6アルキル基であり、
 Rが、水素原子、C1-C6アルキル基又はハロゲン原子であり、
 Rが、C1-C6ハロアルキル基、又はC1-C6ハロアルコキシ基であり、
 Rが、C1-C6アルキル基、C1-C6ハロアルキル基、C1-C6ハロアルコキシ基、又はC1-C6ハロアルキルスルファニル基であり、
 R及びRはそれぞれ独立して水素原子又はC1-C6アルキル基であり、
 Rが、シアノ基であり、
 Rが、C1-C6ハロアルキル基であり、
 Xが、C1-C3アルキル基、C1-C3アルコキシ基、又はハロゲン原子であり、
 nが0であり、mが0又は1である化合物; 
In the compound of the present invention, G 1 , G 2 and G 5 are —CHR 6 —,
G 3 and G 4 are each independently —CHR 6 — or a single bond,
Q is absent or is an oxygen atom, NR 8 , or NC (O) R 9 ;
Each R 6 is independently a hydrogen atom or a C1-C6 alkyl group;
R 1 is a hydrogen atom, a C1-C6 alkyl group or a halogen atom,
R 2 is a C1-C6 haloalkyl group or a C1-C6 haloalkoxy group,
R 3 is a C1-C6 alkyl group, a C1-C6 haloalkyl group, a C1-C6 haloalkoxy group, or a C1-C6 haloalkylsulfanyl group,
R 4 and R 5 are each independently a hydrogen atom or a C1-C6 alkyl group,
R 8 is a cyano group,
R 9 is a C1-C6 haloalkyl group,
X a is a C1-C3 alkyl group, a C1-C3 alkoxy group, or a halogen atom,
a compound wherein n is 0 and m is 0 or 1;
 本発明化合物において、kが0である化合物;
 本発明化合物において、kが1である化合物。
A compound of the present invention in which k is 0;
In the compounds of the present invention, a compound wherein k is 1.
 次に、本発明化合物の製造法について説明する。 Next, a method for producing the compound of the present invention will be described.
 本発明化合物及び中間体化合物は、例えば、以下の製造法1~製造法10に準じて製造することができる。 The compound of the present invention and the intermediate compound can be produced, for example, according to the following production methods 1 to 10.
製造法1
 本発明化合物は、下記の方法に従って製造することができる。
Manufacturing method 1
The compound of the present invention can be produced according to the following method.
Figure JPOXMLDOC01-appb-I000003
Figure JPOXMLDOC01-appb-I000003
[式中、ZはC1-C4アルキル基を表し、その他の記号は式(1)と同じ意味を表す。]
 まず、式(M1)で表される化合物(以下、化合物(M1)と記す。)から式(M2)で表される化合物(以下、化合物(M2)と記す。)を製造する方法について記載する。
[Wherein Z represents a C1-C4 alkyl group, and other symbols have the same meaning as in formula (1). ]
First, it describes about the method of manufacturing the compound (henceforth a compound (M2)) represented by a formula (M2) from the compound (henceforth a compound (M1)) represented by a formula (M1). .
 化合物(M2)は、化合物(M1)と式(R1)で表される化合物(以下、化合物(R1)と記す。)とを塩基の存在下で反応させることにより製造することができる。化合物(M1)は、国際公開第2005/073165号に記載の方法に準じて製造することができる。化合物(R1)は、市販の化合物である。 Compound (M2) can be produced by reacting compound (M1) with a compound represented by formula (R1) (hereinafter referred to as compound (R1)) in the presence of a base. Compound (M1) can be produced according to the method described in International Publication No. 2005/073165. Compound (R1) is a commercially available compound.
 該反応は、通常溶媒の存在下で行われる。反応に用いられる溶媒としては、例えばジクロロメタン、クロロホルム等の脂肪族ハロゲン化炭化水素類(以下、脂肪族ハロゲン化炭化水素類と記す。);アセトニトリル等のニトリル類(以下、ニトリル類と記す。);テトラヒドロフラン(以下、THFと記す。)、エチレングリコールジメチルエーテル、メチルtert-ブチルエーテル(以下、MTBEと記す。)、1,4-ジオキサン等のエーテル類(以下、エーテル類と記す。);アセトン、エチルメチルケトン、イソブチルメチルケトン等のケトン類(以下、ケトン類と記す。);酢酸メチルや酢酸エチル等のエステル類(以下、エステル類と記す。);トルエン、キシレン等の芳香族炭化水素類(以下、芳香族炭化水素類と記す。);ジメチルホルムアミド(以下、DMFと記す。)、N-メチルピロリドン、ジメチルスルホキシド等の非プロトン性極性溶媒(以下、非プロトン性極性溶媒と記す。);及びこれらの混合物が挙げられる。 The reaction is usually performed in the presence of a solvent. Examples of the solvent used in the reaction include aliphatic halogenated hydrocarbons such as dichloromethane and chloroform (hereinafter referred to as aliphatic halogenated hydrocarbons); nitriles such as acetonitrile (hereinafter referred to as nitriles). Ethers such as tetrahydrofuran (hereinafter referred to as THF), ethylene glycol dimethyl ether, methyl tert-butyl ether (hereinafter referred to as MTBE), 1,4-dioxane (hereinafter referred to as ethers); acetone, ethyl Ketones such as methyl ketone and isobutyl methyl ketone (hereinafter referred to as ketones); esters such as methyl acetate and ethyl acetate (hereinafter referred to as esters); aromatic hydrocarbons such as toluene and xylene ( Hereinafter referred to as aromatic hydrocarbons); dimethylformamide (hereinafter referred to as DMF) Be), N- methylpyrrolidone, aprotic polar solvents such as dimethyl sulfoxide (hereinafter, referred to as aprotic polar solvent);.. And mixtures thereof.
 反応に用いられる塩基としては、例えばトリエチルアミン、ジイソプロピルエチルアミン、ピリジン、1,8-ジアザビシクロ[5.4.0]ウンデカ-7-エン等の有機塩基類(以下、有機塩基類と記す。);炭酸ナトリウム、炭酸カリウム等のアルカリ金属炭酸塩類(以下、アルカリ金属炭酸塩類と記す。);炭酸カルシウム等のアルカリ土類金属炭酸塩類(以下、アルカリ土類金属炭酸塩類と記す。);炭酸水素ナトリウム等のアルカリ金属炭酸水素塩類(以下、アルカリ金属炭酸水素塩類と記す。);水酸化ナトリウムや水酸化カリウム等のアルカリ金属水酸化物類(以下、アルカリ金属水酸化物類と記す。);水酸化カルシウム等のアルカリ土類金属水酸化物類(以下、アルカリ土類金属水酸化物類と記す。);ナトリウムメトキシドやナトリウムエトキシド等の金属アルコキシド類(以下、金属アルコキシド類と記す。);水素化ナトリウム等のアルカリ金属水素化物類(以下、アルカリ金属水素化物類と記す。)が挙げられる。 Examples of the base used in the reaction include organic bases such as triethylamine, diisopropylethylamine, pyridine, 1,8-diazabicyclo [5.4.0] undec-7-ene (hereinafter referred to as organic bases); Alkali metal carbonates such as sodium and potassium carbonate (hereinafter referred to as alkali metal carbonates); alkaline earth metal carbonates such as calcium carbonate (hereinafter referred to as alkaline earth metal carbonates); sodium hydrogen carbonate and the like Alkali metal hydrogen carbonates (hereinafter referred to as alkali metal hydrogen carbonates); alkali metal hydroxides such as sodium hydroxide and potassium hydroxide (hereinafter referred to as alkali metal hydroxides); Alkaline earth metal hydroxides such as calcium (hereinafter referred to as alkaline earth metal hydroxides); sodium metho Metal alkoxides such as Sid and sodium ethoxide (hereinafter, referred to as metal alkoxides.); Alkali metal hydrides such as sodium hydride (. Which hereinafter referred to as alkali metal hydrides) are exemplified.
 反応は、必要に応じて触媒を添加して行うこともできる。反応に用いられる触媒としては、例えばジメチルアミノピリジンが挙げられる。 The reaction can be performed by adding a catalyst as necessary. Examples of the catalyst used in the reaction include dimethylaminopyridine.
 反応には、化合物(M1)1モルに対して、化合物(R1)が通常1~2モルの割合、塩基が通常1~2モルの割合、触媒が通常0.01~0.5モルの割合で用いられる。 In the reaction, with respect to 1 mole of the compound (M1), the ratio of the compound (R1) is usually 1 to 2 moles, the base is usually 1 to 2 moles, and the catalyst is usually 0.01 to 0.5 moles Used in
 反応温度は、通常-30~150℃の範囲である。反応時間は通常0.1~12時間の範囲である。 The reaction temperature is usually in the range of −30 to 150 ° C. The reaction time is usually in the range of 0.1 to 12 hours.
 反応終了後は、反応混合物に水を加え、有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作をすることにより、化合物(M2)を得ることができる。 After completion of the reaction, compound (M2) can be obtained by performing post-treatment operations such as adding water to the reaction mixture, extracting with an organic solvent, and drying and concentrating the organic layer.
 次に、化合物(M2)から本発明化合物を製造する方法について記載する。 Next, a method for producing the compound of the present invention from the compound (M2) will be described.
 本発明化合物は、化合物(M2)と式(R2)で表される化合物(以下、化合物(R2)と記す。)と反応させることにより製造することができる。 The compound of the present invention can be produced by reacting the compound (M2) with a compound represented by the formula (R2) (hereinafter referred to as compound (R2)).
 該反応は、通常溶媒の存在下で行われる。反応に用いられる溶媒としては、例えば脂肪族ハロゲン化炭化水素類、ニトリル類、エーテル類、ケトン類、エステル類、芳香族炭化水素類、非プロトン性極性溶媒、メタノール、エタノール、イソプロパノール等のアルコール類(以下、アルコール類と記す。)、水及びこれらの混合物が挙げられる。 The reaction is usually performed in the presence of a solvent. Examples of the solvent used in the reaction include aliphatic halogenated hydrocarbons, nitriles, ethers, ketones, esters, aromatic hydrocarbons, aprotic polar solvents, alcohols such as methanol, ethanol, and isopropanol. (Hereinafter referred to as alcohols), water and mixtures thereof.
 反応は、必要に応じて塩基を添加して行うこともできる。反応に用いられる塩基としては、例えば有機塩基類、アルカリ金属炭酸塩類、アルカリ土類金属炭酸塩類、アルカリ金属炭酸水素塩類、アルカリ金属水酸化物類、アルカリ土類金属水酸化物類、金属アルコキシド類、アルカリ金属水素化物類が挙げられる。 The reaction can be performed by adding a base as necessary. Examples of the base used in the reaction include organic bases, alkali metal carbonates, alkaline earth metal carbonates, alkali metal hydrogen carbonates, alkali metal hydroxides, alkaline earth metal hydroxides, metal alkoxides. And alkali metal hydrides.
 反応には、化合物(M2)1モルに対して、化合物(R2)が通常1~10モルの割合、塩基が通常1~10モルの割合で用いられる。 In the reaction, the compound (R2) is usually used in a proportion of 1 to 10 mol and the base is usually used in a proportion of 1 to 10 mol with respect to 1 mol of the compound (M2).
 反応温度は、通常-30~150℃の範囲である。反応時間は通常0.1~12時間の範囲である。 The reaction temperature is usually in the range of −30 to 150 ° C. The reaction time is usually in the range of 0.1 to 12 hours.
 反応終了後は、反応混合物を有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作をすることにより、本発明化合物を得ることができる。 After completion of the reaction, the compound of the present invention can be obtained by post-treatment operations such as extraction of the reaction mixture with an organic solvent, drying and concentration of the organic layer.
製造法2
 本発明化合物は、下記の方法に従っても製造することができる。
Manufacturing method 2
The compound of the present invention can also be produced according to the following method.
Figure JPOXMLDOC01-appb-I000004
Figure JPOXMLDOC01-appb-I000004
[式中、記号は前記と同じ意味を表す。]
 まず、化合物(M2)から式(M3)で表される化合物(以下、化合物(M3)と記す。)を製造する方法について記載する。
[Wherein the symbols have the same meaning as described above. ]
First, a method for producing a compound represented by formula (M3) from compound (M2) (hereinafter referred to as compound (M3)) will be described.
 化合物(M3)は、化合物(M2)を塩基の存在下で反応させることにより製造することができる。 Compound (M3) can be produced by reacting compound (M2) in the presence of a base.
 該反応は、通常溶媒の存在下で行われる。反応に用いられる溶媒としては、例えば水及びアルコール類と水の混合物が挙げられる。 The reaction is usually performed in the presence of a solvent. Examples of the solvent used for the reaction include water and a mixture of alcohols and water.
 反応に用いられる塩基としては、アルカリ金属水酸化物類、アルカリ土類金属水酸化物類が挙げられる。 Examples of the base used in the reaction include alkali metal hydroxides and alkaline earth metal hydroxides.
 反応は、化合物(M2)1モルに対して、塩基が通常1~10モルの割合で用いられる。 In the reaction, the base is usually used at a ratio of 1 to 10 mol per 1 mol of the compound (M2).
 反応温度は、通常0~150℃の範囲である。反応時間は通常0.1~12時間の範囲である。 The reaction temperature is usually in the range of 0 to 150 ° C. The reaction time is usually in the range of 0.1 to 12 hours.
 反応終了後は、反応混合物に水を加え、有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作をすることにより、化合物(M3)を得ることができる。 After completion of the reaction, compound (M3) can be obtained by performing post-treatment operations such as adding water to the reaction mixture, extracting with an organic solvent, and drying and concentrating the organic layer.
 次に、化合物(M3)から本発明化合物を製造する方法について記載する。 Next, a method for producing the compound of the present invention from the compound (M3) will be described.
 本発明化合物は、化合物(M3)と化合物(R2)とを縮合剤の存在下で反応させることにより製造することができる。 The compound of the present invention can be produced by reacting the compound (M3) and the compound (R2) in the presence of a condensing agent.
 該反応は、通常溶媒の存在下で行われる。反応に用いられる溶媒としては、例えば脂肪族ハロゲン化炭化水素類、ニトリル類、エーテル類、ケトン類、エステル類、芳香族炭化水素類、非プロトン性極性溶媒、ピリジン、キノリン等の含窒素芳香族化合物類(以下、含窒素芳香族化合物類と記す。)、水及びこれらの混合物が挙げられる。 The reaction is usually performed in the presence of a solvent. Examples of the solvent used in the reaction include aliphatic halogenated hydrocarbons, nitriles, ethers, ketones, esters, aromatic hydrocarbons, aprotic polar solvents, nitrogen-containing aromatics such as pyridine and quinoline. Examples thereof include compounds (hereinafter referred to as nitrogen-containing aromatic compounds), water, and mixtures thereof.
 縮合剤としては、例えば1-エチル-3-(3-ジメチルアミノプロピル)カルボジイミド塩酸塩、1,3-ジシクロヘキシルカルボジイミド等のカルボジイミド類(以下、カルボジイミド類と記す。)、N,N’-カルボニルジイミダゾール等のイミダゾール類(以下、イミダゾール類と記す。)、4-(4,6-ジメトキシ-1,3,5-トリアジン-2-イル)-4-メチルモルホニウムクロリドn水和物、トリフルオロメタンスルホン酸(4,6-ジメトキシ-1,3,5-トリアジン-2-イル)-(2-オクトキシ-2-オキソエチル)ジメチルアンモニウム等のトリアジン類(以下、トリアジン類と記す。)、1H-ベンゾトリアゾール-1-イルオキシトリス(ジメチルアミノ)ホスホニウムヘキサフルオロりん酸塩、クロロトリピロリジノホスホニウムヘキサフルオロりん酸塩等のホスホニウム類(以下、ホスホニウム類と記す。)、O-(7-アザベンゾトリアゾール-1-イル)-N,N,N’,N’-テトラメチルウロニウムヘキサフルオロりん酸塩、O-(7-アザベンゾトリアゾール-1-イル)-N,N,N’,N’-テトラメチルウロニウムヘキサフルオロりん酸塩(以下、HATUと記す。)等のウロニウム類(以下、ウロニウム類と記す。)が挙げられる。 Examples of the condensing agent include carbodiimides such as 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride and 1,3-dicyclohexylcarbodiimide (hereinafter referred to as carbodiimides), N, N′-carbonyldi- Imidazoles such as imidazole (hereinafter referred to as imidazoles), 4- (4,6-dimethoxy-1,3,5-triazin-2-yl) -4-methylmorphonium chloride n hydrate, trifluoro Triazines such as romethanesulfonic acid (4,6-dimethoxy-1,3,5-triazin-2-yl)-(2-octoxy-2-oxoethyl) dimethylammonium (hereinafter referred to as triazines), 1H— Benzotriazol-1-yloxytris (dimethylamino) phosphonium hexafluorophosphate, Phosphoniums such as rotripyrrolidinophosphonium hexafluorophosphate (hereinafter referred to as phosphoniums), O- (7-azabenzotriazol-1-yl) -N, N, N ′, N′-tetramethyluro Nium hexafluorophosphate, O- (7-azabenzotriazol-1-yl) -N, N, N ′, N′-tetramethyluronium hexafluorophosphate (hereinafter referred to as HATU), etc. Uroniums (hereinafter referred to as uroniums).
 反応は、必要に応じて触媒を加えて行うこともできる。触媒としては、例えば1-ヒドロキシベンゾトリアゾール(以下、HOBtと記す)、1-ヒドロキシアザベンゾトリアオール(以下、HOAtと記す。)が挙げられる。 The reaction can be performed by adding a catalyst as necessary. Examples of the catalyst include 1-hydroxybenzotriazole (hereinafter referred to as HOBt) and 1-hydroxyazabenzotriol (hereinafter referred to as HOAt).
 反応には、化合物(M3)1モルに対して、化合物(R2)が通常0.5~2モルの割合、縮合剤が通常1~5モルの割合、触媒が通常0.01~1モルの割合で用いられる。 In the reaction, with respect to 1 mol of the compound (M3), the compound (R2) is usually 0.5 to 2 mol, the condensing agent is usually 1 to 5 mol, and the catalyst is usually 0.01 to 1 mol. Used in proportions.
 反応温度は通常0~120℃の範囲内である。反応時間は通常0.1~24時間の範囲内である。 The reaction temperature is usually in the range of 0 to 120 ° C. The reaction time is usually in the range of 0.1 to 24 hours.
 反応終了後は、反応混合物を有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作をすることにより、本発明化合物を得ることができる。 After completion of the reaction, the compound of the present invention can be obtained by post-treatment operations such as extraction of the reaction mixture with an organic solvent, drying and concentration of the organic layer.
製造法3
 本発明化合物は、下記の方法に従っても製造することができる。
Production method 3
The compound of the present invention can also be produced according to the following method.
Figure JPOXMLDOC01-appb-I000005
Figure JPOXMLDOC01-appb-I000005
[式中、記号は前記と同じ意味を表す。]
 まず、化合物(R2)から式(M5)で表される化合物(以下、化合物(M5)と記す。)を製造する方法について記載する。
[Wherein the symbols have the same meaning as described above. ]
First, a method for producing a compound represented by the formula (M5) from the compound (R2) (hereinafter referred to as the compound (M5)) will be described.
 化合物(M5)は、化合物(R2)と化合物(R1)とを塩基の存在下で反応させることにより製造することができる。 Compound (M5) can be produced by reacting compound (R2) with compound (R1) in the presence of a base.
 該反応は、通常溶媒の存在下で行われる。反応に用いられる溶媒としては、例えば脂肪族ハロゲン化炭化水素類、ニトリル類、エーテル類、ケトン類、エステル類、芳香族炭化水素類、非プロトン性極性溶媒及びこれらの混合物が挙げられる。 The reaction is usually performed in the presence of a solvent. Examples of the solvent used in the reaction include aliphatic halogenated hydrocarbons, nitriles, ethers, ketones, esters, aromatic hydrocarbons, aprotic polar solvents, and mixtures thereof.
 反応に用いられる塩基としては、例えば有機塩基類、アルカリ金属炭酸塩類、アルカリ土類金属炭酸塩類、アルカリ金属炭酸水素塩類、アルカリ金属水酸化物類、アルカリ土類金属水酸化物類、金属アルコキシド類、アルカリ金属水素化物類が挙げられる。 Examples of the base used in the reaction include organic bases, alkali metal carbonates, alkaline earth metal carbonates, alkali metal hydrogen carbonates, alkali metal hydroxides, alkaline earth metal hydroxides, metal alkoxides. And alkali metal hydrides.
 反応は、必要に応じて触媒を添加して行うこともできる。反応に用いられる触媒としては、例えばジメチルアミノピリジンが挙げられる。 The reaction can be performed by adding a catalyst as necessary. Examples of the catalyst used in the reaction include dimethylaminopyridine.
 反応には、化合物(R2)1モルに対して、化合物(R1)が通常1~2モルの割合、塩基が通常1~2モルの割合、触媒が通常0.01~0.5モルの割合で用いられる。 In the reaction, with respect to 1 mol of compound (R2), compound (R1) is usually in a proportion of 1 to 2 mol, base is usually in a proportion of 1 to 2 mol, and catalyst is usually in a proportion of 0.01 to 0.5 mol. Used in
 反応温度は、通常-30~150℃の範囲である。反応時間は通常0.1~12時間の範囲である。 The reaction temperature is usually in the range of −30 to 150 ° C. The reaction time is usually in the range of 0.1 to 12 hours.
 反応終了後は、反応混合物に水を加え、有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作をすることにより、化合物(M5)を得ることができる。 After completion of the reaction, compound (M5) can be obtained by performing post-treatment operations such as adding water to the reaction mixture, extracting with an organic solvent, and drying and concentrating the organic layer.
 次に、化合物(M5)から式(M6)で表される化合物(以下、化合物(M6)と記す。)を製造する方法について記載する。 Next, a method for producing a compound represented by formula (M6) from compound (M5) (hereinafter referred to as compound (M6)) will be described.
 化合物(M6)は、化合物(M5)を塩基の存在下で反応させることにより製造することができる。 Compound (M6) can be produced by reacting compound (M5) in the presence of a base.
 該反応は、通常溶媒の存在下で行われる。反応に用いられる溶媒としては、例えば水及びアルコール類と水の混合物が挙げられる。 The reaction is usually performed in the presence of a solvent. Examples of the solvent used for the reaction include water and a mixture of alcohols and water.
 反応に用いられる塩基としては、アルカリ金属水酸化物類、アルカリ土類金属水酸化物類が挙げられる。 Examples of the base used in the reaction include alkali metal hydroxides and alkaline earth metal hydroxides.
 反応は、化合物(M5)1モルに対して、塩基が通常1~10モルの割合で用いられる。 In the reaction, the base is usually used at a ratio of 1 to 10 mol per 1 mol of the compound (M5).
 反応温度は、通常0~150℃の範囲である。反応時間は通常0.1~12時間の範囲である。 The reaction temperature is usually in the range of 0 to 150 ° C. The reaction time is usually in the range of 0.1 to 12 hours.
 反応終了後は、反応混合物を有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作をすることにより、化合物(M6)を得ることができる。 After completion of the reaction, the compound (M6) can be obtained by performing post-treatment operations such as extraction of the reaction mixture with an organic solvent and drying and concentration of the organic layer.
 次に、化合物(M6)から本発明化合物を製造する方法について記載する。 Next, a method for producing the compound of the present invention from the compound (M6) will be described.
 本発明化合物は、化合物(M6)と化合物(M1)とを縮合剤の存在下で反応させることにより製造することができる。 The compound of the present invention can be produced by reacting the compound (M6) and the compound (M1) in the presence of a condensing agent.
 該反応は、通常溶媒の存在下で行われる。反応に用いられる溶媒としては、例えば脂肪族ハロゲン化炭化水素類、ニトリル類、エーテル類、ケトン類、エステル類、芳香族炭化水素類、非プロトン性極性溶媒、ピリジン、キノリン等の含窒素芳香族化合物類(以下、含窒素芳香族化合物類と記す。)、水及びこれらの混合物が挙げられる。 The reaction is usually performed in the presence of a solvent. Examples of the solvent used in the reaction include aliphatic halogenated hydrocarbons, nitriles, ethers, ketones, esters, aromatic hydrocarbons, aprotic polar solvents, nitrogen-containing aromatics such as pyridine and quinoline. Examples thereof include compounds (hereinafter referred to as nitrogen-containing aromatic compounds), water, and mixtures thereof.
 縮合剤としては、例えばカルボジイミド類、イミダゾール類、トリアジン類、ホスホニウム類、ウロニウム類が挙げられる。 Examples of the condensing agent include carbodiimides, imidazoles, triazines, phosphoniums, and uroniums.
 反応は、必要に応じて触媒を加えて行うこともできる。触媒としては、例えばHOBt、HOAtが挙げられる。 The reaction can be performed by adding a catalyst as necessary. Examples of the catalyst include HOBt and HOAt.
 反応には、化合物(M6)1モルに対して、化合物(M1)が通常0.5~2モルの割合、縮合剤が通常1~5モルの割合、触媒が通常0.01~1モルの割合で用いられる。 In the reaction, with respect to 1 mol of the compound (M6), the compound (M1) is usually 0.5 to 2 mol, the condensing agent is usually 1 to 5 mol, and the catalyst is usually 0.01 to 1 mol. Used in proportions.
 反応温度は通常0~120℃の範囲内である。反応時間は通常0.1~24時間の範囲内である。 The reaction temperature is usually in the range of 0 to 120 ° C. The reaction time is usually in the range of 0.1 to 24 hours.
 反応終了後は、反応混合物に水を加え、有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作をすることにより、本発明化合物を得ることができる。 After completion of the reaction, the compound of the present invention can be obtained by post-treatment operations such as adding water to the reaction mixture, extracting with an organic solvent, and drying and concentrating the organic layer.
製造法4
 本発明化合物は、下記の方法に従っても製造することができる。
Manufacturing method 4
The compound of the present invention can also be produced according to the following method.
Figure JPOXMLDOC01-appb-I000006
Figure JPOXMLDOC01-appb-I000006
[式中、記号は式(1)と同じ意味を表す。]
 本発明化合物は、化合物(M1)と化合物(M7)とを塩基の存在下で反応させることにより製造することができる。
[Wherein the symbols have the same meaning as in formula (1). ]
The compound of the present invention can be produced by reacting compound (M1) with compound (M7) in the presence of a base.
 該反応は、通常溶媒の存在下で行われる。反応に用いられる溶媒としては、例えば脂肪族ハロゲン化炭化水素類、ニトリル類、エーテル類、ケトン類、エステル類、芳香族炭化水素類、非プロトン性極性溶媒及びこれらの混合物が挙げられる。 The reaction is usually performed in the presence of a solvent. Examples of the solvent used in the reaction include aliphatic halogenated hydrocarbons, nitriles, ethers, ketones, esters, aromatic hydrocarbons, aprotic polar solvents, and mixtures thereof.
 反応に用いられる塩基としては、例えば有機塩基類、アルカリ金属炭酸塩類、アルカリ土類金属炭酸塩類、アルカリ金属炭酸水素塩類、アルカリ金属水酸化物類、アルカリ土類金属水酸化物類、金属アルコキシド類、アルカリ金属水素化物類が挙げられる。 Examples of the base used in the reaction include organic bases, alkali metal carbonates, alkaline earth metal carbonates, alkali metal hydrogen carbonates, alkali metal hydroxides, alkaline earth metal hydroxides, metal alkoxides. And alkali metal hydrides.
 反応は、必要に応じて触媒を添加して行うこともできる。反応に用いられる触媒としては、例えばジメチルアミノピリジンが挙げられる。 The reaction can be performed by adding a catalyst as necessary. Examples of the catalyst used in the reaction include dimethylaminopyridine.
 反応には、化合物(M1)1モルに対して、化合物(M7)が通常0.5~2モルの割合、塩基が通常1~2モルの割合、触媒が通常0.01~0.5モルの割合で用いられる。 In the reaction, with respect to 1 mol of compound (M1), compound (M7) is usually in a proportion of 0.5 to 2 mol, base is usually in a proportion of 1 to 2 mol, and catalyst is usually in a proportion of 0.01 to 0.5 mol. It is used in the ratio.
 反応温度は、通常-30~150℃の範囲である。反応時間は通常0.1~12時間の範囲である。 The reaction temperature is usually in the range of −30 to 150 ° C. The reaction time is usually in the range of 0.1 to 12 hours.
 反応終了後は、反応混合物に水を加え、有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作をすることにより、本発明化合物を得ることができる。 After completion of the reaction, the compound of the present invention can be obtained by post-treatment operations such as adding water to the reaction mixture, extracting with an organic solvent, and drying and concentrating the organic layer.
製造法5
 次に、化合物(M6)から式(M7)を製造する方法について記載する。
Manufacturing method 5
Next, a method for producing formula (M7) from compound (M6) will be described.
Figure JPOXMLDOC01-appb-I000007
Figure JPOXMLDOC01-appb-I000007
[式中、記号は式(1)と同じ意味を表す。]
 化合物(M7)は、化合物(M6)を塩素化剤と反応させることにより製造することができる。
[Wherein the symbols have the same meaning as in formula (1). ]
Compound (M7) can be produced by reacting compound (M6) with a chlorinating agent.
 該反応は、溶媒の存在下、又は非存在下で行われる。反応に用いられる溶媒としては、例えば脂肪族ハロゲン化炭化水素類、ニトリル類、エーテル類、ケトン類、エステル類、芳香族炭化水素類、非プロトン性極性溶媒及びこれらの混合物が挙げられる。 The reaction is performed in the presence or absence of a solvent. Examples of the solvent used in the reaction include aliphatic halogenated hydrocarbons, nitriles, ethers, ketones, esters, aromatic hydrocarbons, aprotic polar solvents, and mixtures thereof.
 反応に用いられる塩素化剤としては、例えば塩化チオニル、塩化オキサリル、塩化ホスホリル、塩化スルフリル、三塩化リン、五塩化リンが挙げられる。 Examples of the chlorinating agent used in the reaction include thionyl chloride, oxalyl chloride, phosphoryl chloride, sulfuryl chloride, phosphorus trichloride, and phosphorus pentachloride.
 反応には、化合物(M6)1モルに対して、塩素化剤が通常1~100モルの割合で用いられる。 In the reaction, the chlorinating agent is usually used at a ratio of 1 to 100 mol per 1 mol of the compound (M6).
 反応温度は、通常-30~150℃の範囲である。反応時間は通常0.1~12時間の範囲である。 The reaction temperature is usually in the range of −30 to 150 ° C. The reaction time is usually in the range of 0.1 to 12 hours.
 反応終了後は、反応混合物に水を加え、濃縮する等の後処理操作をすることにより、化合物(M7)を得ることができる。 After completion of the reaction, the compound (M7) can be obtained by post-treatment such as adding water to the reaction mixture and concentrating.
製造法6
 式(1b)で示される化合物(以下、化合物(1b)と記す。)、及び式(1c)で示される化合物(以下、化合物(1c)と記す。)は、下記スキームにより製造することができる。
Figure JPOXMLDOC01-appb-I000008
Manufacturing method 6
A compound represented by formula (1b) (hereinafter referred to as compound (1b)) and a compound represented by formula (1c) (hereinafter referred to as compound (1c)) can be produced by the following scheme. .
Figure JPOXMLDOC01-appb-I000008
[式中、記号は式(1)と同じ意味を表す。]
 まず、式(1a)で示される化合物(以下、化合物(1a)と記す。)から化合物(1b)を製造する方法について記載する。
[Wherein the symbols have the same meaning as in formula (1). ]
First, a method for producing the compound (1b) from the compound represented by the formula (1a) (hereinafter referred to as the compound (1a)) will be described.
 化合物(1b)は化合物(1a)と酸化剤とを反応させることにより製造することができる。 Compound (1b) can be produced by reacting compound (1a) with an oxidizing agent.
 該反応は、通常溶媒の存在下で行われる。反応に用いられる溶媒としては、例えば脂肪族ハロゲン化炭化水素類、ニトリル類、アルコール類、酢酸、水及びこれらの混合物が挙げられる。 The reaction is usually performed in the presence of a solvent. Examples of the solvent used in the reaction include aliphatic halogenated hydrocarbons, nitriles, alcohols, acetic acid, water, and mixtures thereof.
 反応に用いられる酸化剤としては、例えば過ヨウ素酸ナトリウム、m-クロロ過安息香酸(以下、mCPBAと記す。)、及び過酸化水素が挙げられる。 Examples of the oxidizing agent used in the reaction include sodium periodate, m-chloroperbenzoic acid (hereinafter referred to as mCPBA), and hydrogen peroxide.
 酸化剤として過酸化水素を用いる場合は、必要に応じて塩基、又は触媒を加えてもよい。 When hydrogen peroxide is used as the oxidizing agent, a base or a catalyst may be added as necessary.
 反応に用いられる塩基としては、炭酸ナトリウムが挙げられる。 As the base used in the reaction, sodium carbonate can be mentioned.
 反応に用いられる触媒としては、例えばタングステン酸、タングステン酸ナトリウムが挙げられる。 Examples of the catalyst used in the reaction include tungstic acid and sodium tungstate.
 反応には、化合物(1a)1モルに対して、酸化剤が通常1~1.2モルの割合、塩基が通常0.01~1モルの割合、触媒が通常0.01~0.5モルの割合で用いられる。 In the reaction, with respect to 1 mol of the compound (1a), the oxidizing agent is usually in a proportion of 1 to 1.2 mol, the base is usually in a proportion of 0.01 to 1 mol, and the catalyst is usually in a proportion of 0.01 to 0.5 mol. It is used in the ratio.
 反応温度は、通常-20~80℃の範囲である。反応時間は通常0.1~12時間の範囲である。 The reaction temperature is usually in the range of −20 to 80 ° C. The reaction time is usually in the range of 0.1 to 12 hours.
 反応終了後は、反応混合物に水を加え、有機溶媒で抽出し、有機層を必要に応じて還元剤(例えば亜硫酸ナトリウム、チオ硫酸ナトリウム)の水溶液、及び塩基(例えば炭酸水素ナトリウム)の水溶液で洗浄する。有機層を乾燥、濃縮することにより、化合物(1b)を得ることができる。 After completion of the reaction, water is added to the reaction mixture and extracted with an organic solvent, and the organic layer is extracted with an aqueous solution of a reducing agent (for example, sodium sulfite, sodium thiosulfate) and an aqueous solution of a base (for example, sodium bicarbonate) as necessary. Wash. Compound (1b) can be obtained by drying and concentrating the organic layer.
 次に、化合物(1b)から化合物(1c)を製造する方法について記載する。 Next, a method for producing the compound (1c) from the compound (1b) will be described.
 化合物(1c)は化合物(1b)と酸化剤とを反応させることにより製造することができる。 Compound (1c) can be produced by reacting compound (1b) with an oxidizing agent.
 該反応は、通常溶媒の存在下で行われる。反応に用いられる溶媒としては、例えば脂肪族ハロゲン化炭化水素類、ニトリル類、アルコール類、酢酸、水及びこれらの混合物が挙げられる。 The reaction is usually performed in the presence of a solvent. Examples of the solvent used in the reaction include aliphatic halogenated hydrocarbons, nitriles, alcohols, acetic acid, water, and mixtures thereof.
 反応に用いられる酸化剤としては、例えばmCPBA及び過酸化水素が挙げられる。酸化剤として過酸化水素を用いる場合は、必要に応じて塩基、又は触媒を加えてもよい。 Examples of the oxidizing agent used in the reaction include mCPBA and hydrogen peroxide. When hydrogen peroxide is used as the oxidizing agent, a base or a catalyst may be added as necessary.
 反応に用いられる塩基としては、炭酸ナトリウムが挙げられる。 As the base used in the reaction, sodium carbonate can be mentioned.
 反応に用いられる触媒としては、タングステン酸ナトリウムが挙げられる。 Examples of the catalyst used in the reaction include sodium tungstate.
 反応には、化合物(1b)1モルに対して、酸化剤が通常1~4モルの割合、塩基が通常0.01~1モルの割合、触媒が通常0.01~0.5モルの割合で用いられる。 In the reaction, with respect to 1 mol of compound (1b), the oxidizing agent is usually in a proportion of 1 to 4 mol, the base is usually in a proportion of 0.01 to 1 mol, and the catalyst is usually in a proportion of 0.01 to 0.5 mol. Used in
 反応温度は、通常-20~120℃の範囲である。反応時間は通常0.1~12時間の範囲である。 The reaction temperature is usually in the range of −20 to 120 ° C. The reaction time is usually in the range of 0.1 to 12 hours.
 反応終了後は、反応混合物に水を加え、有機溶媒で抽出し、有機層を必要に応じて還元剤(例えば亜硫酸ナトリウム、チオ硫酸ナトリウム)の水溶液、及び塩基(例えば炭酸水素ナトリウム)の水溶液で洗浄する。この有機層を乾燥、濃縮することにより、化合物(1c)を得ることができる。 After completion of the reaction, water is added to the reaction mixture and extracted with an organic solvent, and the organic layer is extracted with an aqueous solution of a reducing agent (for example, sodium sulfite, sodium thiosulfate) and an aqueous solution of a base (for example, sodium bicarbonate) as necessary. Wash. Compound (1c) can be obtained by drying and concentrating the organic layer.
 また、化合物(1c)は、化合物(1a)と酸化剤とを反応させることで、一段階反応(ワンポット)で製造することができる。 Also, the compound (1c) can be produced in a one-step reaction (one pot) by reacting the compound (1a) with an oxidizing agent.
 該反応は、通常溶媒の存在下で行われる。反応に用いられる溶媒としては、例えば脂肪族ハロゲン化炭化水素類、ニトリル類、アルコール類、酢酸、水及びこれらの混合物が挙げられる。 The reaction is usually performed in the presence of a solvent. Examples of the solvent used in the reaction include aliphatic halogenated hydrocarbons, nitriles, alcohols, acetic acid, water, and mixtures thereof.
 反応に用いられる酸化剤としては、例えばmCPBA及び過酸化水素が挙げられる。 Examples of the oxidizing agent used in the reaction include mCPBA and hydrogen peroxide.
 反応の酸化剤として過酸化水素を用いる場合は、必要に応じて塩基、又は触媒を加えてもよい。 When hydrogen peroxide is used as the oxidant for the reaction, a base or a catalyst may be added as necessary.
 反応に用いられる塩基としては、炭酸ナトリウムが挙げられる。 As the base used in the reaction, sodium carbonate can be mentioned.
 反応に用いられる触媒としては、タングステン酸、タングステン酸ナトリウムが挙げられる。 Examples of the catalyst used for the reaction include tungstic acid and sodium tungstate.
 反応には、化合物(1a)1モルに対して、酸化剤が通常2~5モルの割合、塩基が通常0.01~1モルの割合、触媒が通常0.01~0.5モルの割合で用いられる。 In the reaction, with respect to 1 mol of compound (1a), the oxidizing agent is usually in a proportion of 2 to 5 mol, the base is usually in a proportion of 0.01 to 1 mol, and the catalyst is usually in a proportion of 0.01 to 0.5 mol. Used in
 反応温度は、通常0~120℃の範囲である。反応時間は通常0.1~12時間の範囲である。 The reaction temperature is usually in the range of 0 to 120 ° C. The reaction time is usually in the range of 0.1 to 12 hours.
 反応終了後は、反応混合物に水を加え、有機溶媒で抽出し、有機層を必要に応じて還元剤(例えば亜硫酸ナトリウム、チオ硫酸ナトリウム)の水溶液、及び塩基(例えば炭酸水素ナトリウム)の水溶液で洗浄する。有機層を、乾燥、濃縮することにより、化合物(1c)を得ることができる。 After completion of the reaction, water is added to the reaction mixture and extracted with an organic solvent, and the organic layer is extracted with an aqueous solution of a reducing agent (for example, sodium sulfite, sodium thiosulfate) and an aqueous solution of a base (for example, sodium bicarbonate) as necessary. Wash. Compound (1c) can be obtained by drying and concentrating the organic layer.
製造法7
 式(1e)で示される化合物(以下、化合物(1e)と記す。)は、式(1d)で示される化合物(以下、化合物(1d)と記す。)と酸化剤とを反応させることにより製造することができる。
Manufacturing method 7
A compound represented by formula (1e) (hereinafter referred to as compound (1e)) is produced by reacting a compound represented by formula (1d) (hereinafter referred to as compound (1d)) with an oxidizing agent. can do.
Figure JPOXMLDOC01-appb-I000009
Figure JPOXMLDOC01-appb-I000009
[式中、記号は式(1)と同じ意味を表す。]
 該反応は、通常溶媒の存在下で行われる。反応に用いられる溶媒としては、例えば脂肪族ハロゲン化炭化水素類、ニトリル類、アルコール類、酢酸、水及びこれらの混合物が挙げられる。
[Wherein the symbols have the same meaning as in formula (1). ]
The reaction is usually performed in the presence of a solvent. Examples of the solvent used in the reaction include aliphatic halogenated hydrocarbons, nitriles, alcohols, acetic acid, water, and mixtures thereof.
 反応に用いられる酸化剤としては、例えば過ヨウ素酸ナトリウム、mCPBA及び過酸化水素が挙げられる。 Examples of the oxidizing agent used in the reaction include sodium periodate, mCPBA, and hydrogen peroxide.
 酸化剤として過酸化水素を用いる場合は、必要に応じて塩基、又は触媒を加えてもよい。 When hydrogen peroxide is used as the oxidizing agent, a base or a catalyst may be added as necessary.
 反応に用いられる塩基としては、炭酸ナトリウムが挙げられる。 As the base used in the reaction, sodium carbonate can be mentioned.
 反応に用いられる触媒としては、タングステン酸、タングステン酸ナトリウムが挙げられる。 Examples of the catalyst used for the reaction include tungstic acid and sodium tungstate.
 反応には、化合物(1d)1モルに対して、酸化剤が通常1~1.2モルの割合、塩基が通常0.01~1モルの割合、触媒が通常0.01~0.5モルの割合で用いられる。 In the reaction, with respect to 1 mol of the compound (1d), the oxidizing agent is usually in a proportion of 1 to 1.2 mol, the base is usually in a proportion of 0.01 to 1 mol, and the catalyst is usually in a proportion of 0.01 to 0.5 mol. It is used in the ratio.
 反応温度は、通常-20~80℃の範囲である。反応時間は通常0.1~12時間の範囲である。 The reaction temperature is usually in the range of −20 to 80 ° C. The reaction time is usually in the range of 0.1 to 12 hours.
 反応終了後は、反応混合物に水を加え、有機溶媒で抽出し、有機層を必要に応じて還元剤(例えば亜硫酸ナトリウム、チオ硫酸ナトリウム)の水溶液、及び塩基(例えば炭酸水素ナトリウム)の水溶液で洗浄する。有機層を乾燥、濃縮することにより、化合物(1e)を得ることができる。 After completion of the reaction, water is added to the reaction mixture and extracted with an organic solvent, and the organic layer is extracted with an aqueous solution of a reducing agent (for example, sodium sulfite, sodium thiosulfate) and an aqueous solution of a base (for example, sodium bicarbonate) as necessary. Wash. Compound (1e) can be obtained by drying and concentrating the organic layer.
製造法8
 式(1f)で示される化合物(以下、化合物(1f)と記す。)は、下記スキームにより製造することができる。
Manufacturing method 8
The compound represented by the formula (1f) (hereinafter referred to as the compound (1f)) can be produced by the following scheme.
Figure JPOXMLDOC01-appb-I000010
Figure JPOXMLDOC01-appb-I000010
[式中、QはNR又はNC(O)Rを表し、その他の記号は式(1)と同じ意味を表す。]
 化合物(1f)は、化合物(1a)を用い、Organic Letters,Vol.9,No.19,2007,3809-3811に記載の方法に準じて製造することができる。
[Wherein Q a represents NR 8 or NC (O) R 9 , and other symbols represent the same meaning as in formula (1). ]
Compound (1f) was prepared using Compound (1a) from Organic Letters, Vol. 9, no. 19, 2007, 3809-3811.
製造法9
 式(1g)で示される化合物(以下、化合物(1g)と記す。)は、下記スキームにより製造することができる。
Manufacturing method 9
The compound represented by the formula (1g) (hereinafter referred to as the compound (1g)) can be produced by the following scheme.
Figure JPOXMLDOC01-appb-I000011
Figure JPOXMLDOC01-appb-I000011
[式中、R1a及びEはそれぞれ独立して、塩素原子、臭素原子又はヨウ素原子を表し、R2aはC1-C6パーフルオロアルキル基を表し、R4a及びR5aはそれぞれ独立して、C1-C6アルキル基又はC1-C6ハロアルキル基を表し、その他の記号は前記と同じ意味を表す。]
 式(M8)で示される化合物(以下、化合物(M8)と記す。)は、Journal of the American Chemical Society,1931,vol.53,p.3143-3146に記載の方法に準じて製造することができる。
[Wherein, R 1a and E each independently represent a chlorine atom, a bromine atom or an iodine atom, R 2a represents a C1-C6 perfluoroalkyl group, and R 4a and R 5a each independently represent C1 —C6 alkyl group or C1-C6 haloalkyl group, and other symbols have the same meanings as described above. ]
The compound represented by the formula (M8) (hereinafter referred to as the compound (M8)) is described in Journal of the American Chemical Society, 1931, vol. 53, p. It can be produced according to the method described in 3143-3146.
 式(M9)で示される化合物(以下、化合物(M9)と記す。)は、化合物(M8)と式(R3)で表される化合物とを塩基の存在下で反応させることにより製造することができる。該反応は、例えば国際公開第2003/024961号に記載の方法に準じて実施することができる。 A compound represented by formula (M9) (hereinafter referred to as compound (M9)) can be produced by reacting compound (M8) with a compound represented by formula (R3) in the presence of a base. it can. The reaction can be carried out according to the method described in, for example, International Publication No. 2003/024961.
 式(M10)で示される化合物(以下、化合物(M10)と記す。)は、化合物(M9)を用い、国際公開第2005/073165号に記載の方法に準じて製造することができる。 The compound represented by the formula (M10) (hereinafter referred to as the compound (M10)) can be produced using the compound (M9) according to the method described in International Publication No. 2005/073165.
 式(M11)で示される化合物(以下、化合物(M11)と記す。)は、国際公開第2003/024961号に記載の方法に準じて製造することができる。 A compound represented by the formula (M11) (hereinafter referred to as compound (M11)) can be produced according to the method described in International Publication No. 2003/024961.
 式(M12)で示される化合物(以下、化合物(M12)と記す。)は、化合物(M11)を用い、製造法1に記載の化合物(M1)から化合物(M2)を製造する方法に準じて製造することができる。 The compound represented by the formula (M12) (hereinafter referred to as the compound (M12)) is prepared according to the method for producing the compound (M2) from the compound (M1) described in the production method 1 using the compound (M11). Can be manufactured.
 式(M14)で示される化合物(以下、化合物(M14)と記す。)は、化合物(M12)を用い、製造法2に記載の方法に準じて製造することができる。 The compound represented by formula (M14) (hereinafter referred to as compound (M14)) can be produced according to the method described in production method 2 using compound (M12).
 次に、化合物(M14)から化合物(1g)を製造する方法について記載する。 Next, a method for producing the compound (1 g) from the compound (M14) will be described.
 化合物(1g)は、化合物(M14)と式(R5)で示される化合物(以下、化合物(R5)と記す)とを添加剤の存在下で反応させることにより製造することができる。 Compound (1g) can be produced by reacting compound (M14) with a compound represented by formula (R5) (hereinafter referred to as compound (R5)) in the presence of an additive.
 該反応は、通常溶媒の存在下で行われる。反応に用いられる溶媒としては、例えば非プロトン性極性溶媒が挙げられる。 The reaction is usually performed in the presence of a solvent. Examples of the solvent used for the reaction include aprotic polar solvents.
 反応に用いられる添加剤としては、例えばJournal of Fluorine Chemistry,102(2000)293-300に記載の方法により活性化された銅粉末が挙げられる。 Examples of the additive used in the reaction include copper powder activated by the method described in Journal of Fluorine Chemistry, 102 (2000) 293-300.
 反応には、化合物(M14)1モルに対して、化合物(R5)が通常1~10モルの割合、添加剤が通常1~10モルの割合で用いられる。 In the reaction, with respect to 1 mole of the compound (M14), the compound (R5) is usually used at a ratio of 1 to 10 moles, and the additive is usually used at a ratio of 1 to 10 moles.
 反応温度は、通常0~150℃の範囲である。反応時間は通常0.1~48時間の範囲である。 The reaction temperature is usually in the range of 0 to 150 ° C. The reaction time is usually in the range of 0.1 to 48 hours.
 反応終了後は、添加剤をろ過により除去した後、反応混合物に水を加え、有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作をすることにより、化合物(1g)を得ることができる。 After completion of the reaction, the additive is removed by filtration, water is added to the reaction mixture, extraction is performed with an organic solvent, and post-treatment operations such as drying and concentration of the organic layer are performed to obtain the compound (1 g). be able to.
製造法10
 化合物(1g)は、下記スキームにより製造することができる。
Manufacturing method 10
Compound (1g) can be produced according to the following scheme.
Figure JPOXMLDOC01-appb-I000012
Figure JPOXMLDOC01-appb-I000012
[式中、記号は式(1)と同じ意味を表す。]
 式(M15)で示される化合物(以下、化合物(M15)と記す。)は、化合物(M6)と式(R6)で示される化合物とを用い、製造法2に記載の化合物(M3)から本発明化合物を製造する方法に準じて製造することができる。
[Wherein the symbols have the same meaning as in formula (1). ]
The compound represented by the formula (M15) (hereinafter referred to as the compound (M15)) is obtained from the compound (M3) described in the production method 2 using the compound (M6) and the compound represented by the formula (R6). It can be produced according to the method for producing the inventive compound.
 式(M16)で示される化合物(以下、化合物(M16)と記す。)は、化合物(M15)を用い、製造法2に記載の化合物(M2)から化合物(M3)を製造する方法に準じて製造することができる。 The compound represented by formula (M16) (hereinafter referred to as compound (M16)) was prepared according to the method for producing compound (M3) from compound (M2) described in production method 2 using compound (M15). Can be manufactured.
 式(M17)で示される化合物(以下、化合物(M17)と記す。)は、化合物(M16)と式(R7)で示される化合物とを用い、製造法2に記載の化合物(M3)から本発明化合物を製造する方法に準じて製造することができる。式(R6)で示される化合物及び式(R7)で示される化合物は、市販の化合物か、公知の方法に準じて製造することができる。 The compound represented by the formula (M17) (hereinafter referred to as the compound (M17)) is obtained from the compound (M3) described in the production method 2 using the compound (M16) and the compound represented by the formula (R7). It can be produced according to the method for producing the inventive compound. The compound represented by the formula (R6) and the compound represented by the formula (R7) are commercially available compounds or can be produced according to known methods.
 次に、化合物(M17)から式(M18)で示される化合物(以下、化合物(M18)と記す。)を製造する方法について記載する。 Next, a method for producing a compound represented by formula (M18) (hereinafter referred to as compound (M18)) from compound (M17) will be described.
 化合物(M18)は、化合物(M17)と化合物(R5)とを添加剤の存在下で反応させることにより製造することができる。 Compound (M18) can be produced by reacting compound (M17) and compound (R5) in the presence of an additive.
 該反応は、通常溶媒の存在下で行われる。反応に用いられる溶媒としては、例えば脂肪族ハロゲン化炭化水素類、ニトリル類、エーテル類、ケトン類、エステル類、芳香族炭化水素類、非プロトン性極性溶媒及びこれらの混合物が挙げられる。 The reaction is usually performed in the presence of a solvent. Examples of the solvent used in the reaction include aliphatic halogenated hydrocarbons, nitriles, ethers, ketones, esters, aromatic hydrocarbons, aprotic polar solvents, and mixtures thereof.
 反応に用いられる添加剤としては、例えば亜ジチオン酸ナトリウム等の亜ジチオン酸塩又は亜鉛-亜硫酸水等が挙げられる。 Examples of the additive used in the reaction include dithionite such as sodium dithionite or zinc-sulfite water.
 反応に用いられる塩基としては、例えば有機塩基類、アルカリ金属炭酸塩類、アルカリ金属水酸化物類が挙げられる。 Examples of the base used in the reaction include organic bases, alkali metal carbonates, and alkali metal hydroxides.
 該反応は、必要に応じて相関移動触媒を用いることもできる。反応に用いられる相関移動触媒としては、例えばテトラブチルアンモニウムハイドロジェンサルフェートなどの四級アンモニウム塩、テトラブチルホスホニウムブロミド等の有機リン塩類、トリス(メトキシエトキシエチル)アミン等のアルキルポリエーテルアルキルアミン化合物類が挙げられる。 In the reaction, a phase transfer catalyst can be used as necessary. Examples of the phase transfer catalyst used in the reaction include quaternary ammonium salts such as tetrabutylammonium hydrogen sulfate, organic phosphorus salts such as tetrabutylphosphonium bromide, and alkyl polyether alkylamine compounds such as tris (methoxyethoxyethyl) amine. Is mentioned.
 反応には、化合物(M17)1モルに対して、化合物(R5)が通常1~10モルの割合、添加剤が通常0.1~2モルの割合、塩基が通常1~10モルの割合、相関移動触媒が通常0.01~2モルの割合で用いられる。 In the reaction, with respect to 1 mol of compound (M17), compound (R5) is usually in a proportion of 1 to 10 mol, additive is usually in a proportion of 0.1 to 2 mol, base is usually in a proportion of 1 to 10 mol, A phase transfer catalyst is usually used at a ratio of 0.01 to 2 mol.
 反応温度は、通常0~150℃の範囲である。反応時間は通常0.1~48時間の範囲である。 The reaction temperature is usually in the range of 0 to 150 ° C. The reaction time is usually in the range of 0.1 to 48 hours.
 反応終了後は、反応混合物に水を加え、有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作をすることにより、化合物(M18)を得ることができる。 After completion of the reaction, the compound (M18) can be obtained by performing post-treatment operations such as adding water to the reaction mixture, extracting with an organic solvent, and drying and concentrating the organic layer.
 次に、化合物(M18)から化合物(1g)を製造する方法について記載する。 Next, a method for producing the compound (1 g) from the compound (M18) will be described.
 化合物(1g)は、化合物(M18)をハロゲン化剤と反応させることにより製造することができる。 Compound (1g) can be produced by reacting compound (M18) with a halogenating agent.
 該反応は、通常溶媒の存在下で行われる。反応に用いられる溶媒としては、例えば脂肪族ハロゲン化炭化水素類、ニトリル類、エーテル類、ケトン類、エステル類、芳香族炭化水素類、非プロトン性極性溶媒及びこれらの混合物が挙げられる。 The reaction is usually performed in the presence of a solvent. Examples of the solvent used in the reaction include aliphatic halogenated hydrocarbons, nitriles, ethers, ketones, esters, aromatic hydrocarbons, aprotic polar solvents, and mixtures thereof.
 反応に用いられるハロゲン化剤としては、例えばN-クロロこはく酸イミド(以下、NCSと記す。)、塩素、N-ブロモこはく酸イミド(以下、NBSと記す。)、臭素、N-ヨードこはく酸イミド(以下、NISと記す。)、ヨウ素等が挙げられる。 Examples of the halogenating agent used in the reaction include N-chlorosuccinimide (hereinafter referred to as NCS), chlorine, N-bromosuccinimide (hereinafter referred to as NBS), bromine, and N-iodosuccinic acid. Examples include imide (hereinafter referred to as NIS), iodine and the like.
 反応には、化合物(M18)1モルに対して、ハロゲン化剤が通常1~10モルの割合で用いられる。 In the reaction, the halogenating agent is usually used at a ratio of 1 to 10 mol per 1 mol of the compound (M18).
 反応温度は、通常0~100℃の範囲である。反応時間は通常0.1~12時間の範囲である。 The reaction temperature is usually in the range of 0 to 100 ° C. The reaction time is usually in the range of 0.1 to 12 hours.
 反応終了後は、反応混合物に水を加え、有機溶媒で抽出し、有機層を乾燥、濃縮することにより、化合物(1g)を得ることができる。 After completion of the reaction, the compound (1 g) can be obtained by adding water to the reaction mixture, extracting with an organic solvent, and drying and concentrating the organic layer.
 式(R9)で示される化合物(以下、化合物(R9)と記す)、式(R10)で示される化合物(以下、化合物(R10)と記す)、式(R11)で示される化合物(以下、化合物(R11)と記す)、及び式(R12)で示される化合物(以下、化合物(R12)と記す)は、下記スキームにより製造することができる。 Compound represented by formula (R9) (hereinafter referred to as compound (R9)), compound represented by formula (R10) (hereinafter referred to as compound (R10)), compound represented by formula (R11) (hereinafter referred to as compound) (Denoted as R11) and a compound represented by formula (R12) (hereinafter referred to as compound (R12)) can be produced by the following scheme.
Figure JPOXMLDOC01-appb-I000013
Figure JPOXMLDOC01-appb-I000013
[式中、記号は前記と同じ意味を表す。]
 化合物(R9)は、式(R8)で示される化合物(以下、化合物(R8)と記す)を用い、製造法8に記載の方法に準じて製造することができる。
[Wherein the symbols have the same meaning as described above. ]
Compound (R9) can be produced according to the method described in production method 8 using the compound represented by formula (R8) (hereinafter referred to as compound (R8)).
 化合物(R10)は、化合物(R9)を用い、製造法7に記載の方法に準じて製造することができる。 Compound (R10) can be produced according to the method described in Production Method 7 using Compound (R9).
 化合物(R11)及び化合物(R12)は、化合物(R8)を用い、製造法6に記載の方法に準じて製造することができる。 Compound (R11) and Compound (R12) can be produced according to the method described in Production Method 6 using Compound (R8).
 化合物(R8)は、市販の化合物か、公知の方法に準じて製造することができる。 Compound (R8) is a commercially available compound or can be produced according to a known method.
 化合物(R8)~化合物(R12)は、化合物(R2)に包含される。 Compound (R8) to Compound (R12) are included in Compound (R2).
 次に、本発明化合物の具体例を以下に示すが、本発明はこれに限定されるものではない。
なお、表中、「Me」はメチル基を、「Et」はエチル基を、「Ac」はアセチル基を、「Pr」はヘプタフルオロイソプロピル基を、「-」は存在しないことを表す。
式(1-1)
Next, although the specific example of this invention compound is shown below, this invention is not limited to this.
In the table, “Me” represents a methyl group, “Et” represents an ethyl group, “Ac” represents an acetyl group, “ i Pr F ” represents a heptafluoroisopropyl group, and “−” does not exist. .
Formula (1-1)
Figure JPOXMLDOC01-appb-I000014
Figure JPOXMLDOC01-appb-I000014
において、R、R、R、R、R、R6a、R7a、R6b、R7b、R6c、R7c、R6d、R7d、Q及びkが[表1]~[表10]に記載の組み合わせである本発明化合物。  R 1 , R 2 , R 3 , R 4 , R 5 , R 6a , R 7a , R 6b , R 7b , R 6c , R 7c , R 6d , R 7d , Q and k are [Table 1] to The compound of the present invention which is a combination described in [Table 10].
Figure JPOXMLDOC01-appb-T000015
Figure JPOXMLDOC01-appb-T000015
Figure JPOXMLDOC01-appb-T000016
Figure JPOXMLDOC01-appb-T000016
Figure JPOXMLDOC01-appb-T000017
Figure JPOXMLDOC01-appb-T000017
Figure JPOXMLDOC01-appb-T000018
Figure JPOXMLDOC01-appb-T000018
Figure JPOXMLDOC01-appb-T000019
Figure JPOXMLDOC01-appb-T000019
Figure JPOXMLDOC01-appb-T000020
Figure JPOXMLDOC01-appb-T000020
Figure JPOXMLDOC01-appb-T000021
Figure JPOXMLDOC01-appb-T000021
Figure JPOXMLDOC01-appb-T000022
Figure JPOXMLDOC01-appb-T000022
Figure JPOXMLDOC01-appb-T000023
Figure JPOXMLDOC01-appb-T000023
Figure JPOXMLDOC01-appb-T000024
Figure JPOXMLDOC01-appb-T000024
式(1-2) Formula (1-2)
Figure JPOXMLDOC01-appb-I000025
Figure JPOXMLDOC01-appb-I000025
において、R6c、R7c、R6d及びR7dが水素原子であり、R、R、R、R、R、R6a、R7a、R6b、R7b、Q及びkが[表11]~[表18]に記載の組み合わせである本発明化合物。  R 6c , R 7c , R 6d and R 7d are hydrogen atoms, and R 1 , R 2 , R 3 , R 4 , R 5 , R 6a , R 7a , R 6b , R 7b , Q and k are The compounds of the present invention which are combinations described in [Table 11] to [Table 18].
Figure JPOXMLDOC01-appb-T000026
Figure JPOXMLDOC01-appb-T000026
Figure JPOXMLDOC01-appb-T000027
Figure JPOXMLDOC01-appb-T000027
Figure JPOXMLDOC01-appb-T000028
Figure JPOXMLDOC01-appb-T000028
Figure JPOXMLDOC01-appb-T000029
Figure JPOXMLDOC01-appb-T000029
Figure JPOXMLDOC01-appb-T000030
Figure JPOXMLDOC01-appb-T000030
Figure JPOXMLDOC01-appb-T000031
Figure JPOXMLDOC01-appb-T000031
Figure JPOXMLDOC01-appb-T000032
Figure JPOXMLDOC01-appb-T000032
Figure JPOXMLDOC01-appb-T000033
Figure JPOXMLDOC01-appb-T000033
式(1-3) Formula (1-3)
Figure JPOXMLDOC01-appb-I000034
Figure JPOXMLDOC01-appb-I000034
において、R、R、R、R、R、R6a、R7a、R6b、R7b、R6c、R7c、Q及びkが[表19]~[表27]に記載の組み合わせである本発明化合物。  R 1 , R 2 , R 3 , R 4 , R 5 , R 6a , R 7a , R 6b , R 7b , R 6c , R 7c , Q and k are described in [Table 19] to [Table 27] The compound of the present invention which is a combination of
Figure JPOXMLDOC01-appb-T000035
Figure JPOXMLDOC01-appb-T000035
Figure JPOXMLDOC01-appb-T000036
Figure JPOXMLDOC01-appb-T000036
Figure JPOXMLDOC01-appb-T000037
Figure JPOXMLDOC01-appb-T000037
Figure JPOXMLDOC01-appb-T000038
Figure JPOXMLDOC01-appb-T000038
Figure JPOXMLDOC01-appb-T000039
Figure JPOXMLDOC01-appb-T000039
Figure JPOXMLDOC01-appb-T000040
Figure JPOXMLDOC01-appb-T000040
Figure JPOXMLDOC01-appb-T000041
Figure JPOXMLDOC01-appb-T000041
Figure JPOXMLDOC01-appb-T000042
Figure JPOXMLDOC01-appb-T000042
Figure JPOXMLDOC01-appb-T000043
Figure JPOXMLDOC01-appb-T000043
 本発明化合物が効力を有する有害節足動物としては、例えば、有害昆虫類や有害ダニ類等が挙げられる。かかる有害節足動物としては、具体的には例えば、以下のものが挙げられる。 Examples of harmful arthropods for which the compounds of the present invention are effective include harmful insects and harmful mites. Specific examples of such harmful arthropods include the following.
 半翅目害虫:ヒメトビウンカ(Laodelphax striatellus)、トビイロウンカ(Nilaparvata lugens)、セジロウンカ(Sogatella furcifera)、トウモロコシウンカ(Peregrinus maidis)等のウンカ類、ツマグロヨコバイ(Nephotettix cincticeps)、タイワンツマグロヨコバイ(Nephotettix virescens)、Rice green leafhopper (Nephotettix nigropictus)、イナズマヨコバイ(Recilia dorsalis)、チャノミドリヒメヨコバイ(Empoasca onukii)、ポテトリーフホッパー(Empoasca fabae)、コーンリーフホッパー(Dalbulus maidis)、Sugarcane froghopper(Mahanarva posticata)、Sugarcane root spittlebug(Mahanarva fimbriolota)、シロオオヨコバイ(Cofana spectra)、クロスジツマグロヨコバイ(Nephotettix nigropictus)、イナズマヨコバイ(Recilia dorsalis)等のヨコバイ類、ワタアブラムシ(Aphis gossypii)、モモアカアブラムシ(Myzus persicae)、ダイコンアブラムシ(Brevicoryne brassicae)、ユキヤナギアブラムシ(Aphis spiraecola)、チューリップヒゲナガアブラムシ(Macrosiphum euphorbiae)、ジャガイモヒゲナガアブラムシ(Aulacorthum solani)、ムギクビレアブラムシ(Rhopalosiphum padi)、ミカンクロアブラムシ(Toxoptera citricidus)、モモコフキアブラムシ(Hyalopterus pruni)、ダイズアブラムシ(Aphis glycines Matsumura)、トウモロコシアブラムシ(Rhopalosiphum  maidis)、オカボノクロアブラムシ(Tetraneura nigriabdominalis)、ブドウネアブラムシ(Viteus vitifoliae)、Grape Phylloxera(Daktulosphaira vitifoliae)、Pecan phylloxera (Phylloxera devastatrix Pergande)、Pecan leaf phylloxera (Phylloxera notabilis pergande)、Southern pecan leaf phylloxera (Phylloxera russellae Stoetzel)等のアブラムシ類、イネクロカメムシ(Scotinophara lurida)、Malayan rice black bug (Scotinophara coarctata)、アオクサカメムシ(Nezara antennata)、トゲシラホシカメムシ(Eysarcoris parvus)、クサギカメムシ(Halyomorpha mista)、ミナミアオカメムシ(Nezara viridula)、Brown stink bug (Euschistus heros)、Southern green stink bug (Nezara viridula)、Red banded stink bug (Piezodorus guildinii)、Burrower brown bug (Scaptocoris castanea)、Oebalus pugnax、Dichelops melacanthus等のカメムシ類、ホソヘリカメムシ(Riptortus clavetus)、クモヘリカメムシ(Leptocorisa chinensis)、ホソクモヘリカメムシ(Leptocorisa acuta)、Leptocorisa属等のホソヘリカメムシ類、アカヒゲホソミドリカスミカメ(Trigonotylus caelestialium)、アカスジカスミカメ(Stenotus rubrovittatus)、ターニッシュドプラントバグ(Lygus lineolaris)、Chinchi bug(Blissus leucopterus leucopterus)等のカスミカメ類、オンシツコナジラミ(Trialeurodes vaporariorum)、タバココナジラミ(Bemisia tabaci)、ミカンコナジラミ(Dialeurodes citri)、ミカントゲコナジラミ(Aleurocanthus spiniferus)等のコナジラミ類、アカマルカイガラムシ(Aonidiella aurantii)、サンホーゼカイガラムシ(Comstockaspis perniciosa)、シトラススノースケール(Unaspis citri)、ルビーロウムシ(Ceroplastes rubens)、イセリヤカイガラムシ(Icerya purchasi)、フジコナカイガラムシ(Planococcus kraunhiae)、クワコナカイガラムシ(Pseudococcus longispinis)、クワシロカイガラムシ(Pseudaulacaspis pentagona)、タトルミーリーバグ(Brevennia rehi)等のカイガラムシ類、ミカンキジラミ(Diaphorina citri)、ナシキジラミ(Psylla pyrisuga)、ポテトプシリッド(Bactericerca cockerelli)等のキジラミ類、ナシグンバイ(Stephanitis nasi)等のグンバイムシ類、トコジラミ(Cimex lectularius)等のトコジラミ類及びGiant Cicada(Quesada gigas)。 Hemiptera pests: Japanese brown planthoppers (Laodelphax striatellus), brown planthoppers (Nilaparvata lugens), white planthoppers (Sogatella furcifera), corn planters (Peregrinus maidis), etc. (Nephotettix nigropictus), Recipe dorsalis, Emporasca onukii, Potato reef hopper (Empoasca fabae), Corn leaf hopper (Dalbulus maidis), Sugarcane ugicine (Suhana) ), Leafhoppers (Cofana spectra), leafhoppers (Nephotettix nigropictus), leafhoppers (Recilia dorsalis), cotton aphids (Aphis gossypii), peach moa Aphids (Myzus persicae), radish aphids (Brevicoryne brassicae), snowy aphids (Aphis spiraecola), tulip beetle aphids (Macrosiphum euphorbiae), potato beetle aphids (Aulacorthum solani), hum ), Peach beetle (Hyalopterus pruni), soybean aphid (Aphis glycines Matsumura), corn aphid (Rhopalosiphum maidis), scallop aphid (Tetraneura nigriabdominalis), grape aphid (Viteusoxvitifiraeae, Pera (Phylloxera devastatrix Pergande), Pecan leaf phylloxera (Phylloxera notabilis pergande), Southern pecan leaf phylloxera (Phylloxera russellae Stoetzel) Stink bug (Scotinophara lurida), Malayan rice black bug (Scotinophara coarctata), blue beetle (Nezara antennata), bark beetle (Eysarcoris parvus), black beetle (Halyomorphastula メ vira) Euskistus heros), Southern green stink bug (Nezara viridula), Red banded stink bug (Piezodorus guildinii), Burrower brown bug (Scaptocoris castanea), Oebalus pugnax, Dichelops melacanthus, etc. Stinkbugs (Leptocorisa chinensis), Helicoptera helicopters (Leptocorisa acuta), Leptocorisa genus, etc. , Chinchi Bugs (Blissus leucopterus leucopterus) and other turtles, whitefly (Trialeurodes vaporariorum), tobacco whitefly (Bemisia tabaci), citrus whitefly (Dialeurodes citri), citrus whitefly (Aleurocanthus spiniferus San Jose scale insect (Comstockaspis perniciosa), citrus snow scale (Unaspis citri), ruby rot beetle (Ceroplastes rubens), Icerya scale insect (Icerya purchasi), Fujicona scale insect (Planococcus kraunhiae), staghorn beetle (Pseuocis) Pseudaulacaspis pentagona), scale insects such as Brevennia リ ー rehi, Diaphorina citri, psylla pyrisuga, potato topslide (Bacterice) larvae such as rca キ cockerelli), beetles such as Stephanitis 、 nasi, bed bugs such as Cimex lectularius, and Giant Cicada (Quesada。gigas).
 鱗翅目害虫:ニカメイガ(Chilo suppressalis)、Darkheaded stm borer (Chilo polychrysus)、サンカメイガ(Tryporyza incertulas)、ネッタイメイチュウ(Chilo polychrysus)、シロメイチュウ(Scirpophaga innotata)、Yellow stem borer(Scirpophaga incertulas)、Pink borer (Sesamia inferens)、Rupela albinella、コブノメイガ(Cnaphalocrocis medinalis)、Marasmia patnalis、Marasmia exigna、ワタノメイガ(Notarcha derogata)、ノシメマダラメイガ(Plodia interpunctella)、アワノメイガ(Ostrinia furnacalis)、ハイマダラノメイガ(Hellula undalis)、シバツトガ(Pediasia teterrellus)、ライスケースワーム(Nymphula depunctalis)、Marasmia属、Hop vine borer (Hydraecia immanis)、European corn borer (Ostrinia nubilalis)、Lesser cornstalk borer(Elasmopalpus lignosellus)、Bean Shoot Borer (Epinotia aporema)、Sugarcane borer(Diatraea saccharalis)、Giant Sugarcane borer(Telchin licus)等のメイガ類、ハスモンヨトウ(Spodoptera litura)、シロイチモジヨトウ(Spodoptera exigua)、アワヨトウ(Pseudaletia separata)、ヨトウガ(Mamestra brassicae)、イネヨトウ(Sesamia inferens)、シロナヨトウ(Spodoptera mauritia)、ツマジロクサヨトウ(Spodoptera frugiperda)、Spodoptera exempta、タマナヤガ(Agrotis ipsilon)、タマナギンウワバ(Plusia nigrisigna)、Soybean looper (Pseudoplusia includens)、トリコプルシア属、タバコガ(Heliothis virescens)等ヘリオティス属、オオタバコガ(Helicoverpa armigera)等ヘリコベルパ属、Velvetbean caterpillar(Anticarsia gammatalis)、Cotton leafworm (Alabama argillacea)等のヤガ類、モンシロチョウ(Pieris rapae)等のシロチョウ類、アドキソフィエス属、ナシヒメシンクイ(Grapholita molesta)、マメシンクイガ(Leguminivora glycinivorella)、アズキサヤムシガ(Matsumuraeses azukivora)、リンゴコカクモンハマキ(Adoxophyes orana fasciata)、チャノコカクモンハマキ(Adoxophyes honmai.)、チャハマキ(Homona magnanima)、ミダレカクモンハマキ(Archips fuscocupreanus)、コドリンガ(Cydia pomonella)等のハマキガ類、チャノホソガ(Caloptilia theivora)、キンモンホソガ(Phyllonorycter ringoneella)のホソガ類、モモシンクイガ(Carposina niponensis)、Citrus fruit borer 
(Ecdytolopha aurantiana)等のシンクイガ類、Coffee Leaf miner(Leucoptera coffeela)、リオネティア属等のハモグリガ類、リマントリア属、ユープロクティス属等のドクガ類、コナガ(Plutella xylostella)等のスガ類、ワタアカミムシ(Pectinophora gossypiella)ジャガイモガ(Phthorimaea operculella)等のキバガ類、アメリカシロヒトリ(Hyphantria cunea)等のヒトリガ類。
Lepidoptera: Chilo suppressalis, Darkheaded stm borer (Chilo polychrysus), Sunpikeza (Tryporyza incertulas), Netloi (Chilo polychrysus), White-meicho (Scirpophaga innotata), Yellow stem borer (Scirpophaga incertulas) Sesamia inferens, Rupela albinella, Cnaphalocrocis medinalis, Marasmia patnalis, Marasmia exigna, Notarcha derogata, Plodia interpunctella, Odalian Hula isla teterrellus), rice case worm (Nymphula depunctalis), Marasmia spp., Hop vine borer (Hydraecia immanis), European corn borer (Ostrinia nubilalis), Lesser cornstalk borer (Elasmopalpus lignosellus), Bean Shoot Borane (Epinotiaapore, Epinotiaatraia) saccharalis), Giant Suga Common moths such as rcane borer (Telchin licus), Spodoptera litura, Spodoptera exigua, Pseudaletia separata, Mamestra brassicae, Sesamia inoptera, Suria inoptera Spodoptera frugiperda, Spodoptera exempta, Tamanayaga (Agrotis ipsilon), Tamanaginuwaba (Plusia nigrisigna), Soybean looper (Pseudoplusia includens), Trichopulsia, Heliothis virescens, etc. Goats such as Velvetbean caterpillar (Anticarsia gammatalis) and Cotton leafworm (Alabama argillacea), white butterflies such as Pieris rapae, genus Adoxofies, Grapholita molesta, Leguminivora glycinivorella , Azukisayamushiga (Matsumuraeses azukivora), apple Coca summer fruit tortrix (Adoxophyes orana fasciata), smaller tea tortrix (Adoxophyes honmai. ), Chamonaki (Homona magnanima), Midelekamonmon (Archips fuscocupreanus), Codialinga (Cydia pomonella), etc., Chanohosoga (Caloptilia theivora), Kinmonhosoga (Phyllonorycter ringoneella), moss borer
(Ecdytolopha aurantiana) and other common moths, Coffee Leaf miner (Leucoptera coffeela), Rionetia sp. ) Potatoes such as potato moth (Phthorimaea operculella) and hitorigers such as Hyphantria cunea.
 総翅目害虫:ミカンキイロアザミウマ(Frankliniella occidentalis)、ミナミキイロアザミウマ(Thrips parmi)、チャノキイロアザミウマ(Scirtothrips dorsalis)、ネギアザミウマ(Thrips tabaci)、ヒラズハナアザミウマ(Frankliniella intonsa)、ウェスタンフラワースリップス(Frankliniella occidentalis)イネクダアザミウマ(Haplothrips aculeatus)、イネアザミウマ(Stenchaetothrips biformis)等のアザミウマ類。 Common pests: Citrus thrips (Frankliniella occidentalis), Thrips parmi, Scirtothrips dorsalis, Thrips tabaci Thrips such as Kapida thrips (Haplothrips aculeatus), Rice thrips (Stenchaetothrips biformis).
 双翅目害虫:アカイエカ(Culex pipiens pallens)、コガタアカイエカ(Culex tritaeniorhynchus)、ネッタイイエカ(Culex quinquefasciatus)等のイエカ類、ネッタイシマカ(Aedes aegypti)、ヒトスジシマカ(Aedes albopictus)等のエーデス属、シナハマダラカ(Anopheles sinensis)等のアノフェレス属、ユスリカ類、イエバエ(Musca domestica)、オオイエバエ(Muscina stabulans)等のイエバエ類、タネバエ(Delia platura)、タマネギバエ(Delia antiqua)シュガービートルートマゴット(Tetanops myopaeformis)等のハナバエ類、イネハモグリバエ(Agromyza oryzae)、イネヒメハモグリバエ(Hydrellia griseola)、トマトハモグリバエ(Liriomyza sativae)、マメハモグリバエ(Liriomyza trifolii)、ナモグリバエ(Chromatomyia horticola)等のハモグリバエ類、イネキモグリバエ(Chlorops oryzae)等のキモグリバエ類、ウリミバエ(Dacus cucurbitae)、チチュウカイミバエ(Ceratitis capitata)等のミバエ類、トウヨウイネクキミギワバエ(Hydrellia philippina)イネクキミギワバエ(Hydrellia sasakii)等のミギワバエ類、ショウジョウバエ類、オオキモンノミバエ(Megaselia spiracularis)等のノミバエ類、オオチョウバエ(Clogmia albipunctata)等のチョウバエ類、クロバネキノコバエ類。ヘシアンバエ(Mayetiola destructor)、イネノシントメタマバエ(Orseolia oryzae)等のタマバエ類、Diopsis macrophthalma等のシュモクバエ類、Common cranefly(Tipula oleracea)、European cranefly(Tipula paludosa)等のガガンボ類。 Diptera: Culex pipiens pallens, Culex tritaeniorhynchus, Culex quinquefasciatus and other mosquitoes, Aedes ophegos Genus Anopheles, Chironomid, Musca domestica, Muscina stabulans, etc. Agromyza oryzae), rice leaflet (Hydrellia griseola), tomato leaffly (Liriomyza sativae), beetle leaflet (Liriomyza trifolii), leafhopper (Chromatomyia horticola) and other leafhoppers (Chromatomyia horticola), ryzae and other fruit fly, Dacus cucurbitae, fruit fly such as Ceratitis capitata, Hydrellia philippina, and Fleas such as fleas (Megaselia spiracularis), butterflies such as Clogmia albipunctata, and black fly flies. Crane fly such as Hessian fly (Mayetiola destructor), Oreseolia oryzae, Crane fly such as Diopsis macrophthalma, Common cranefly (Tipula oleracea), European gantry such as Europeanopecranefly (Tipula paludosa).
 鞘翅目害虫:ウエスタンコーンルートワーム(Diabrotica virgifera virgifera)、サザンコーンルートワーム(Diabrotica undecimpunctata howardi)、ノザンコーンルートワーム(Diabrotica barberi)、メキシカンコーンルートワームDiabrotica virgifera zeae)、バンデッドキューカンバービートル(Diabrotica balteata LeConte)、サンアントニオビートル(Diabrotica speciosa)、Cucurbit Beetle(Diabrotica speciosa)、ビーンリーフビートル(Cerotoma trifurcata)、シリアルリーフビートル(Oulema melanopus)、ウリハムシ(Aulacophora femoralis)、キスジノミハムシ(Phyllotreta striolata)、コロラドハムシ(Leptinotarsa decemlineata)、イネドロオイムシ(Oulema oryzae)、グレープ・コラスピス(Colaspis brunnea)、コーン・フレアビートル(Chaetocnema pulicaria)、ポテト・フレアビートル(Epitrix cucumeris)、イネトゲハムシ(Dicladispa armigera)、Seedcorn beetle(Stenolophus lecontei)、Slender seedcorn beetle (Clivinia impressifrons )等のハムシ類、ドウガネブイブイ(Anomala cuprea)、ヒメコガネ(Anomala rufocuprea)、マメコガネ(Popillia japonica)、European Chafer(Rhizotrogus majalis)carrot beetle (Bothynus gibbosus)、Grape Colaspis(Colaspis brunnea)、southern Corn leaf beetle (Myochrous denticollis)、Holotrichia属、ジューン・ビートル(Phyllophaga crinita)等Phyllophaga属等のコガネムシ類、コクゾウムシ(Sitophilus zeamais)、イネゾウムシ(Echinocnemus squameus)、イネミズゾウムシ(Lissorhoptrus oryzophilus)、シバオサゾウムシ(Sphenophorus venatus)等のイネゾウムシ類、ワタミゾウムシ(Anthonomus grandis)、Southern Corn Billbug(Sphenophorus callosus)、Soybean stalk weevil (Sternechus subsignatus)及びSphenophorus levis等Sphenophorus属等のゾウムシ類、ニジュウヤホシテントウ(Epilachna vigintioctopunctata)等のエピラクナ類、ヒラタキクイムシ(Lyctus brunneus)、マツノキクイムシ(Tomicus piniperda)等のキクイムシ類、ナガシンクイムシ類、ヒョウホンムシ類、ゴマダラカミキリ(Anoplophora malasiaca)、Migdolus fryanus等のカミキリムシ類、オキナワカンシャクコメツキ(Melanotus okinawensis)、トビイロムナボソコメツキ(Agriotes ogurae fuscicollis)、クシコメツキ(Melanotus legatus)等のコメツキムシ類(Agriotes sp.、Aelous sp.、Anchastus sp.、Melanotus sp.、Limonius sp.、Conoderus sp.、Ctenicera sp.)、アオバアリガタハネカクシ(Paederus fuscipes)等のハネカクシ類及びCoffee Barry Borer(Hypothenemus hampei)。 Coleoptera: Western corn root worm (Diabrotica virgifera virgifera), Southern corn root worm (Diabrotica undecimpunctata howardi), Northern corn root worm (Diabrotica virgifera zeae), Banded cucumber beetle (Diabrotica virgifera zeae) , San Antonio beetle (Diabrotica speciosa), Cucurbit Beetle (Diabrotica speciosa), bean leaf beetle (Cerotoma trifurcata), cereal leaf beetle (Oulema melanopus), cucumber horn beetle (Aulacophora) femoralis), pheasant potato beetle (Phylolsa ラ decor) , Rice beetle (Oulema oryzae), grape colaspis (Colaspis brunnea), corn flare beetle (Chaetocnema pulicaria), potato flare beetle (Epitrix) cucumeris), rice beetle (Dicladispa armigera), Seedcorn beetle (Stenolophus lecontei), Slender seedcorn beetle (Clivinia impressifrons), etc. majalis) carrot beetle (Bothynus gibbosus), Grape Colaspis (Colaspis brunnea), southern Corn leaf beetle (Myochrous denticollis), Holotrichia genus, June beetle (Phyllophaga crinita) (Echinocnemus squameus), rice weevil (Lissorhoptrus oryzophilus), weevil (Sphenophorus venatus), weevil (Anthonomus grandis), Southern Corn Billbug (Sphenophorus scallus) subsignatus) and Sphenophorus levis and other weevil species such as the genus Sphenophorus; Beetles (Anoplophora malasiaca), beetles of Migdolus fryanus, Okinawa beetle (Melanotus okinawensis), spider moth (Agriotes ogurae fuscicollis), legis gris , Anchastus sp., Melanotus sp., Limonius sp., Conoderus sp., Ctenicera sp.), Aedes, Paederus fuscipes, and Coffee Barry Borer (Hypothenemus hampei).
 直翅目害虫:トノサマバッタ(Locusta migratoria)、ケラ(Gryllotalpa africana)、モロッコトビバッタ(Dociostaurus maroccanus)、オーストラリアトビバッタ(Chortoicetes terminifera)、アカトビバッタ(Nomadacris septemfasciata)、Brown Locust(Locustana pardalina)、Tree Locust (Anacridium melanorhodon)、Italian Locust (Calliptamus italicus)、Differential grasshopper(Melanoplus differentialis)、Twostriped grasshopper(Melanoplus bivittatus)、Migratory grasshopper(Melanoplus sanguinipes)、Red-Legged grasshopper(Melanoplus femurrubrum)、Clearwinged grasshopper(Camnula pellucida)、サバクワタリバッタ(Schistocerca gregaria)、Yellow-winged locust (Gastrimargus musicus)、Spur-throated locust (Austracris guttulosa)、コバネイナゴ(Oxya yezoensis)、ハネナガイナゴ(Oxya japonica)、タイワンツチイナゴ(Patanga succincta)、イエコオロギ(Acheta domesticus)、及びエンマコオロギ(Teleogryllus emma)、Mormon cricket (Anabrus simplex)等コオロギ類。 Insect pests: Tosama locust (Locusta migratoria), Kera (Gryllotalpa africana), Moroccan flying grasshopper (Dociostaurus maroccanus), Australian flying grasshopper (Chortoicetes terminifera), Red-spotted grasshopper (Nomadacris septemfa ciaustal Locna, Loc) melanorhodon), Italian Locust (Calliptamus italicus), Differential grasshopper (Melanoplus differentialis), Twostriped grasshopper (Melanoplus bivittatus), Migratory grasshopper (Melanoplus sanguinipes), Red-Legged grasshopper (Melanoplus sanguinipes), Red-Legged grasshopper (Melanoplus sanguinipes) (Schistocerca gregaria), Yellow-winged locust (Gastrimargus musicus), Spur-throated locust (Austracris guttulosa), Coxenago (Oxya yezoensis), Oxya japonica, Taiwan Chicos (Patanga ucci) , House cricket (Acheta domesticus), and Enmakoorogi (Teleogryllus emma), Mormon cricket (Anabrus simplex) or the like crickets acids.
 膜翅目害虫:カブラハバチ(Athalia rosae)、ニホンカブラバチ(Athalia japonica)等のハバチ類。ファイアーアント類。Brown leaf-cutting ant (Atta capiguara)等ハキリアリ類。 Hymenopteran pests: bees such as Athalia rosae and Japanese bee (Athalia japonica). Fire Ants. Hachiriari such as Brown leaf-cutting ant (Atta capiguara).
 ゴキブリ目害虫:チャバネゴキブリ(Blattella germanica)、クロゴキブリ(Periplaneta fuliginosa)、ワモンゴキブリ(Periplaneta americana)、トビイロゴキブリ(Periplaneta brunnea)、トウヨウゴキブリ(Blatta orientalis)。 Cockroach eye insects: German cockroach (Blattella germanica), Black cockroach (Periplaneta fliginosa), American cockroach (Periplaneta americana), Great cockroach (Periplaneta brunnea), Great cockroach (Blatta orientalis).
 シロアリ目害虫:ヤマトシロアリ(Reticulitermes speratus),イエシロアリ(Coptotermes formosanus),アメリカカンザイシロアリ(Incisitermes minor),ダイコクシロアリ(Cryptotermes domesticus),タイワンシロアリ(Odontotermes formosanus),コウシュンシロアリ(Neotermes koshunensis),サツマシロアリ(Glyptotermes satsumensis),ナカジマシロアリ(Glyptotermes nakajimai),カタンシロアリ(Glyptotermes fuscus),コダマシロアリ(Glyptotermes kodamai),クシモトシロアリ(Glyptotermes kushimensis),オオシロアリ(Hodotermopsis japonica),コウシュウイエシロアリ(Coptotermes guangzhoensis),アマミシロアリ(Reticulitermes miyatakei),キアシシロアリ(Reticulitermes flaviceps amamianus),カンモンシロアリ(Reticulitermes sp.),タカサゴシロアリ(Nasutitermes takasagoensis),ニトベシロアリ(Pericapritermes nitobei),ムシャシロアリ(Sinocapritermes mushae)、Cornitermes cumulans等。 Termite insect pests: Yamato termite (Reticulitermes speratus), termite (Coptotermes formosanus), American ant termite (Incisitermes minor), daiko termite (Cryptotermes domesticus), ant-white termite (Odontotermes formosaterm), ants Glyptotermes satsumensis), long term termite (Glyptotermes miyatakei), white termite (Reticulitermes flaviceps amamianus), common termite (Reticulitermes sp.), white termite (Nasutitermes takasagoensis), nitobeshi Lori (Pericapritermes nitobei), Mushy termite (Sinocapritermes mushae), Cornitermes cumulans, etc.
 ダニ目害虫:ナミハダニ(Tetranychus urticae)、カンザワハダニ(Tetranychus kanzawai)、ミカンハダニ(Panonychus citri)、リンゴハダニ(Panonychus ulmi)、オリゴニカス属及びSouthern Turkey spider mites (Brevipalpus phoenicis)等のハダニ類、ミカンサビダニ(Aculops pelekassi)、リュウキュウミカンサビダニ(Phyllocoptruta citri)、トマトサビダニ(Aculops lycopersici)、チャノサビダニ(Calacarus carinatus)、チャノナガサビダニ(Acaphylla theavagrans)、ニセナシサビダニ(Eriophyes chibaensis)、リンゴサビダニ(Aculus schlechtendali)等のフシダニ類、チャノホコリダニ(Polyphagotarsonemus latus)等のホコリダニ類、ミナミヒメハダニ(Brevipalpus phoenicis)等のヒメハダニ類、ケナガハダニ類、フタトゲチマダニ(Haemaphysalis longicornis)、ヤマトチマダニ(Haemaphysalis flava)、タイワンカクマダニ(Dermacentor taiwanicus)、アメリカンイヌカクマダニ(Dermacentor variabilis)、ヤマトマダニ(Ixodes ovatus)、シュルツマダニ(Ixodes persulcatus)、ブラックレッグドチック(Ixodes scapularis)、アメリカキララマダニ(Amblyomma americanum)、オウシマダニ(Boophilus microplus)、クリイロコイタマダニ(Rhipicephalus sanguineus)等のマダニ類、ケナガコナダニ(Tyrophagus putrescentiae)、ホウレンソウケナガコナダニ(Tyrophagus similis)等のコナダニ類、コナヒョウヒダニ(Dermatophagoides farinae)、ヤケヒョウヒダニ(Dermatophagoides ptrenyssnus)等のヒョウヒダニ類。 Acarid pests: Nite spider mite (Tetranychus urticae), Kanzawa spider mite (Tetranychus kanzawai), Scarlet spider mite (Panonychus citri), Apple spider mite (Panonychus ulmi), Oligonicus spp. , Phyllocoptruta citri, tomato rustic mite (Aculops lycopersici), green rustic mite (Calacarus carinatus), green rusted mite (Acaphylla theavagrans), green rust mite (Eriophyes schibalech), ali Dust mites (Polyphagotarsonemus latus), Mite spider mites (Brevipalpus phoenicis), Mite, Mites, Haemaphysalis longicornis, Haemaphysalis flav a), Dermacentor taiwanicus, Dermacentor variabilis, Yamato tick (Ixodes ovatus), Ixodes persulcatus, Black-legged tick (Ixodes scapularis), American thorny tick (Amblyomma america) Tick such as Boophilus microplus, Rhipicephalus sanguineus Kind.
 本発明の有害節足動物防除剤は、本発明化合物と不活性担体とを含有する。本発明の有害節足動物防除剤は、通常、本発明化合物と固体担体、液体担体、ガス状担体等の不活性担体とを混合し、必要に応じて界面活性剤、その他の製剤用補助剤を添加して、乳剤、油剤、粉剤、粒剤、水和剤、フロアブル剤、マイクロカプセル剤、エアゾール剤、燻煙剤、毒餌剤、樹脂製剤、シャンプー剤、ペースト状製剤、泡沫剤、炭酸ガス製剤、錠剤等に製剤化されている。これらの製剤は蚊取り線香、電気蚊取りマット、液体蚊取り製剤、燻煙剤、燻蒸剤、シート製剤、スポットオン剤、経口処理剤に加工されて、使用されることもある。また、本発明の有害節足動物防除剤は、他の殺虫剤、殺ダニ剤、殺線虫剤、殺菌剤、植物成長調節剤、除草剤及び共力剤と混用することもできる。 The harmful arthropod control agent of the present invention contains the compound of the present invention and an inert carrier. The harmful arthropod control agent of the present invention is usually a mixture of the compound of the present invention and an inert carrier such as a solid carrier, a liquid carrier, a gaseous carrier, etc., and if necessary, a surfactant and other adjuvants for formulation. Emulsions, oils, powders, granules, wettable powders, flowables, microcapsules, aerosols, smokers, poisonous baits, resin preparations, shampoos, pastes, foams, carbon dioxide It is formulated into preparations, tablets and the like. These preparations may be used after being processed into mosquito coils, electric mosquito mats, liquid mosquito traps, fumigants, fumigants, sheet preparations, spot-on agents, or oral treatments. Moreover, the harmful arthropod control agent of the present invention can be mixed with other insecticides, acaricides, nematicides, fungicides, plant growth regulators, herbicides and synergists.
 本発明の有害節足動物防除剤は、本発明化合物を通常0.01~95重量%含有する。 The harmful arthropod control agent of the present invention usually contains 0.01 to 95% by weight of the compound of the present invention.
 製剤化の際に用いられる固体担体としては、例えば粘土類(カオリンクレー、珪藻土、ベントナイト、フバサミクレー、酸性白土等)、合成含水酸化珪素、タルク、セラミック、その他の無機鉱物(セリサイト、石英、硫黄、活性炭、炭酸カルシウム、水和シリカ等)、化学肥料(硫安、燐安、硝安、尿素、塩安等)等の微粉末及び粒状物等、並びに合成樹脂(ポリプロピレン、ポリアクリロニトリル、ポリメタクリル酸メチル、ポリエチレンテレフタレート等のポリエステル樹脂、ナイロン-6、ナイロン-11、ナイロン-66等のナイロン樹脂、ポリアミド樹脂、ポリ塩化ビニル、ポリ塩化ビニリデン、塩化ビニル-プロピレン共重合体等)があげられる。 Examples of solid carriers used for formulation include clays (kaolin clay, diatomaceous earth, bentonite, fusami clay, acidic clay), synthetic hydrous silicon oxide, talc, ceramics, and other inorganic minerals (sericite, quartz, sulfur). , Activated carbon, calcium carbonate, hydrated silica, etc.), fine powders and granules of chemical fertilizers (ammonium sulfate, phosphorous acid, ammonium nitrate, urea, ammonium chloride, etc.), and synthetic resins (polypropylene, polyacrylonitrile, polymethyl methacrylate) Polyester resins such as polyethylene terephthalate, nylon resins such as nylon-6, nylon-11, and nylon-66, polyamide resins, polyvinyl chloride, polyvinylidene chloride, and vinyl chloride-propylene copolymers).
 液体担体としては、例えば水、アルコール類(メタノール、エタノール、イソプロピルアルコール、ブタノール、ヘキサノール、ベンジルアルコール、エチレングリコール、プロピレングリコール、フェノキシエタノール等)、ケトン類(アセトン、メチルエチルケトン、シクロヘキサノン等)、芳香族炭化水素類(トルエン、キシレン、エチルベンゼン、ドデシルベンゼン、フェニルキシリルエタン、メチルナフタレン等)、脂肪族炭化水素類(ヘキサン、シクロヘキサン、灯油、軽油等)、エステル類(酢酸エチル、酢酸ブチル、ミリスチン酸イソプロピル、オレイン酸エチル、アジピン酸ジイソプロピル、アジピン酸ジイソブチル、プロピレングリコールモノメチルエーテルアセテート等)、ニトリル類(アセトニトリル、イソブチロニトリル等)、エーテル類(ジイソプロピルエーテル、1,4-ジオキサン、エチレングリコールジメチルエーテル、ジエチレングリコールジメチルエーテル、ジエチレングリコールモノメチルエーテル、プロピレングリコールモノメチルエーテル、ジプロピレングリコールモノメチルエーテル、3-メトキシ-3-メチル-1-ブタノール等)、酸アミド類(DMF、N,N-ジメチルアセトアミド等)、ハロゲン化炭化水素類(ジクロロメタン、トリクロロエタン、四塩化炭素等)、スルホキシド類(ジメチルスルホキシド等)、炭酸プロピレン及び植物油(大豆油、綿実油等)が挙げられる。 Examples of the liquid carrier include water, alcohols (methanol, ethanol, isopropyl alcohol, butanol, hexanol, benzyl alcohol, ethylene glycol, propylene glycol, phenoxyethanol, etc.), ketones (acetone, methyl ethyl ketone, cyclohexanone, etc.), aromatic hydrocarbons (Toluene, xylene, ethylbenzene, dodecylbenzene, phenylxylylethane, methylnaphthalene, etc.), aliphatic hydrocarbons (hexane, cyclohexane, kerosene, light oil, etc.), esters (ethyl acetate, butyl acetate, isopropyl myristate, Ethyl oleate, diisopropyl adipate, diisobutyl adipate, propylene glycol monomethyl ether acetate, etc.), nitriles (acetonitrile, isobutyrate) Nitriles), ethers (diisopropyl ether, 1,4-dioxane, ethylene glycol dimethyl ether, diethylene glycol dimethyl ether, diethylene glycol monomethyl ether, propylene glycol monomethyl ether, dipropylene glycol monomethyl ether, 3-methoxy-3-methyl-1-butanol, etc. ), Acid amides (DMF, N, N-dimethylacetamide, etc.), halogenated hydrocarbons (dichloromethane, trichloroethane, carbon tetrachloride, etc.), sulfoxides (dimethylsulfoxide, etc.), propylene carbonate and vegetable oils (soybean oil, cottonseed oil) Etc.).
 ガス状担体としては、例えばフルオロカーボン、ブタンガス、LPG(液化石油ガス)、ジメチルエーテル及び炭酸ガスがあげられる。 Examples of the gaseous carrier include fluorocarbon, butane gas, LPG (liquefied petroleum gas), dimethyl ether, and carbon dioxide gas.
 界面活性剤としては、例えばポリオキシエチレンアルキルエーテル、ポリオキシエチレンアルキルアリールエーテル、ポリエチレングリコール脂肪酸エステル等の非イオン界面活性剤、及びアルキルスルホン酸塩、アルキルベンゼンスルホン酸塩、アルキル硫酸塩等の陰イオン界面活性剤が挙げられる。 Examples of the surfactant include nonionic surfactants such as polyoxyethylene alkyl ether, polyoxyethylene alkyl aryl ether, and polyethylene glycol fatty acid ester, and anions such as alkyl sulfonate, alkyl benzene sulfonate, and alkyl sulfate. Surfactant is mentioned.
 その他の製剤用補助剤としては、固着剤、分散剤、着色剤及び安定剤等、具体的には例えばカゼイン、ゼラチン、糖類(でんぷん、アラビアガム、セルロース誘導体、アルギン酸等)、リグニン誘導体、ベントナイト、合成水溶性高分子(ポリビニルアルコール、ポリビニルピロリドン、ポリアクリル酸類等)、PAP(酸性りん酸イソプロピル)、BHT(2,6-ジ-tert-ブチル-4-メチルフェノール)、BHA(2-tert-ブチル-4-メトキシフェノールと3-tert-ブチル-4-メトキシフェノールとの混合物)が挙げられる。 Examples of other adjuvants for preparation include fixing agents, dispersants, colorants and stabilizers, such as casein, gelatin, saccharides (starch, gum arabic, cellulose derivatives, alginic acid, etc.), lignin derivatives, bentonite, Synthetic water-soluble polymers (polyvinyl alcohol, polyvinylpyrrolidone, polyacrylic acids, etc.), PAP (isopropyl acid phosphate), BHT (2,6-di-tert-butyl-4-methylphenol), BHA (2-tert- And a mixture of butyl-4-methoxyphenol and 3-tert-butyl-4-methoxyphenol).
 樹脂製剤の基材としては、例えば塩化ビニル系重合体、ポリウレタン等を挙げることができ、これらの基材には必要によりフタル酸エステル類(フタル酸ジメチル、フタル酸ジオクチル等)、アジピン酸エステル類、ステアリン酸等の可塑剤が添加されていてもよい。樹脂製剤は該基材中に化合物を通常の混練装置を用いて混練した後、射出成型、押出成型、プレス成型等により成型することにより得られ、必要により更に成型、裁断等の工程を経て、板状、フィルム状、テープ状、網状、ひも状等の樹脂製剤に加工できる。これらの樹脂製剤は、例えば動物用首輪、動物用イヤータッグ、シート製剤、誘引ひも、園芸用支柱として加工される。 Examples of the base material of the resin preparation include vinyl chloride polymers, polyurethanes, etc., and these base materials include phthalic acid esters (dimethyl phthalate, dioctyl phthalate, etc.) and adipic acid esters as necessary. Further, a plasticizer such as stearic acid may be added. The resin formulation is obtained by kneading the compound in the base material using a normal kneading apparatus, and then molding by injection molding, extrusion molding, press molding, etc., and if necessary, through steps such as molding, cutting, It can be processed into resin preparations such as plate, film, tape, net, and string. These resin preparations are processed, for example, as animal collars, animal ear tags, sheet preparations, attracting strings, or gardening supports.
 毒餌の基材としては、例えば穀物粉、植物油、糖、結晶セルロース等が挙げられ、更に必要に応じて、ジブチルヒドロキシトルエン、ノルジヒドログアイアレチン酸等の酸化防止剤、デヒドロ酢酸等の保存料、トウガラシ末等の子供やペットによる誤食防止剤、チーズ香料、タマネギ香料ピーナッツオイル等の害虫誘引性香料等が添加される。 Examples of the bait base include cereal flour, vegetable oil, sugar, crystalline cellulose and the like, and if necessary, antioxidants such as dibutylhydroxytoluene and nordihydroguaiaretic acid, and preservatives such as dehydroacetic acid. Additives for preventing accidental eating by children and pets such as pepper powder, pests such as cheese flavor, onion flavor and peanut oil are added.
 本発明の有害節足動物防除方法は、本発明化合物の有効量を有害節足動物に直接、及び/又は、有害節足動物の生息場所(植物、土壌、家屋内、動物体等)に施用することにより行われる。本発明の有害節足動物防除方法には、通常、本発明の有害節足動物防除剤の形態で用いられる。 In the method for controlling harmful arthropods of the present invention, an effective amount of the compound of the present invention is applied directly to harmful arthropods and / or to the place where the harmful arthropods live (plants, soil, households, animal bodies, etc.). Is done. The harmful arthropod control method of the present invention is usually used in the form of the harmful arthropod control agent of the present invention.
 本発明の有害節足動物防除剤を農業分野の有害節足動物防除に用いる場合、その施用量は、10000mあたりの本発明化合物量で通常1~10000gである。本発明の有害節足動物防除剤が乳剤、水和剤、フロアブル剤等に製剤化されている場合は、通常、有効成分濃度が0.01~10000ppmとなるように水で希釈して施用し、粒剤、粉剤等は、通常、そのまま施用する。 When the harmful arthropod control agent of the present invention is used for controlling harmful arthropods in the agricultural field, the application amount is usually 1 to 10,000 g in the amount of the compound of the present invention per 10,000 m 2 . When the harmful arthropod control agent of the present invention is formulated into an emulsion, a wettable powder, a flowable agent, etc., it is usually applied by diluting with water so that the active ingredient concentration becomes 0.01 to 10,000 ppm. Granules, powders and the like are usually applied as they are.
 これらの製剤や製剤の水希釈液は、有害節足動物又は有害節足動物から保護すべき作物等の植物に直接散布処理してもよく、また耕作地の土壌に生息する有害節足動物を防除するために、該土壌に処理してもよい。 These preparations and water dilutions of these preparations may be sprayed directly on harmful arthropods or plants such as crops to be protected from harmful arthropods, and harmful arthropods that inhabit the soil of cultivated land. You may treat to this soil in order to control.
 また、シート状やひも状に加工した樹脂製剤を作物に巻き付ける、作物近傍に張り渡す、株元土壌に敷く等の方法により処理することもできる。 Also, it can be treated by methods such as wrapping a resin preparation processed into a sheet or string around the crop, stretching it around the crop, or laying it on the stock soil.
 本発明の有害節足動物防除剤を家屋内に生息する有害節足動物の防除に用いる場合、その施用量は、面上に処理する場合は処理面積1mあたりの本発明化合物量で、通常、0.01~1000mgであり、空間に処理する場合は処理空間1mあたりの本発明化合物量で、通常、0.01~500mgである。本発明の有害節足動物防除剤が乳剤、水和剤、フロアブル剤等に製剤化されている場合は、通常有効成分濃度が0.1~10000ppmとなるように水で希釈して施用し、油剤、エアゾール剤、燻煙剤、毒餌剤等はそのまま施用する。 When the harmful arthropod control agent of the present invention is used for controlling harmful arthropods that live in the house, the amount applied is usually the amount of the compound of the present invention per 1 m 2 when treated on the surface. 0.01 to 1000 mg, and when processing in a space, the amount of the compound of the present invention per 1 m 3 of the processing space is usually 0.01 to 500 mg. When the harmful arthropod control agent of the present invention is formulated into an emulsion, a wettable powder, a flowable agent, etc., it is usually diluted with water so that the active ingredient concentration is 0.1 to 10,000 ppm. Apply oils, aerosols, smoke, poison baits, etc. as they are.
 本発明の有害節足動物防除剤をウシ、ウマ、ブタ、ヒツジ、ヤギ、ニワトリ用の家畜、イヌ、ネコ、ラット、マウス等の小動物の外部寄生虫防除に用いる場合は、獣医学的に公知の方法で動物に使用することができる。具体的な使用方法としては、全身抑制を目的にする場合には、例えば錠剤、飼料混入、坐薬、注射(筋肉内、皮下、静脈内、腹腔内等)により投与され、非全身的抑制を目的とする場合には、例えば油剤若しくは水性液剤を噴霧する、ポアオン処理若しくはスポットオン処理を行う、シャンプー製剤で動物を洗う又は樹脂製剤を首輪や耳札にして動物に付ける等の方法により用いられる。動物体に投与する場合の本発明化合物の量は、通常動物の体重1kgに対して、0.1~1000mgの範囲である。 When the harmful arthropod control agent of the present invention is used to control ectoparasites of cattle, horses, pigs, sheep, goats, chickens, small animals such as dogs, cats, rats, mice, etc., it is well known in veterinary medicine. Can be used on animals. As a specific method of use, for the purpose of systemic suppression, for example, administration by tablet, feed mixing, suppository, injection (intramuscular, subcutaneous, intravenous, intraperitoneal, etc.) is intended for non-systemic suppression. In this case, for example, an oil agent or an aqueous liquid is sprayed, a pour-on treatment or a spot-on treatment is performed, the animal is washed with a shampoo preparation, or a resin preparation is attached to the animal with a collar or ear tag. The amount of the compound of the present invention when administered to an animal body is usually in the range of 0.1 to 1000 mg per 1 kg body weight of the animal.
 以下、本発明を製造例、参考製造例、製剤例及び試験例等によりさらに詳しく説明するが、本発明はこれらの例のみに限定されるものではない。 Hereinafter, the present invention will be described in more detail with reference to production examples, reference production examples, formulation examples, and test examples, but the present invention is not limited to these examples.
 まず、本発明化合物の製造について、参考製造例及び製造例を示す。 First, reference production examples and production examples are shown for production of the compound of the present invention.
参考製造例1
 チオモルホリン5.0g、4-(ジメチルアミノ)ピリジン0.89g、トリエチルアミン10.1mL及びTHF50mLの混合物に、氷冷下、クロログリオキシル酸メチル4.5mLを滴下し、室温下で4時間撹拌した。反応混合物に水を加え、MTBEで抽出した後、無水硫酸マグネシウムで乾燥した。減圧下濃縮した後、得られた残渣をシリカゲルカラムクロマトグラフィーに付し、下記に示される中間体A7.45gを得た。
中間体A
Figure JPOXMLDOC01-appb-I000044
Reference production example 1
To a mixture of 5.0 g of thiomorpholine, 0.89 g of 4- (dimethylamino) pyridine, 10.1 mL of triethylamine and 50 mL of THF, 4.5 mL of methyl chloroglyoxylate was added dropwise under ice cooling, and the mixture was stirred at room temperature for 4 hours. Water was added to the reaction mixture, extracted with MTBE, and then dried over anhydrous magnesium sulfate. After concentration under reduced pressure, the resulting residue was subjected to silica gel column chromatography to obtain 7.45 g of intermediate A shown below.
Intermediate A
Figure JPOXMLDOC01-appb-I000044
1H-NMR (CDCl3) δ: 3.95-3.90 (5H, m), 3.72-3.68 (2H, m), 2.74-2.69 (4H, m). 1 H-NMR (CDCl 3 ) δ: 3.95-3.90 (5H, m), 3.72-3.68 (2H, m), 2.74-2.69 (4H, m).
参考製造例2
 中間体A7.45g、2N水酸化ナトリウム水溶液8mL及びエタノール80mLの混合物を、60℃で4時間撹拌した。室温まで放冷した反応混合物に水を加え、MTBEで洗浄した。水層を2N塩酸でpHを2~3に調整し、MTBEで抽出した後、無水硫酸マグネシウムで乾燥した。減圧下濃縮し、下記に示される中間体B5.35gを得た。
中間体B
Reference production example 2
A mixture of Intermediate A (7.45 g), 2N aqueous sodium hydroxide solution (8 mL) and ethanol (80 mL) was stirred at 60 ° C. for 4 hours. Water was added to the reaction mixture allowed to cool to room temperature, and the mixture was washed with MTBE. The aqueous layer was adjusted to pH 2-3 with 2N hydrochloric acid, extracted with MTBE, and dried over anhydrous magnesium sulfate. Concentration under reduced pressure yielded 5.35 g of intermediate B shown below.
Intermediate B
Figure JPOXMLDOC01-appb-I000045
Figure JPOXMLDOC01-appb-I000045
1H-NMR (CDCl3) δ: 4.42-4.37 (2H, m), 4.02-3.97 (2H, m), 2.81-2.74 (4H, m). 1 H-NMR (CDCl 3 ) δ: 4.42-4.37 (2H, m), 4.02-3.97 (2H, m), 2.81-2.74 (4H, m).
参考製造例3
 中間体Aに代えて3-[(メトキシオキサリル)アミノ]-N-[2-ブロモ-6-(ジフルオロメトキシ)-4-(ヘプタフルオロイソプロピル)フェニル]ベンズアミド(以下、中間体Cと記す。)を用い、参考製造例2記載の方法に準じて、下記に示される中間体Dを得た。
中間体D
Reference production example 3
Instead of Intermediate A, 3-[(methoxyoxalyl) amino] -N- [2-bromo-6- (difluoromethoxy) -4- (heptafluoroisopropyl) phenyl] benzamide (hereinafter referred to as Intermediate C) In accordance with the method described in Reference Production Example 2, Intermediate D shown below was obtained.
Intermediate D
Figure JPOXMLDOC01-appb-I000046
Figure JPOXMLDOC01-appb-I000046
1H-NMR (CDCl3) δ: 9.25-9.21 (1H, m), 8.31-8.29 (1H, m), 7.94-7.90 (1H, m), 7.84-7.81 (2H, m), 7.75-7.71 (1H, m), 7.64-7.59 (1H, m), 7.55-7.53 (1H, m), 6.63 (1H, t). 1 H-NMR (CDCl 3 ) δ: 9.25-9.21 (1H, m), 8.31-8.29 (1H, m), 7.94-7.90 (1H, m), 7.84-7.81 (2H, m), 7.75-7.71 ( 1H, m), 7.64-7.59 (1H, m), 7.55-7.53 (1H, m), 6.63 (1H, t).
参考製造例4
 4-フルオロ-3-ニトロ安息香酸2.74g、DMF0.1mL及びTHF30mLの混合物に、オキサリルクロリド1.37mLを滴下した後、還流下、1時間撹拌した。室温まで放冷した反応混合物を濃縮し、4-フルオロ-3-ニトロベンゾイルクロリドを得た。
Reference production example 4
1.37 mL of oxalyl chloride was added dropwise to a mixture of 2.74 g of 4-fluoro-3-nitrobenzoic acid, 0.1 mL of DMF and 30 mL of THF, and the mixture was stirred for 1 hour under reflux. The reaction mixture allowed to cool to room temperature was concentrated to give 4-fluoro-3-nitrobenzoyl chloride.
 2-ブロモ-6-(ジフルオロメトキシ)-4-(ヘプタフルオロイソプロピル)アニリン(以下、中間体Eと記す。)5.0g及び1,3-ジメチル-2-イミダゾリジノン(以下、DMIと記す。)30mLの混合物に上記で得られた4-フルオロ-3-ニトロベンゾイルクロリド全量及びDMI5mLの混合物を滴下した後、100℃で5時間撹拌した。室温まで放冷した反応混合物に水を加え、MTBEで抽出した後、無水硫酸マグネシウムで乾燥した。減圧下濃縮した後、得られた残渣をシリカゲルカラムクロマトグラフィーに付し、下記に示される中間体N1-1を5.79g得た。
中間体N1-1
5.0 g of 2-bromo-6- (difluoromethoxy) -4- (heptafluoroisopropyl) aniline (hereinafter referred to as Intermediate E) and 1,3-dimethyl-2-imidazolidinone (hereinafter referred to as DMI) .) A mixture of the whole amount of 4-fluoro-3-nitrobenzoyl chloride obtained above and 5 mL of DMI was added dropwise to 30 mL of the mixture, followed by stirring at 100 ° C. for 5 hours. Water was added to the reaction mixture allowed to cool to room temperature, extracted with MTBE, and then dried over anhydrous magnesium sulfate. After concentration under reduced pressure, the resulting residue was subjected to silica gel column chromatography to obtain 5.79 g of intermediate N1-1 shown below.
Intermediate N1-1
Figure JPOXMLDOC01-appb-I000047
Figure JPOXMLDOC01-appb-I000047
1H-NMR (CDCl3) δ: 8.67-8.63 (1H, m), 8.28-8.23 (1H, m), 7.83-7.80 (1H, m), 7.65-7.62 (1H, m), 7.53-7.47 (2H, m), 6.59 (1H, t). 1 H-NMR (CDCl 3 ) δ: 8.67-8.63 (1H, m), 8.28-8.23 (1H, m), 7.83-7.80 (1H, m), 7.65-7.62 (1H, m), 7.53-7.47 ( 2H, m), 6.59 (1H, t).
参考製造例5
 1.97gの中間体N1-1、炭酸カリウム0.95g及びメタノール34mLの混合物を還流下、2時間撹拌した。室温まで放冷した反応混合物に水を加え、MTBEで抽出した後、無水硫酸マグネシウムで乾燥した。減圧下濃縮した後、得られた残渣をシリカゲルカラムクロマトグラフィーに付し、下記に示される中間体N1-2を1.68g得た。
中間体N1-2
Reference production example 5
A mixture of 1.97 g of intermediate N1-1, 0.95 g of potassium carbonate and 34 mL of methanol was stirred under reflux for 2 hours. Water was added to the reaction mixture allowed to cool to room temperature, extracted with MTBE, and then dried over anhydrous magnesium sulfate. After concentration under reduced pressure, the resulting residue was subjected to silica gel column chromatography to obtain 1.68 g of intermediate N1-2 shown below.
Intermediate N1-2
Figure JPOXMLDOC01-appb-I000048
Figure JPOXMLDOC01-appb-I000048
1H-NMR (CDCl3) δ: 8.45-8.42 (1H, m), 8.20-8.15 (1H, m), 7.81-7.78 (1H, m), 7.63-7.60 (1H, m), 7.52-7.49 (1H, m), 7.27-7.22 (1H, m), 6.58 (1H, t), 4.07 (3H, s). 1 H-NMR (CDCl 3 ) δ: 8.45-8.42 (1H, m), 8.20-8.15 (1H, m), 7.81-7.78 (1H, m), 7.63-7.60 (1H, m), 7.52-7.49 ( 1H, m), 7.27-7.22 (1H, m), 6.58 (1H, t), 4.07 (3H, s).
参考製造例6
 3.79gの中間体N1-1、電解鉄粉11.1g、塩化アンモニウム10.6g、エタノール53mL及び水13mLの混合物を80℃で5時間撹拌した。室温まで放冷した反応混合物に水を加え、セライトでろ過し、ろ物をMTBEで洗浄した。ろ液を分液し、有機層を無水硫酸マグネシウムで乾燥し、減圧下濃縮した後、得られた残渣をシリカゲルカラムクロマトグラフィーに付し、下記に示される中間体N2-1を3.48g得た。
中間体N2-1
Reference production example 6
A mixture of 3.79 g of intermediate N1-1, 11.1 g of electrolytic iron powder, 10.6 g of ammonium chloride, 53 mL of ethanol and 13 mL of water was stirred at 80 ° C. for 5 hours. Water was added to the reaction mixture which was allowed to cool to room temperature, filtered through celite, and the residue was washed with MTBE. The filtrate was separated, and the organic layer was dried over anhydrous magnesium sulfate and concentrated under reduced pressure. The resulting residue was subjected to silica gel column chromatography to obtain 3.48 g of intermediate N2-1 shown below. It was.
Intermediate N2-1
Figure JPOXMLDOC01-appb-I000049
Figure JPOXMLDOC01-appb-I000049
1H-NMR (CDCl3) δ: 7.79-7.77 (1H, m), 7.52-7.48 (2H, m), 7.40-7.37 (1H, m), 7.26-7.21 (1H, m), 7.14-7.08 (1H, m), 6.59 (1H, t), 3.97-3.94 (2H, m). 1 H-NMR (CDCl 3 ) δ: 7.79-7.77 (1H, m), 7.52-7.48 (2H, m), 7.40-7.37 (1H, m), 7.26-7.21 (1H, m), 7.14-7.08 ( 1H, m), 6.59 (1H, t), 3.97-3.94 (2H, m).
参考製造例7
 チオモルホリンに代えて中間体N2-1を用い、参考製造例1記載の方法に準じて、下記に示される中間体N3-1を得た。
中間体N3-1
Reference production example 7
The intermediate N3-1 shown below was obtained according to the method described in Reference Production Example 1 using the intermediate N2-1 instead of thiomorpholine.
Intermediate N3-1
Figure JPOXMLDOC01-appb-I000050
Figure JPOXMLDOC01-appb-I000050
1H-NMR (CDCl3) δ: 9.25-9.21 (1H, m), 9.02-8.98 (1H, m), 7.88-7.82 (2H, m), 7.81-7.78 (1H, m), 7.52-7.49 (1H, m), 7.36-7.29 (1H, m), 6.60 (1H, t), 4.02 (3H, s). 1 H-NMR (CDCl 3 ) δ: 9.25-9.21 (1H, m), 9.02-8.98 (1H, m), 7.88-7.82 (2H, m), 7.81-7.78 (1H, m), 7.52-7.49 ( 1H, m), 7.36-7.29 (1H, m), 6.60 (1H, t), 4.02 (3H, s).
参考製造例8
 中間体Aに代えて中間体N3-1を用い、参考製造例2記載の方法に準じて、下記に示される中間体N4-1を得た。
中間体N4-1
Reference production example 8
Intermediate N4-1 shown below was obtained according to the method described in Reference Production Example 2 using Intermediate N3-1 instead of Intermediate A.
Intermediate N4-1
Figure JPOXMLDOC01-appb-I000051
Figure JPOXMLDOC01-appb-I000051
1H-NMR (CDCl3) δ: 9.35-9.30 (1H, m), 8.94-8.89 (1H, m), 7.88-7.73 (3H, m), 7.53-7.48 (1H, m), 7.38-7.31 (1H, m), 6.59 (1H, t). 1 H-NMR (CDCl 3 ) δ: 9.35-9.30 (1H, m), 8.94-8.89 (1H, m), 7.88-7.73 (3H, m), 7.53-7.48 (1H, m), 7.38-7.31 ( 1H, m), 6.59 (1H, t).
参考製造例9
 N-[2-ブロモ-6-(ジフルオロメトキシ)-4-(ヘプタフルオロイソプロピル)フェニル]-3-ニトロベンズアミド7.0g及びDMF70mLの混合物に氷冷下、60%水素化ナトリウム(油性)604mgを加え、25分間撹拌した。この混合物にヨウ化メチル2.15gを加え、さらに1時間撹拌した。反応混合物を氷水に加え、MTBEで抽出した後、有機層を水、飽和食塩水で順次洗浄した。有機層を無水硫酸マグネシウムで乾燥し、減圧下濃縮した後、得られた残渣をシリカゲルカラムクロマトグラフィーに付し、下記に示される中間体N1-8を6.0g得た。
中間体N1-8
Reference production example 9
To a mixture of 7.0 g of N- [2-bromo-6- (difluoromethoxy) -4- (heptafluoroisopropyl) phenyl] -3-nitrobenzamide and 70 mL of DMF was added 604 mg of 60% sodium hydride (oily) under ice-cooling. Added and stirred for 25 minutes. To this mixture, 2.15 g of methyl iodide was added, and the mixture was further stirred for 1 hour. The reaction mixture was added to ice water and extracted with MTBE, and then the organic layer was washed successively with water and saturated brine. The organic layer was dried over anhydrous magnesium sulfate and concentrated under reduced pressure, and then the resulting residue was subjected to silica gel column chromatography to obtain 6.0 g of intermediate N1-8 shown below.
Intermediate N1-8
Figure JPOXMLDOC01-appb-I000052
Figure JPOXMLDOC01-appb-I000052
1H-NMR (CDCl3) δ: 8.20-8.13 (2H, m), 7.73-7.70 (1H, m), 7.68-7.66 (1H, m), 7.43-7.37 (1H, m), 7.30-7.28 (1H, m), 6.76-6.39 (1H, m), (3.38 + 3.26) (1H, s). 1 H-NMR (CDCl 3 ) δ: 8.20-8.13 (2H, m), 7.73-7.70 (1H, m), 7.68-7.66 (1H, m), 7.43-7.37 (1H, m), 7.30-7.28 ( 1H, m), 6.76-6.39 (1H, m), (3.38 + 3.26) (1H, s).
参考製造例10
 5.7gの中間体N1-8、塩化スズ(II)及びエタノール63mLの混合物に12N塩酸6.3mLを加え、還流下1.5時間撹拌した。室温まで放冷した後、減圧下溶媒を留去した。この反応混合物に氷20g及び10%水酸化ナトリウム水溶液72mLを加え、セライトでろ過をした。ろ液をMTBEで抽出し、有機層を水、飽和食塩水で順次洗浄した。有機層を無水硫酸マグネシウムで乾燥した後、減圧下濃縮し、以下に示される中間体N2-8を5.0g得た。
中間体N2-8
Reference production example 10
To a mixture of 5.7 g of intermediate N1-8, tin (II) chloride and ethanol (63 mL), 12N hydrochloric acid (6.3 mL) was added and stirred under reflux for 1.5 hours. After cooling to room temperature, the solvent was distilled off under reduced pressure. To this reaction mixture, 20 g of ice and 72 mL of 10% aqueous sodium hydroxide solution were added, followed by filtration through celite. The filtrate was extracted with MTBE, and the organic layer was washed successively with water and saturated brine. The organic layer was dried over anhydrous magnesium sulfate and concentrated under reduced pressure to obtain 5.0 g of intermediate N2-8 shown below.
Intermediate N2-8
Figure JPOXMLDOC01-appb-I000053
Figure JPOXMLDOC01-appb-I000053
1H-NMR (CDCl3) δ: ((7.83-7.48)+(7.25-7.22)+(7.03-6.95)+(6.89-6.84)+(6.82-6.73)+(6.59-6.53)+(6.49-6.12)) (7H, m), ((3.85-3.83)+(3.62-3.60)) (2H, m), (3.33+3.23) (3H, s). 1 H-NMR (CDCl 3 ) δ: ((7.83-7.48) + (7.25-7.22) + (7.03-6.95) + (6.89-6.84) + (6.82-6.73) + (6.59-6.53) + (6.49- 6.12)) (7H, m), ((3.85-3.83) + (3.62-3.60)) (2H, m), (3.33 + 3.23) (3H, s).
参考製造例11
 4-(トリフルオロメトキシ)-2-(トリフルオロメチル)アニリン3.0g、酢酸エチル25mL及びDMF5mLの混合物にN-ブロモスクシンイミド2.39gを加え、室温下で2.5時間撹拌した。この反応混合物に20%チオ硫酸ナトリウム水溶液を加え、酢酸エチルで抽出した。有機層を水、飽和食塩水で順次洗浄した。有機層を無水硫酸マグネシウムで乾燥し、減圧下濃縮した後、得られた残渣をシリカゲルカラムクロマトグラフィーに付し、2-ブロモ-4-(トリフルオロメトキシ)-6-(トリフルオロメチル)アニリン3.2gを得た。
Reference production example 11
2.39 g of N-bromosuccinimide was added to a mixture of 3.0 g of 4- (trifluoromethoxy) -2- (trifluoromethyl) aniline, 25 mL of ethyl acetate and 5 mL of DMF, and the mixture was stirred at room temperature for 2.5 hours. To this reaction mixture was added 20% aqueous sodium thiosulfate solution, and the mixture was extracted with ethyl acetate. The organic layer was washed successively with water and saturated brine. The organic layer was dried over anhydrous magnesium sulfate and concentrated under reduced pressure. The obtained residue was subjected to silica gel column chromatography to give 2-bromo-4- (trifluoromethoxy) -6- (trifluoromethyl) aniline 3 0.2 g was obtained.
Figure JPOXMLDOC01-appb-I000054
Figure JPOXMLDOC01-appb-I000054
1H-NMR (CDCl3) δ: 7.54-7.52 (1H, m), 7.33-7.31 (1H, m), 4.75 (2H, br s).
前記の参考製造例に記載の方法に準じた製造方法により製造される化合物及びその物性値を表に示す。
式(N1)
1 H-NMR (CDCl 3 ) δ: 7.54-7.52 (1H, m), 7.33-7.31 (1H, m), 4.75 (2H, br s).
The compounds produced by the production method according to the method described in the above Reference Production Examples and their physical property values are shown in the table.
Formula (N1)
Figure JPOXMLDOC01-appb-I000055
Figure JPOXMLDOC01-appb-I000055
で示される化合物において、R、R及びXが、[表28]で示される化合物。 In which R 1 , R 3 and X a are represented by [Table 28].
Figure JPOXMLDOC01-appb-T000056
Figure JPOXMLDOC01-appb-T000056
式(N1-8)で示される化合物。 A compound represented by the formula (N1-8).
Figure JPOXMLDOC01-appb-I000057
Figure JPOXMLDOC01-appb-I000057
1H-NMR (CDCl3) δ: 8.78-8.75 (1H, m), 8.51-8.46 (1H, m), 8.31-8.26 (1H, m), 7.84-7.80 (1H, m), 7.80-7.74 (1H, m), 7.67-7.62 (1H, m), 7.61-7.59 (1H, m).
式(N2) 
1 H-NMR (CDCl 3 ) δ: 8.78-8.75 (1H, m), 8.51-8.46 (1H, m), 8.31-8.26 (1H, m), 7.84-7.80 (1H, m), 7.80-7.74 ( 1H, m), 7.67-7.62 (1H, m), 7.61-7.59 (1H, m).
Formula (N2)
Figure JPOXMLDOC01-appb-I000058
Figure JPOXMLDOC01-appb-I000058
で示される化合物において、R、R及びXが、[表29]で示される化合物。 In which R 1 , R 3 and X a are represented by [Table 29].
Figure JPOXMLDOC01-appb-T000059
Figure JPOXMLDOC01-appb-T000059
式(N2-8)で示される化合物。 A compound represented by the formula (N2-8).
Figure JPOXMLDOC01-appb-I000060
Figure JPOXMLDOC01-appb-I000060
1H-NMR (CDCl3) δ: 7.80-7.76 (1H, m), 7.57-7.54 (1H, m), 7.51-7.47 (1H, m), 7.32-7.20 (3H, m), 6.91-6.87 (1H, m), 3.87 (2H, br s).
式(N3) 
1 H-NMR (CDCl 3 ) δ: 7.80-7.76 (1H, m), 7.57-7.54 (1H, m), 7.51-7.47 (1H, m), 7.32-7.20 (3H, m), 6.91-6.87 ( 1H, m), 3.87 (2H, br s).
Formula (N3)
Figure JPOXMLDOC01-appb-I000061
Figure JPOXMLDOC01-appb-I000061
で示される化合物において、R、R及びXが、[表30]及び[表31]で示される化合物。 In which R 1 , R 3 and X a are represented by [Table 30] and [Table 31].
Figure JPOXMLDOC01-appb-T000062
Figure JPOXMLDOC01-appb-T000062
Figure JPOXMLDOC01-appb-T000063
Figure JPOXMLDOC01-appb-T000063
式(N4)  Formula (N4)
Figure JPOXMLDOC01-appb-I000064
Figure JPOXMLDOC01-appb-I000064
で示される化合物において、R、R及びXが、[表32]及び[表33]で示される化合物。 Wherein R 1 , R 3 and X a are represented by [Table 32] and [Table 33].
Figure JPOXMLDOC01-appb-T000065
Figure JPOXMLDOC01-appb-T000065
Figure JPOXMLDOC01-appb-T000066
Figure JPOXMLDOC01-appb-T000066
式(N5-1)で示される化合物。 A compound represented by formula (N5-1):
Figure JPOXMLDOC01-appb-I000067
Figure JPOXMLDOC01-appb-I000067
1H-NMR (CDCl3) δ: 9.53-9.51 (1H, m), 8.29-8.25 (1H, m), 7.88-7.86 (1H, m), 7.76-7.74 (1H, m), 7.36-7.31 (2H, m), 4.44-4.34 (1H, m), 4.17 (3H, s), 3.70 (3H, s), 3.57-3.47 (1H, m), 1.31-1.20 (3H, m).
式(N5-2)で示される化合物。
1 H-NMR (CDCl 3 ) δ: 9.53-9.51 (1H, m), 8.29-8.25 (1H, m), 7.88-7.86 (1H, m), 7.76-7.74 (1H, m), 7.36-7.31 ( 2H, m), 4.44-4.34 (1H, m), 4.17 (3H, s), 3.70 (3H, s), 3.57-3.47 (1H, m), 1.31-1.20 (3H, m).
A compound represented by the formula (N5-2).
Figure JPOXMLDOC01-appb-I000068
Figure JPOXMLDOC01-appb-I000068
1H-NMR (CDCl3) δ: 9.37-9.35 (1H, m), 8.24-8.20 (1H, m), 7.87-7.85 (1H, m), 7.75-7.73 (1H, m), 7.37-7.31 (2H, m), 4.36-4.25 (1H, m), 4.07 (3H, s), 3.62-3.51 (1H, m), 1.30-1.25 (3H, m).
式(N6-1)で示される化合物。
1 H-NMR (CDCl 3 ) δ: 9.37-9.35 (1H, m), 8.24-8.20 (1H, m), 7.87-7.85 (1H, m), 7.75-7.73 (1H, m), 7.37-7.31 ( 2H, m), 4.36-4.25 (1H, m), 4.07 (3H, s), 3.62-3.51 (1H, m), 1.30-1.25 (3H, m).
A compound represented by formula (N6-1):
Figure JPOXMLDOC01-appb-I000069
Figure JPOXMLDOC01-appb-I000069
1H-NMR (DMSO-D6) δ: 11.03-10.98 (1H, m), 10.49-10.45 (1H, m), 8.32-8.26 (2H, m), 7.95-7.90 (2H, m), 7.75-7.71 (1H, m), 7.56-7.49 (1H, m), 3.84 (3H, s).
式(N6-2)で示される化合物。
1 H-NMR (DMSO-D6) δ: 11.03-10.98 (1H, m), 10.49-10.45 (1H, m), 8.32-8.26 (2H, m), 7.95-7.90 (2H, m), 7.75-7.71 (1H, m), 7.56-7.49 (1H, m), 3.84 (3H, s).
A compound represented by the formula (N6-2).
Figure JPOXMLDOC01-appb-I000070
Figure JPOXMLDOC01-appb-I000070
1H-NMR (DMSO-D6) δ: 10.95-10.92 (1H, m), 10.49-10.47 (1H, m), 8.37-8.35 (1H, m), 8.32-8.30 (1H, m), 7.98-7.93 (2H, m), 7.76-7.72 (1H, m), 7.57-7.52 (1H, m). 1 H-NMR (DMSO-D6) δ: 10.95-10.92 (1H, m), 10.49-10.47 (1H, m), 8.37-8.35 (1H, m), 8.32-8.30 (1H, m), 7.98-7.93 (2H, m), 7.76-7.72 (1H, m), 7.57-7.52 (1H, m).
製造例1
 中間体E0.69g、中間体B0.23g、HATU0.50g、ジイソプロピルエチルアミン0.23mL及びDMF26mLの混合物を、50℃で4時間撹拌した。室温まで放冷した反応混合物に水を加え、MTBEで抽出した後、無水硫酸マグネシウムで乾燥した。減圧下濃縮した後、得られた残渣をシリカゲルカラムクロマトグラフィーに付し、以下に示す本発明化合物1-1を0.75g得た。
本発明化合物1-1
Production Example 1
A mixture of 0.69 g of Intermediate E, 0.23 g of Intermediate B, 0.50 g of HATU, 0.23 mL of diisopropylethylamine and 26 mL of DMF was stirred at 50 ° C. for 4 hours. Water was added to the reaction mixture allowed to cool to room temperature, extracted with MTBE, and then dried over anhydrous magnesium sulfate. After concentration under reduced pressure, the resulting residue was subjected to silica gel column chromatography to obtain 0.75 g of the present compound 1-1 shown below.
Compound 1-1 of the present invention
Figure JPOXMLDOC01-appb-I000071
Figure JPOXMLDOC01-appb-I000071
1H-NMR (CDCl3) δ: 9.36-9.34 (1H, m), 8.27-8.25 (1H, m), 7.86-7.80 (2H, m), 7.77-7.74 (1H, m), 7.68-7.66 (1H, m), 7.58-7.52 (2H, m), 6.63 (1H, t), 4.48-4.44 (2H, m), 4.03-3.99 (2H, m), 2.84-2.75 (4H, m). 1 H-NMR (CDCl 3 ) δ: 9.36-9.34 (1H, m), 8.27-8.25 (1H, m), 7.86-7.80 (2H, m), 7.77-7.74 (1H, m), 7.68-7.66 ( 1H, m), 7.58-7.52 (2H, m), 6.63 (1H, t), 4.48-4.44 (2H, m), 4.03-3.99 (2H, m), 2.84-2.75 (4H, m).
製造例2
 本発明化合物1-1(0.47g)及びクロロホルム14mLの混合物に、氷冷下、mCPBA(純度65%以上)0.24gを加え、室温で4時間撹拌した。反応混合物に飽和チオ硫酸ナトリウム水溶液、飽和炭酸水素ナトリウム水溶液を順次加え、クロロホルムで抽出した後、無水硫酸マグネシウムで乾燥した。減圧下濃縮した後、得られた残渣をシリカゲルカラムクロマトグラフィーに付し、以下に示す本発明化合物1-2を0.25g及び以下に示す本発明化合物1-3を0.22g得た。
本発明化合物1-2
Production Example 2
0.24 g of mCPBA (purity 65% or more) was added to a mixture of the compound 1-1 of the present invention (0.47 g) and 14 mL of chloroform under ice cooling, followed by stirring at room temperature for 4 hours. A saturated aqueous sodium thiosulfate solution and a saturated aqueous sodium hydrogen carbonate solution were sequentially added to the reaction mixture, extracted with chloroform, and then dried over anhydrous magnesium sulfate. After concentration under reduced pressure, the resulting residue was subjected to silica gel column chromatography to obtain 0.25 g of the present compound 1-2 shown below and 0.22 g of the present compound 1-3 shown below.
Compound 1-2 of the present invention
Figure JPOXMLDOC01-appb-I000072
Figure JPOXMLDOC01-appb-I000072
1H-NMR (CDCl3) δ: 9.37-9.35 (1H, m), 8.28-8.26 (1H, m), 7.86-7.75 (4H, m), 7.60-7.53 (2H, m), 6.62 (1H, t), 5.24-5.16 (1H, m), 4.64-4.57 (1H, m), 4.37-4.27 (1H, m), 4.00-3.92 (1H, m), 3.04-2.91 (3H, m), 2.86-2.77 (1H, m).
本発明化合物1-3
1 H-NMR (CDCl 3 ) δ: 9.37-9.35 (1H, m), 8.28-8.26 (1H, m), 7.86-7.75 (4H, m), 7.60-7.53 (2H, m), 6.62 (1H, t), 5.24-5.16 (1H, m), 4.64-4.57 (1H, m), 4.37-4.27 (1H, m), 4.00-3.92 (1H, m), 3.04-2.91 (3H, m), 2.86- 2.77 (1H, m).
Compound 1-3 of the present invention
Figure JPOXMLDOC01-appb-I000073
Figure JPOXMLDOC01-appb-I000073
1H-NMR (CDCl3) δ: 9.33-9.31 (1H, m), 8.27-8.25 (1H, m), 7.87-7.77 (3H, m), 7.75-7.73 (1H, m), 7.61-7.53 (2H, m), 6.62 (1H, t), 4.75-4.70 (2H, m), 4.27-4.23 (2H, m), 3.32-3.27 (2H, m), 3.22-3.17 (2H, m). 1 H-NMR (CDCl 3 ) δ: 9.33-9.31 (1H, m), 8.27-8.25 (1H, m), 7.87-7.77 (3H, m), 7.75-7.73 (1H, m), 7.61-7.53 ( 2H, m), 6.62 (1H, t), 4.75-4.70 (2H, m), 4.27-4.23 (2H, m), 3.32-3.27 (2H, m), 3.22-3.17 (2H, m).
製造例3
 中間体C1.4g、1,3-チアゾリジン0.41g、トリエチルアミン0.96mL及びメタノール22mLの混合物を、加熱還流下、14.5時間撹拌した。室温まで放冷した反応混合物を減圧下濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィーに付し、以下に示す本発明化合物1-4を0.52g得た。 
本発明化合物1-4
Production Example 3
A mixture of 1.4 g of Intermediate C, 0.41 g of 1,3-thiazolidine, 0.96 mL of triethylamine and 22 mL of methanol was stirred with heating under reflux for 14.5 hours. The reaction mixture allowed to cool to room temperature was concentrated under reduced pressure. The obtained residue was subjected to silica gel column chromatography to obtain 0.52 g of the present compound 1-4 shown below.
Compound 1-4 of the present invention
Figure JPOXMLDOC01-appb-I000074
Figure JPOXMLDOC01-appb-I000074
1H-NMR (CDCl3) δ: 9.63-9.59 (1H, m), 8.32-8.29 (1H, m), 7.88-7.75 (4H, m), 7.60-7.53 (2H, m), 6.63 (1H, t), 5.20-5.18 (1H, m), 4.76-4.75 (1H, m), 4.47-4.43 (1H, m), 4.03-3.98 (1H, m), 3.21-3.17 (1H, m), 3.09-3.05 (1H, m). 1 H-NMR (CDCl 3 ) δ: 9.63-9.59 (1H, m), 8.32-8.29 (1H, m), 7.88-7.75 (4H, m), 7.60-7.53 (2H, m), 6.63 (1H, t), 5.20-5.18 (1H, m), 4.76-4.75 (1H, m), 4.47-4.43 (1H, m), 4.03-3.98 (1H, m), 3.21-3.17 (1H, m), 3.09- 3.05 (1H, m).
製造例4
 中間体D0.52g、3-メチルチオモルホリン0.10g、HATU0.33g、ジイソプロピルエチルアミン0.15mL及びDMF30mLの混合物を、50℃で4時間撹拌した。室温まで放冷した反応混合物に水を加え、MTBEで抽出した後、無水硫酸マグネシウムで乾燥した。減圧下濃縮した後、得られた残渣をシリカゲルカラムクロマトグラフィーに付し、以下に示す本発明化合物1-7を0.54g得た。
本発明化合物1-7
Production Example 4
A mixture of 0.52 g of intermediate D, 0.10 g of 3-methylthiomorpholine, 0.33 g of HATU, 0.15 mL of diisopropylethylamine and 30 mL of DMF was stirred at 50 ° C. for 4 hours. Water was added to the reaction mixture allowed to cool to room temperature, extracted with MTBE, and then dried over anhydrous magnesium sulfate. After concentration under reduced pressure, the resulting residue was subjected to silica gel column chromatography to obtain 0.54 g of the present compound 1-7 shown below.
Compound 1-7 of the present invention
Figure JPOXMLDOC01-appb-I000075
Figure JPOXMLDOC01-appb-I000075
1H-NMR (CDCl3) δ: 9.30-9.23 (1H, m), 8.29-8.25 (1H, m), 7.86-7.80 (2H, m), 7.78-7.74 (1H, m), 7.69-7.67 (1H, m), 7.59-7.52 (2H, m), 6.63 (1H, t), ((5.62-5.53)+(5.14-5.06)) (1H, m), ((5.22-5.15)+(4.72-4.65)) (1H, m), ((3.61-3.52)+(3.35-3.25)) (1H, m), 3.22-3.10 (1H, m), ((3.02-2.93)+(2.89-2.80)) (1H, m), 2.64-2.54 (1H, m), 2.52-2.45 (1H, m), ((1.62-1.57)+(1.52-1.49)) (3H, m). 1 H-NMR (CDCl 3 ) δ: 9.30-9.23 (1H, m), 8.29-8.25 (1H, m), 7.86-7.80 (2H, m), 7.78-7.74 (1H, m), 7.69-7.67 ( 1H, m), 7.59-7.52 (2H, m), 6.63 (1H, t), ((5.62-5.53) + (5.14-5.06)) (1H, m), ((5.22-5.15) + (4.72- 4.65)) (1H, m), ((3.61-3.52) + (3.35-3.25)) (1H, m), 3.22-3.10 (1H, m), ((3.02-2.93) + (2.89-2.80)) (1H, m), 2.64-2.54 (1H, m), 2.52-2.45 (1H, m), ((1.62-1.57) + (1.52-1.49)) (3H, m).
製造例5
 本発明化合物1-1(0.15g)、シアナミド12mg、tert-ブトキシカリウム29mg及びメタノール7mLの混合物に、N-ブロモスクシンイミド59mgを加え、室温で5時間撹拌した。反応混合物に飽和チオ硫酸ナトリウム水溶液を加え、酢酸エチルで抽出した後、無水硫酸マグネシウムで乾燥した。得られた残渣をシリカゲルカラムクロマトグラフィーに付し、以下に示す本発明化合物1-10を0.13g得た。
本発明化合物1-10
Production Example 5
N-bromosuccinimide (59 mg) was added to a mixture of the compound of the present invention 1-1 (0.15 g), cyanamide (12 mg), tert-butoxypotassium (29 mg) and methanol (7 mL), and the mixture was stirred at room temperature for 5 hours. A saturated aqueous sodium thiosulfate solution was added to the reaction mixture, extracted with ethyl acetate, and dried over anhydrous magnesium sulfate. The obtained residue was subjected to silica gel column chromatography to obtain 0.13 g of the present compound 1-10 shown below.
Compound 1-10 of the present invention
Figure JPOXMLDOC01-appb-I000076
Figure JPOXMLDOC01-appb-I000076
1H-NMR (CDCl3) δ: 9.35-9.32 (1H, m), 8.27-8.24 (1H, m), 7.89-7.77 (3H, m), 7.72-7.69 (1H, m), 7.62-7.53 (2H, m), 6.63 (1H, t), 5.11-5.03 (1H, m), 4.68-4.58 (1H, m), 4.54-4.46 (1H, m), 4.25-4.11 (2H, m), 3.35-3.08 (3H, m). 1 H-NMR (CDCl 3 ) δ: 9.35-9.32 (1H, m), 8.27-8.24 (1H, m), 7.89-7.77 (3H, m), 7.72-7.69 (1H, m), 7.62-7.53 ( 2H, m), 6.63 (1H, t), 5.11-5.03 (1H, m), 4.68-4.58 (1H, m), 4.54-4.46 (1H, m), 4.25-4.11 (2H, m), 3.35- 3.08 (3H, m).
製造例6
 本発明化合物1-10(0.27g)、炭酸カリウム0.15g及びエタノール12mLの混合物に、氷冷下、mCPBA(純度65%以上)0.14gを加え、室温で4時間撹拌した。反応混合物に飽和チオ硫酸ナトリウム水溶液、飽和炭酸水素ナトリウム水溶液を順次加え、MTBEで抽出した後、無水硫酸マグネシウムで乾燥した。減圧下濃縮した後、得られた残渣をシリカゲルカラムクロマトグラフィーに付し、以下に示す本発明化合物1-11を0.27g得た。 
本発明化合物1-11
Production Example 6
To a mixture of the compound of the present invention 1-10 (0.27 g), potassium carbonate 0.15 g and ethanol 12 mL, 0.14 g of mCPBA (purity 65% or more) was added under ice cooling, and the mixture was stirred at room temperature for 4 hours. A saturated aqueous sodium thiosulfate solution and a saturated aqueous sodium hydrogen carbonate solution were sequentially added to the reaction mixture, extracted with MTBE, and then dried over anhydrous magnesium sulfate. After concentration under reduced pressure, the resulting residue was subjected to silica gel column chromatography to obtain 0.27 g of the present compound 1-11 shown below.
Compound 1-11 of the present invention
Figure JPOXMLDOC01-appb-I000077
Figure JPOXMLDOC01-appb-I000077
1H-NMR (CDCl3) δ: 9.27-9.24 (1H, m), 8.26-8.23 (1H, m), 7.90-7.86 (1H, m), 7.84-7.78 (2H, m), 7.63-7.58 (2H, m), 7.56-7.53 (1H, m), 6.63 (1H, t), 5.39-5.30 (1H, m), 4.82-4.74 (1H, m), 4.25-4.15 (1H, m), 3.85-3.58 (4H, m), 3.47-3.38 (1H, m). 1 H-NMR (CDCl 3 ) δ: 9.27-9.24 (1H, m), 8.26-8.23 (1H, m), 7.90-7.86 (1H, m), 7.84-7.78 (2H, m), 7.63-7.58 ( 2H, m), 7.56-7.53 (1H, m), 6.63 (1H, t), 5.39-5.30 (1H, m), 4.82-4.74 (1H, m), 4.25-4.15 (1H, m), 3.85- 3.58 (4H, m), 3.47-3.38 (1H, m).
製造例7
 本発明化合物1-1(0.3g)、トリフルオロアセトアミド99mg、ヨードベンゼンジアセタート0.21g、酸化マグネシウム71mg、ジロジウム(II)テトラアセタート10mg及びクロロホルム9mLの混合物を、室温で時間撹拌した。反応混合物をセライトろ過し、ろ液を減圧下濃縮した後、得られた残渣をシリカゲルカラムクロマトグラフィーに付し、以下に示す本発明化合物1-18を0.20g得た。 
本発明化合物1-18
Production Example 7
A mixture of the present compound 1-1 (0.3 g), 99 mg of trifluoroacetamide, 0.21 g of iodobenzene diacetate, 71 mg of magnesium oxide, 10 mg of dirhodium (II) tetraacetate and 9 mL of chloroform was stirred at room temperature for an hour. . The reaction mixture was filtered through Celite, and the filtrate was concentrated under reduced pressure. The obtained residue was subjected to silica gel column chromatography to obtain 0.20 g of the present compound 1-18 shown below.
Compound 1-18 of the present invention
Figure JPOXMLDOC01-appb-I000078
Figure JPOXMLDOC01-appb-I000078
1H-NMR (CDCl3) δ: 9.30-9.28 (1H, m), 8.26-8.24 (1H, m), 7.89-7.76 (3H, m), 7.66-7.53 (3H, m), 6.63 (1H, t), 5.40-5.33 (1H, m), 4.77-4.70 (1H, m), 4.29-4.20 (1H, m), 3.92-3.83 (1H, m), 3.54-3.45 (2H, m), 3.36-3.26 (1H, m), 3.16-3.07 (1H, m). 1 H-NMR (CDCl 3 ) δ: 9.30-9.28 (1H, m), 8.26-8.24 (1H, m), 7.89-7.76 (3H, m), 7.66-7.53 (3H, m), 6.63 (1H, t), 5.40-5.33 (1H, m), 4.77-4.70 (1H, m), 4.29-4.20 (1H, m), 3.92-3.83 (1H, m), 3.54-3.45 (2H, m), 3.36- 3.26 (1H, m), 3.16-3.07 (1H, m).
製造例8
 本発明化合物1-1に代えて、本発明化合物1-2を用い、製造例7記載の方法に準じて、以下に示す本発明化合物1-19を得た。
本発明化合物1-19
Production Example 8
The present compound 1-19 shown below was obtained according to the method described in Production Example 7 using the present compound 1-2 instead of the present compound 1-1.
Compound 1-19 of the present invention
Figure JPOXMLDOC01-appb-I000079
Figure JPOXMLDOC01-appb-I000079
1H-NMR (CDCl3) δ: 9.33-9.30 (1H, m), 8.26-8.23 (1H, m), 7.90-7.87 (1H, m), 7.84-7.77 (2H, m), 7.68-7.66 (1H, m), 7.62-7.57 (1H, m), 7.56-7.53 (1H, m), 6.63 (1H, t), 5.10-5.01 (1H, m), 4.57-4.47 (2H, m), 4.08-3.85 (3H, m), 3.70-3.62 (1H, m), 3.56-3.47 (1H, m). 1 H-NMR (CDCl 3 ) δ: 9.33-9.30 (1H, m), 8.26-8.23 (1H, m), 7.90-7.87 (1H, m), 7.84-7.77 (2H, m), 7.68-7.66 ( 1H, m), 7.62-7.57 (1H, m), 7.56-7.53 (1H, m), 6.63 (1H, t), 5.10-5.01 (1H, m), 4.57-4.47 (2H, m), 4.08- 3.85 (3H, m), 3.70-3.62 (1H, m), 3.56-3.47 (1H, m).
製造例9
 本発明化合物1-1(0.70g)及びDMF21mLの混合物に氷冷下、60%水素化ナトリウム(油性)を加え、30分間撹拌した。この混合物にヨウ化メチル0.44gを加え、40℃でさらに2時間撹拌した。この混合物を室温まで放冷した後、水を加え、MTBEで抽出した。有機層を無水硫酸マグネシウムで乾燥し、減圧下濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィーに付し、以下に示す本発明化合物3-1を0.59g得た。
本発明化合物3-1
Production Example 9
To a mixture of the compound 1-1 of the present invention (0.70 g) and 21 mL of DMF was added 60% sodium hydride (oil) under ice cooling, and the mixture was stirred for 30 minutes. To this mixture, 0.44 g of methyl iodide was added, and the mixture was further stirred at 40 ° C. for 2 hours. The mixture was allowed to cool to room temperature, water was added, and the mixture was extracted with MTBE. The organic layer was dried over anhydrous magnesium sulfate and concentrated under reduced pressure. The obtained residue was subjected to silica gel column chromatography to obtain 0.59 g of the present compound 3-1 shown below.
Compound 3-1 of the present invention
Figure JPOXMLDOC01-appb-I000080
Figure JPOXMLDOC01-appb-I000080
1H-NMR (CDCl3) δ: ((7.87-7.85)+(7.70-7.40)+(7.37-7.35)+(7.28-7.12)) (6H, m), 7.03-6.36 (1H, m), ((4.07-3.21)+(2.80-2.40)) (14H, m).
 前記の製造例に記載の化合物及び前記の製造例に記載の方法に準じた製造方法により製造される化合物及びその物性値を表に示す。
式(1-a)で表される化合物。 
1 H-NMR (CDCl 3 ) δ: ((7.87-7.85) + (7.70-7.40) + (7.37-7.35) + (7.28-7.12)) (6H, m), 7.03-6.36 (1H, m), ((4.07-3.21) + (2.80-2.40)) (14H, m).
The compounds described in the above production examples, the compounds produced by the production methods according to the methods described in the above production examples, and physical properties thereof are shown in the table.
A compound represented by formula (1-a).
Figure JPOXMLDOC01-appb-I000081
Figure JPOXMLDOC01-appb-I000081
式中のTは、下記の[表34]~[表36]に記載の置換基を表す。 T in the formula represents a substituent described in [Table 34] to [Table 36] below.
Figure JPOXMLDOC01-appb-T000082
Figure JPOXMLDOC01-appb-T000082
Figure JPOXMLDOC01-appb-T000083
Figure JPOXMLDOC01-appb-T000083
Figure JPOXMLDOC01-appb-T000084
Figure JPOXMLDOC01-appb-T000084
式(1-b)で表される化合物。 A compound represented by formula (1-b).
Figure JPOXMLDOC01-appb-I000085
Figure JPOXMLDOC01-appb-I000085
式中のR、R、X及びnは、下記の[表37]~[表40]に記載の組み合わせを表す。 R 1 , R 3 , X 1 and n in the formula represent the combinations described in the following [Table 37] to [Table 40].
Figure JPOXMLDOC01-appb-T000086
Figure JPOXMLDOC01-appb-T000086
Figure JPOXMLDOC01-appb-T000087
Figure JPOXMLDOC01-appb-T000087
Figure JPOXMLDOC01-appb-T000088
Figure JPOXMLDOC01-appb-T000088
Figure JPOXMLDOC01-appb-T000089
Figure JPOXMLDOC01-appb-T000089
式(1-c)で表される化合物。 A compound represented by formula (1-c).
Figure JPOXMLDOC01-appb-C000090
Figure JPOXMLDOC01-appb-C000090
式中のR、R及びnは、下記の[表41]に記載の組み合わせを表す。 R 4 , R 5 and n in the formula represent the combinations described in [Table 41] below.
Figure JPOXMLDOC01-appb-T000091
Figure JPOXMLDOC01-appb-T000091
式(1-d)で表される化合物。 A compound represented by the formula (1-d).
Figure JPOXMLDOC01-appb-I000092
Figure JPOXMLDOC01-appb-I000092
式中のXは、[表42]に記載の組み合わせを表す。 X a in the formula represents a combination described in [Table 42].
Figure JPOXMLDOC01-appb-T000093
Figure JPOXMLDOC01-appb-T000093
式(1-e)で示される化合物(以下、本発明化合物5-1と記す。)。 Compound represented by formula (1-e) (hereinafter referred to as the present compound 5-1).
Figure JPOXMLDOC01-appb-I000094
Figure JPOXMLDOC01-appb-I000094
1H-NMR (CDCl3) δ: 9.56-9.50 (1H, m), 8.29-8.24 (1H, m), 7.87-7.85 (1H, m), 7.75-7.72 (1H, m), ((7.47-7.37)+(7.31-7.26)+(7.17-7.14)) (2H, m), ((4.49-4.38)+(4.07-3.99)+(3.81-3.73)+(3.55-3.39)+(3.05-2.97)+(2.78-2.63)+(2.56-2.49)) (10H ,m), (4.25 + 4.11) (3H, s), ((1.91-1.86)+(1.31-1.19)) (3H, m).
式(1-f)で示される化合物(以下、本発明化合物6-1と記す。)。
1 H-NMR (CDCl 3 ) δ: 9.56-9.50 (1H, m), 8.29-8.24 (1H, m), 7.87-7.85 (1H, m), 7.75-7.72 (1H, m), ((7.47- 7.37) + (7.31-7.26) + (7.17-7.14)) (2H, m), ((4.49-4.38) + (4.07-3.99) + (3.81-3.73) + (3.55-3.39) + (3.05-2.97 ) + (2.78-2.63) + (2.56-2.49)) (10H, m), (4.25 + 4.11) (3H, s), ((1.91-1.86) + (1.31-1.19)) (3H, m).
Compound represented by formula (1-f) (hereinafter referred to as the present compound 6-1).
Figure JPOXMLDOC01-appb-I000095
Figure JPOXMLDOC01-appb-I000095
1H-NMR (CDCl3) δ: 9.32-9.30 (1H, m), 8.25-8.23 (1H, m), 7.87-7.81 (2H, m), 7.77-7.73 (1H, m), 7.64-7.54 (3H, m), 4.49-4.45 (2H, m), 4.03-4.00 (2H, m), 2.85-2.81 (2H, m), 2.80-2.76 (2H, m).
 次に本発明化合物の製剤例を示す。なお、部は重量部を表す。
1 H-NMR (CDCl 3 ) δ: 9.32-9.30 (1H, m), 8.25-8.23 (1H, m), 7.87-7.81 (2H, m), 7.77-7.73 (1H, m), 7.64-7.54 ( 3H, m), 4.49-4.45 (2H, m), 4.03-4.00 (2H, m), 2.85-2.81 (2H, m), 2.80-2.76 (2H, m).
Next, the formulation example of this invention compound is shown. In addition, a part represents a weight part.
製剤例1
 本発明化合物1-1~1-20、2-1~2-31、3-1~3-7、4-1~4-4、5-1及び6-1のいずれか1種 10部を、キシレン35部とDMF35部との混合物に溶解し、そこにポリオキシエチレンスチリルフェニルエーテル14部及びドデシルベンゼンスルホン酸カルシウム6部を加え、混合して各々の製剤を得る。
Formulation Example 1
10 parts of any one of compounds 1-1 to 1-20, 2-1 to 2-31, 3-1 to 3-7, 4-1 to 4-4, 5-1, and 6-1 of the present invention In a mixture of 35 parts of xylene and 35 parts of DMF, 14 parts of polyoxyethylene styryl phenyl ether and 6 parts of calcium dodecylbenzenesulfonate are added and mixed to obtain each preparation.
製剤例2
 ラウリル硫酸ナトリウム4部、リグニンスルホン酸カルシウム2部、合成含水酸化珪素微粉末20部及び珪藻土54部を混合し、更に本発明化合物1-1~1-20、2-1~2-31、3-1~3-7、4-1~4-4、5-1及び6-1のいずれか1種 20部を加え、混合して各々の水和剤を得る。
Formulation Example 2
4 parts of sodium lauryl sulfate, 2 parts of calcium lignin sulfonate, 20 parts of a synthetic silicon hydroxide fine powder and 54 parts of diatomaceous earth are mixed, and the compounds of the present invention 1-1 to 1-20, 2-1 to 2-31, 3 20 parts of any one of -1 to 3-7, 4-1 to 4-4, 5-1, and 6-1 are added and mixed to obtain each wettable powder.
製剤例3
 本発明化合物1-1~1-20、2-1~2-31、3-1~3-7、4-1~4-4、5-1及び6-1のいずれか1種 2部に、合成含水酸化珪素微粉末1部、リグニンスルホン酸カルシウム2部、ベントナイト30部及びカオリンクレー65部を加え混合する。ついで、この混合物に適当量の水を加え、さらに攪拌し、造粒機で造粒し、通風乾燥して各々の粒剤を得る。
Formulation Example 3
Compounds of the present invention 1-1 to 1-20, 2-1 to 2-31, 3-1 to 3-7, 4-1 to 4-4, 5-1, and 6-1 Then, 1 part of synthetic silicon hydrous fine powder, 2 parts of calcium lignin sulfonate, 30 parts of bentonite and 65 parts of kaolin clay are added and mixed. Next, an appropriate amount of water is added to the mixture, and the mixture is further stirred, granulated by a granulator, and dried by ventilation to obtain each granule.
製剤例4
 本発明化合物1-1~1-20、2-1~2-31、3-1~3-7、4-1~4-4、5-1及び6-1のいずれか1種 1部を適当量のアセトンに溶解し、これに合成含水酸化珪素微粉末5部、酸性りん酸イソプロピル0.3部及びフバサミクレー93.7部を加え、充分攪拌混合し、アセトンを蒸発除去して各々の粉剤を得る。
Formulation Example 4
One part of any one of the compounds of the present invention 1-1 to 1-20, 2-1 to 2-31, 3-1 to 3-7, 4-1 to 4-4, 5-1, and 6-1 Dissolve in an appropriate amount of acetone, add 5 parts of synthetic hydrous hydroxide fine powder, 0.3 part of isopropyl acid phosphate and 93.7 parts of fusami clay, stir and mix thoroughly, and evaporate and remove acetone to remove each powder. Get.
製剤例5
 ポリオキシエチレンアルキルエーテルサルフェートアンモニウム塩及びホワイトカーボンの混合物(重量比1:1)35部と、本発明化合物1-1~1-20、2-1~2-31、3-1~3-7、4-1~4-4、5-1及び6-1のいずれか1種 10部と、水55部とを混合し、湿式粉砕法で微粉砕することにより、各々のフロアブル剤を得る。
Formulation Example 5
35 parts of a mixture of polyoxyethylene alkyl ether sulfate ammonium salt and white carbon (weight ratio 1: 1), and the compounds of the present invention 1-1 to 1-20, 2-1 to 2-31, 3-1 to 3-7 Each flowable agent is obtained by mixing 10 parts of any one of 4-1 to 4-4, 5-1, and 6-1 and 55 parts of water and finely pulverizing them by a wet pulverization method.
製剤例6
 本発明化合物1-1~1-20、2-1~2-31、3-1~3-7、4-1~4-4、5-1及び6-1のいずれか1種 0.1部をキシレン5部及びトリクロロエタン5部の混合物に溶解し、これをケロシン89.9部に混合して各々の油剤を得る。
Formulation Example 6
Compounds of the present invention 1-1 to 1-20, 2-1 to 2-31, 3-1 to 3-7, 4-1 to 4-4, 5-1, and 6-1 0.1 1 part is dissolved in a mixture of 5 parts xylene and 5 parts trichloroethane, and this is mixed with 89.9 parts kerosene to obtain each oil.
製剤例7
 本発明化合物1-1~1-20、2-1~2-31、3-1~3-7、4-1~4-4、5-1及び6-1のいずれか1種 10mgをアセトン0.5mLに溶解し、この溶液を、動物用固形飼料粉末(飼育繁殖用固形飼料粉末CE-2、日本クレア株式会社商品)5gに滴下し、均一に混合する。ついでアセトンを蒸発乾燥させて各々の毒餌剤を得る。
Formulation Example 7
10 mg of any one of the compounds of the present invention 1-1 to 1-20, 2-1 to 2-31, 3-1 to 3-7, 4-1 to 4-4, 5-1, and 6-1 in acetone Dissolve in 0.5 mL and drop this solution into 5 g of animal solid feed powder (solid feed powder CE-2 for breeding, product of Nippon Claire Co., Ltd.) and mix uniformly. Then acetone is evaporated to dryness to obtain each poisonous bait.
製剤例8
 本発明化合物1-1~1-20、2-1~2-31、3-1~3-7、4-1~4-4、5-1及び6-1のいずれか1種 0.1部、ネオチオゾール(中央化成株式会社製)49.9部をエアゾール缶に入れ、エアゾールバルブを装着した後、ジメチルエーテル25部、LPG25部を充填し振とうを加え、アクチュエータを装着することで油剤エアゾールを得る。
Formulation Example 8
Compounds of the present invention 1-1 to 1-20, 2-1 to 2-31, 3-1 to 3-7, 4-1 to 4-4, 5-1, and 6-1 0.1 Part, neothiozole (manufactured by Chuo Kasei Co., Ltd.) 49.9 parts in an aerosol can, and after mounting an aerosol valve, 25 parts of dimethyl ether and 25 parts of LPG are added, shaken, and an actuator aerosol is attached by attaching an actuator. obtain.
製剤例9
 本発明化合物1-1~1-20、2-1~2-31、3-1~3-7、4-1~4-4、5-1及び6-1のいずれか1種 0.6部、BHT(2,6-ジ-tert-ブチル-4-メチルフェノール)0.01部、キシレン5部、ケロシン3.39部及び乳化剤{レオドールMO-60(花王株式会社製)}1部を混合したものと、蒸留水50部とをエアゾール容器に充填し、バルブを装着した後、該バルブを通じて噴射剤(LPG)40部を加圧充填して水性エアゾールを得る。
Formulation Example 9
Compounds of the present invention 1-1 to 1-20, 2-1 to 2-31, 3-1 to 3-7, 4-1 to 4-4, 5-1, and 6-1 0.6 Parts, BHT (2,6-di-tert-butyl-4-methylphenol) 0.01 part, xylene 5 parts, kerosene 3.39 parts and emulsifier {Rheodor MO-60 (manufactured by Kao Corporation)} 1 part After the mixture and 50 parts of distilled water are filled in an aerosol container and a valve is mounted, 40 parts of propellant (LPG) is pressurized and filled through the valve to obtain an aqueous aerosol.
製剤例10
 本発明化合物1-1~1-20、2-1~2-31、3-1~3-7、4-1~4-4、5-1及び6-1のいずれか1種 0.1gを、プロピレングリコール2mLに混合し、4.0×4.0cm、厚さ1.2cmの多孔セラミック板に含浸させて、加熱式くん煙剤を得る。
Formulation Example 10
Compounds of the present invention 1-1 to 1-20, 2-1 to 2-31, 3-1 to 3-7, 4-1 to 4-4, 5-1, and 6-1 0.1 g Is mixed with 2 mL of propylene glycol and impregnated into a porous ceramic plate of 4.0 × 4.0 cm and a thickness of 1.2 cm to obtain a heating smoke.
製剤例11
 本発明化合物1-1~1-20、2-1~2-31、3-1~3-7、4-1~4-4、5-1及び6-1のいずれか1種 5部とエチレンーメタクリル酸メチル共重合体(共重合体中のメタクリル酸メチルの割合:10重量%、アクリフト(登録商標)WD301、住友化学製)95部を密閉式加圧ニーダー(森山製作所製)で溶融混練し、得られた混練物を押出し成型機から成型ダイスを介して押出し、長さ15cm、直径3mmの棒状成型体を得る。
Formulation Example 11
Compounds of the present invention 1-1 to 1-20, 2-1 to 2-31, 3-1 to 3-7, 4-1 to 4-4, 5-1, and 6-1 5 parts Melt 95 parts of ethylene-methyl methacrylate copolymer (ratio of methyl methacrylate in the copolymer: 10% by weight, ACLIFT (registered trademark) WD301, manufactured by Sumitomo Chemical Co., Ltd.) with a closed pressure kneader (Moriyama Seisakusho) The resulting kneaded product is extruded from an extruder through a molding die to obtain a rod-shaped molded body having a length of 15 cm and a diameter of 3 mm.
製剤例12
 本発明化合物1-1~1-20、2-1~2-31、3-1~3-7、4-1~4-4、5-1及び6-1のいずれか1種 5部と軟質塩化ビニル樹脂95部を密閉式加圧ニーダー(森山製作所製)で溶融混練し、得られた混練物を押出し成型機から成型ダイスを介して押出し、長さ15cm、直径3mmの棒状成型体を得る。
Formulation Example 12
Compounds of the present invention 1-1 to 1-20, 2-1 to 2-31, 3-1 to 3-7, 4-1 to 4-4, 5-1, and 6-1 5 parts 95 parts of a soft vinyl chloride resin is melt-kneaded with a closed pressure kneader (manufactured by Moriyama Seisakusho), and the resulting kneaded product is extruded from an extrusion molding machine through a molding die to obtain a rod-shaped molded body having a length of 15 cm and a diameter of 3 mm. obtain.
製剤例13
 本発明化合物1-1~1-20、2-1~2-31、3-1~3-7、4-1~4-4、5-1及び6-1のいずれか1種 100mg、ラクトース68.75mg、トウモロコシデンプン237.5mg、微結晶性セルロース43.75mg、ポリビニルピロリドン18.75mg、ナトリウムカルボキシメチルデンプン28.75mg、及びステアリン酸マグネシウム2.5mgを混合し、得られた混合物を適切な大きさに圧縮して、錠剤を得る。
Formulation Example 13
Compounds of the present invention 1-1 to 1-20, 2-1 to 2-31, 3-1 to 3-7, 4-1 to 4-4, 5-1, and 6-1 100 mg, lactose 68.75 mg, corn starch 237.5 mg, microcrystalline cellulose 43.75 mg, polyvinylpyrrolidone 18.75 mg, sodium carboxymethyl starch 28.75 mg, and magnesium stearate 2.5 mg are mixed and the resulting mixture is Compress to size to obtain tablets.
製剤例14
 本発明化合物1-1~1-20、2-1~2-31、3-1~3-7、4-1~4-4、5-1及び6-1のいずれか1種 25mg、ラクトース60mg、トウモロコシデンプン25mg、カルメロースカルシウム6mg、及び5%ヒドロキシプロピルメチルセルロース適量を混合し、得られた混合物をハードシェルゼラチンカプセル又はヒドロキシプロピルメチルセルロースカプセルに充填し、カプセル剤を得る。
Formulation Example 14
Compounds of the present invention 1-1 to 1-20, 2-1 to 2-31, 3-1 to 3-7, 4-1 to 4-4, 5-1, and 6-1 25 mg, lactose 60 mg, corn starch 25 mg, carmellose calcium 6 mg, and 5% hydroxypropylmethylcellulose are mixed in an appropriate amount, and the resulting mixture is filled into a hard shell gelatin capsule or hydroxypropylmethylcellulose capsule to obtain a capsule.
製剤例15
 本発明化合物1-1~1-20、2-1~2-31、3-1~3-7、4-1~4-4、5-1及び6-1のいずれか1種 100mg、フマル酸500mg、塩化ナトリウム2000mg、メチルパラベン150mg、プロピルパラベン50mg、顆粒糖25000mg、ソルビトール(70%溶液)13000mg、VeegumK(VanderbiltCo.)100mg、香料35mg、及び着色料500mgに、最終容量が100mLとなるよう蒸留水を加え、混合して、経口投与用サスペンジョンを得る。
Formulation Example 15
Compounds of the present invention 1-1 to 1-20, 2-1 to 2-31, 3-1 to 3-7, 4-1 to 4-4, 5-1, and 6-1 100 mg, fumar Distilled to 500 mL of acid, 2000 mg of sodium chloride, 150 mg of methylparaben, 50 mg of propylparaben, 25000 mg of granular sugar, 13000 mg of sorbitol (70% solution), 100 mg of VeegumK (VanderbiltCo.), 35 mg of fragrance, and 500 mg of colorant to a final volume of 100 mL Add water and mix to obtain a suspension for oral administration.
製剤例16
 本発明化合物1-1~1-20、2-1~2-31、3-1~3-7、4-1~4-4、5-1及び6-1のいずれか1種 5重量%を、ポリソルベート85 5重量%、ベンジルアルコール3重量%、及びプロピレングリコール30重量%に溶解し、この溶液のpHが6.0~6.5となるようにリン酸塩緩衝液を加えた後、残部として水を加えて、経口投与用液剤を得る。
Formulation Example 16
Compounds of the present invention 1-1 to 1-20, 2-1 to 2-31, 3-1 to 3-7, 4-1 to 4-4, 5-1, and 6-1 5% by weight Is dissolved in 5% by weight of polysorbate 85, 3% by weight of benzyl alcohol and 30% by weight of propylene glycol, and a phosphate buffer solution is added so that the pH of this solution is 6.0 to 6.5. Water is added as the balance to obtain a solution for oral administration.
製剤例17
 分留ヤシ油57重量%及びポリソルベート85 3重量%中にジステアリン酸アルミニウム5重量%を加え、加熱により分散させる。これを室温に冷却し、その油状ビヒクル中にサッカリン25重量%を分散させる。これに本発明化合物1-1~1-20、2-1~2-31、3-1~3-7、4-1~4-4、5-1及び6-1のいずれか1種 10重量%を配分し、経口投与用ペースト状製剤を得る。
Formulation Example 17
5% by weight of aluminum distearate in 57% by weight of fractionated coconut oil and 3% by weight of polysorbate 85 is added and dispersed by heating. This is cooled to room temperature and 25% by weight of saccharin is dispersed in the oily vehicle. To this, any one of the compounds of the present invention 1-1 to 1-20, 2-1 to 2-31, 3-1 to 3-7, 4-1 to 4-4, 5-1, and 6-1 10 Distribute the weight percentage to obtain a paste preparation for oral administration.
製剤例18
 本発明化合物1-1~1-20、2-1~2-31、3-1~3-7、4-1~4-4、5-1及び6-1のいずれか1種 5重量%を石灰石粉95重量%と混合し、湿潤顆粒形成法を使用して経口投与用粒剤を得る。
Formulation Example 18
Compounds of the present invention 1-1 to 1-20, 2-1 to 2-31, 3-1 to 3-7, 4-1 to 4-4, 5-1, and 6-1 5% by weight Is mixed with 95% by weight of limestone powder to obtain granules for oral administration using the wet granulation method.
製剤例19
 本発明化合物1-1~1-20、2-1~2-31、3-1~3-7、4-1~4-4、5-1及び6-1のいずれか1種 5部をジエチレングリコールモノエチルエーテル80部に溶解し、これに炭酸プロピレン15部を混合して、スポットオン液剤を得る。
Formulation Example 19
5 parts of any one of compounds 1-1 to 1-20, 2-1 to 2-31, 3-1 to 3-7, 4-1 to 4-4, 5-1, and 6-1 of the present invention Dissolve in 80 parts of diethylene glycol monoethyl ether and mix with 15 parts of propylene carbonate to obtain a spot-on solution.
製剤例20
 本発明化合物1-1~1-20、2-1~2-31、3-1~3-7、4-1~4-4、5-1及び6-1のいずれか1種 10部をジエチレングリコールモノエチルエーテル70部に溶解し、これに2-オクチルドデカノール20部を混合して、ポアオン液剤を得る。
Formulation Example 20
10 parts of any one of compounds 1-1 to 1-20, 2-1 to 2-31, 3-1 to 3-7, 4-1 to 4-4, 5-1, and 6-1 of the present invention Dissolve in 70 parts of diethylene glycol monoethyl ether and mix with 20 parts of 2-octyldodecanol to obtain a pour-on solution.
製剤例21
 本発明化合物1-1~1-20、2-1~2-31、3-1~3-7、4-1~4-4、5-1及び6-1のいずれか1種 0.5部に、ニッコール(登録商標)TEALS-42(日光ケミカルズ・ラウリル硫酸トリエタノールアミンの42%水溶液)60部、プロピレングリコール20部を添加し、均一溶液になるまで充分撹拌混合した後、水19.5部を加えてさらに充分撹拌混合し、均一溶液のシャンプー剤を得る。
Formulation Example 21
Compounds of the present invention 1-1 to 1-20, 2-1 to 2-31, 3-1 to 3-7, 4-1 to 4-4, 5-1, and 6-1 0.5 60 parts of Nikkor (registered trademark) TEALS-42 (42% aqueous solution of Nikko Chemicals lauryl sulfate triethanolamine) and 20 parts of propylene glycol were added to the resulting mixture, and the mixture was stirred and mixed until a homogeneous solution was obtained. Add 5 parts and further stir and mix to obtain a shampoo of a uniform solution.
製剤例22
 本発明化合物1-1~1-20、2-1~2-31、3-1~3-7、4-1~4-4、5-1及び6-1のいずれか1種 0.15重量%、動物飼料95重量%、並びに、第2リン酸カルシウム、珪藻土、Aerosil、及びカーボネート(又はチョーク)からなる混合物4.85重量%を十分攪拌混合し、動物用飼料プレミックスを得る。
Formulation Example 22
Compounds of the present invention 1-1 to 1-20, 2-1 to 2-31, 3-1 to 3-7, 4-1 to 4-4, 5-1, and 6-1 0.15 The animal feed premix is obtained by sufficiently stirring and mixing 4.85% by weight of a mixture consisting of dilute calcium phosphate, diatomaceous earth, Aerosil, and carbonate (or chalk).
製剤例23
 本発明化合物1-1~1-20、2-1~2-31、3-1~3-7、4-1~4-4、5-1及び6-1のいずれか1種 7.2g、及びホスコ(登録商標)S-55(丸石製薬株式会社製)92.8gを100℃で溶解混和し、坐剤形に注いで、冷却固化して、坐剤を得る。
Formulation Example 23
Compounds of the present invention 1-1 to 1-20, 2-1 to 2-31, 3-1 to 3-7, 4-1 to 4-4, 5-1, and 6-1 7.2 g , And 92.8 g of Fosco (registered trademark) S-55 (manufactured by Maruishi Pharmaceutical Co., Ltd.) are dissolved and mixed at 100 ° C., poured into a suppository form, cooled and solidified to obtain a suppository.
 次に、本発明化合物の有害節足動物に対する効力を試験例により示す。 Next, the efficacy of the compound of the present invention against harmful arthropods is shown by test examples.
試験例1
 製剤例5により得られた本発明化合物1-1~1-20、2-1~2-3、2-7~2-9、2-11~2-31、3-1~3-7、4-1~4-3、5-1及び6-1の製剤を、各々本発明化合物の濃度が500ppmとなるように水で希釈し、希釈液を得た。
Test example 1
Compounds of the present invention 1-1 to 1-20, 2-1 to 2-3, 2-7 to 2-9, 2-11 to 2-31, 3-1 to 3-7 obtained by Formulation Example 5 Formulations 4-1 to 4-3, 5-1, and 6-1 were each diluted with water so that the concentration of the compound of the present invention was 500 ppm to obtain a diluted solution.
 一方、プラスチックカップに植えたキュウリ幼苗(第1本葉展開期)にワタアブラムシ(Aphis gossypii)(全ステージ)約30頭を接種し、1日間放置した。この幼苗に、該希釈液20mLを散布した。 On the other hand, about 30 Aphis gossypi (all stages) were inoculated into cucumber seedlings (first true leaf development stage) planted in plastic cups and left for 1 day. The seedling was sprayed with 20 mL of the diluted solution.
 散布6日後に該キュウリの葉上に寄生したワタアブラムシ生存虫数を調査し、以下の式により防除価を求めた。 6 days after spraying, the number of live cotton aphids that parasitized on the cucumber leaves was investigated, and the control value was determined by the following formula.
 防除価(%)={1-(Cb×Tai)/(Cai×Tb)}×100
なお、式中の文字は以下の意味を表す。
Control value (%) = {1− (Cb × Tai) / (Cai × Tb)} × 100
In addition, the character in a formula represents the following meaning.
  Cb:無処理区の処理前の虫数
  Cai:無処理区の調査時の寄生生存虫数
  Tb:処理区の処理前の虫数
  Tai:処理区の調査時の寄生生存虫数
 ここで無処理区とは、製剤例5において本発明化合物を含まない製剤を、処理区と同量の水で希釈した液を散布した区を意味する。
Cb: number of insects before treatment in the untreated section Cai: number of parasitic live insects at the time of investigation in the untreated section Tb: number of insects before the treatment in the treated section Tai: number of parasitic live insects at the time of survey in the treated section The group refers to a group in which a preparation diluted with the same amount of water as the treatment group was sprayed on the preparation not containing the compound of the present invention in Preparation Example 5.
 その結果、本発明化合物を供試したすべての処理区において、防除価90%以上を示した。 As a result, a control value of 90% or more was exhibited in all treatment sections where the compounds of the present invention were tested.
試験例2
 製剤例5により得られた本発明化合物1-1~1-3、1-5~1-8、1-10、1-12~1-14、1-16、1-20、2-1~2-3、2-7~2-9、2-11、2-12、2-14、2-15、2-17~2-19、2-21~2-25、2-27~2-29、3-1~3-7、4-2、5-1及び6-1の製剤を、各々本発明化合物の濃度が200ppmとなるように水で希釈し、希釈液を得た。
Test example 2
Compounds of the present invention 1-1 to 1-3, 1-5 to 1-8, 1-10, 1-12 to 1-14, 1-16, 1-20, 2-1 to 2-3, 2-7 to 2-9, 2-11, 2-12, 2-14, 2-15, 2-17 to 2-19, 2-21 to 2-25, 2-27 to 2- The preparations of 29, 3-1 to 3-7, 4-2, 5-1 and 6-1 were diluted with water so that the concentration of the compound of the present invention was 200 ppm, respectively, to obtain a diluted solution.
 一方、プラスチックカップに植えたキュウリ幼苗(第1本葉展開期)にワタアブラムシ(Aphis gossypii)(全ステージ)約30頭を接種し、1日間放置した。この幼苗に、該希釈液を各々20mL散布した。 On the other hand, about 30 Aphis gossypi (all stages) were inoculated into cucumber seedlings (first true leaf development stage) planted in plastic cups and left for 1 day. 20 mL each of the diluted solution was sprayed on the seedlings.
 散布6日後に該キュウリの葉上に寄生したワタアブラムシ生存虫数を調査し、以下の式により防除価を求めた。 6 days after spraying, the number of live cotton aphids that parasitized on the cucumber leaves was investigated, and the control value was determined by the following formula.
 防除価(%)={1-(Cb×Tai)/(Cai×Tb)}×100
なお、式中の文字は以下の意味を表す。
Control value (%) = {1− (Cb × Tai) / (Cai × Tb)} × 100
In addition, the character in a formula represents the following meaning.
  Cb:無処理区の処理前の虫数
  Cai:無処理区の調査時の寄生生存虫数
  Tb:処理区の処理前の虫数
  Tai:処理区の調査時の寄生生存虫数
 ここで無処理区とは、製剤例5において本発明化合物を含まない製剤を、処理区と同量の水で希釈した液を散布した区を意味する。
Cb: number of insects before treatment in the untreated section Cai: number of parasitic live insects at the time of investigation in the untreated section Tb: number of insects before the treatment in the treated section Tai: number of parasitic live insects at the time of survey in the treated section The group refers to a group in which a preparation diluted with the same amount of water as the treatment group was sprayed on the preparation not containing the compound of the present invention in Preparation Example 5.
 その結果、本発明化合物を供試したすべての処理区において、防除価90%以上を示した。 As a result, a control value of 90% or more was exhibited in all treatment sections where the compounds of the present invention were tested.
試験例3
 製剤例5により得られた本発明化合物1-1~1-20、2-1~2-4、2-7~2-11~2-31、3-1~3-7、4-1~4-3及び5-1の製剤を、各々本発明化合物の濃度が500ppmとなるように水で希釈し、希釈液を得た。
Test example 3
Compounds of the present invention 1-1 to 1-20, 2-1 to 2-4, 2-7 to 2-11 to 2-31, 3-1 to 3-7, 4-1 to 4 The preparations 4-3 and 5-1 were each diluted with water so that the concentration of the compound of the present invention was 500 ppm to obtain a diluted solution.
 一方、ポリエチレンカップに植えた3葉期キャベツに、該希釈液を20mL/カップの割合で散布した。散布後植物を風乾し、茎葉部を切り取って50mLカップに収容し、コナガ(Plutella xylostella)2齢幼虫5頭を放ち、蓋をした。25℃で保管し、5日後に死亡虫数を数え、次式より死虫率を求めた。 On the other hand, the diluted solution was sprayed at a rate of 20 mL / cup on a three-leaf cabbage planted in a polyethylene cup. After spraying, the plants were air-dried, the stems and leaves were cut out and accommodated in a 50 mL cup, and 5 second-instar larvae (Plutella xylostella) were released and capped. After storing at 25 ° C., the number of dead insects was counted after 5 days, and the death rate was calculated from the following formula.
    死虫率(%)=(死亡虫数/供試虫数)×100
 その結果、本発明化合物を供試したすべての処理区において、死虫率80%以上を示した。
Death rate (%) = (Number of dead insects / number of test insects) × 100
As a result, the death rate was 80% or more in all the treatment areas where the compounds of the present invention were tested.
試験例4
 製剤例5により得られた本発明化合物1-1~1-10、1-12~1-15、1-18、1-20、2-1~2-4、2-7~2-9、2-11~2-19、2-21~2-23、2-25~2-29、3-1~3-7、4-1~4-3及び5-1の製剤を、各々本発明化合物の濃度が200ppmとなるように水で希釈し、希釈液を得た。
Test example 4
Compounds of the present invention 1-1 to 1-10, 1-12 to 1-15, 1-18, 1-20, 2-1 to 2-4, 2-7 to 2-9 obtained by Formulation Example 5 Formulations 2-11 to 2-19, 2-21 to 2-23, 2-25 to 2-29, 3-1 to 3-7, 4-1 to 4-3, and 5-1 are respectively represented in the present invention. It diluted with water so that the density | concentration of a compound might be 200 ppm, and the dilution liquid was obtained.
 ポリエチレンカップに植えた3葉期キャベツに、該希釈液を各々20mL/カップの割合で散布した。散布後植物を風乾し、茎葉部を切り取って50mLカップに収容し、コナガ(Plutella xylostella)2齢幼虫5頭を放ち、蓋をした。25℃で保管し、5日後に死亡虫数を数え、次式より死虫率を求めた。 The diluted solution was sprayed at a rate of 20 mL / cup on a three-leaf cabbage planted in a polyethylene cup. After spraying, the plants were air-dried, the stems and leaves were cut out and accommodated in a 50 mL cup, and 5 second-instar larvae (Plutella xylostella) were released and capped. After storing at 25 ° C., the number of dead insects was counted after 5 days, and the death rate was calculated from the following formula.
   死虫率(%)=(死亡虫数/供試虫数)×100
 その結果、本発明化合物を供試したすべての処理区において、死虫率80%以上を示した。
Death rate (%) = (Number of dead insects / number of test insects) × 100
As a result, the death rate was 80% or more in all the treatment areas where the compounds of the present invention were tested.
試験例5
 製剤例5により得られた本発明化合物1-1~1-18、2-20、2-1~2-4、2-7~2-9、2-11~2-19、2-21~2-29、3-1~3-7、4-1、4-2及び5-1の製剤を、各々本発明化合物の濃度が500ppmとなるように水で希釈し、希釈液を得た。
Test Example 5
Compounds of the present invention 1-1 to 1-18, 2-20, 2-1 to 2-4, 2-7 to 2-9, 2-11 to 2-19, 2-21 to Formulations 2-29, 3-1 to 3-7, 4-1, 4-2 and 5-1 were each diluted with water so that the concentration of the compound of the present invention was 500 ppm to obtain a diluted solution.
 直径5.5cmのポリエチレンカップの底に同大の濾紙を敷き、厚さ6mmにスライスして更に半分に切ったインセクタLF(日本農産工業)を置き、該希釈液2mLを灌注した。風乾後、ハスモンヨトウ(Spodoptela litura)3齢幼虫5頭を放ち、蓋をした。6日後に死亡虫数を数え、次式より死虫率を求めた。 A filter paper of the same size was laid on the bottom of a polyethylene cup having a diameter of 5.5 cm, in-sector LF (Nihon Nosan Co., Ltd.) sliced into 6 mm thickness and cut in half was placed, and 2 mL of the diluted solution was irrigated. After air drying, 5 third instar larvae of Spodoptera litura were released and covered. Six days later, the number of dead insects was counted, and the death rate was obtained from the following formula.
   死虫率(%)=(死亡虫数/供試虫数)×100
 その結果、本発明化合物を供試したすべての処理区において、死虫率80%以上を示した。
Death rate (%) = (Number of dead insects / number of test insects) × 100
As a result, the death rate was 80% or more in all the treatment areas where the compounds of the present invention were tested.
試験例6
 製剤例5により得られた本発明化合物1-1~1-18、1-20、2-1~2-3、2-7~2-9、2-11~2-29、2-31、3-1~3-7、4-1~4-3及び5-1の製剤を各々本発明化合物の濃度が200ppmとなるように水で希釈し、希釈液を得た。
Test Example 6
Compounds of the present invention 1-1 to 1-18, 1-20, 2-1 to 2-3, 2-7 to 2-9, 2-11 to 2-29, 2-31 obtained by Formulation Example 5 The preparations of 3-1 to 3-7, 4-1 to 4-3, and 5-1 were each diluted with water so that the concentration of the compound of the present invention was 200 ppm to obtain a diluted solution.
 ポリエチレンカップ植えの5~6葉期キャベツ(Brassicae oleracea)に該希釈液を20mL/カップの割合で散布した。散布後植物を風乾し、ポリエチレンカップ(容量400mL)を被せ、ハスモンヨトウ(Spodoptera litura)4齢幼虫10頭を放ち、テトロンゴースで蓋をした。25℃で保管し、6日後に生存虫数を数え、次式より死虫率を求めた。 The diluted solution was sprayed at a rate of 20 mL / cup on 5-6 leaf cabbage (Brassicae oleracea) planted in a polyethylene cup. After spraying, the plants were air-dried, covered with a polyethylene cup (capacity 400 mL), 10 4th instars of Spodoptera litura were released, and capped with Tetorongose. After storing at 25 ° C., the number of surviving insects was counted after 6 days, and the death rate was determined from the following formula.
   死虫率(%)=(死亡虫数/供試虫数)×100
 その結果、本発明化合物を供試したすべての処理区において、死虫率80%以上を示した。
Death rate (%) = (Number of dead insects / number of test insects) × 100
As a result, the death rate was 80% or more in all the treatment areas where the compounds of the present invention were tested.
試験例7
 製剤例5により得られた本発明化合物1-1~1-3、1-5~1-10、1-13、1-14、1-16、1-17、2-1、2-2、2-7~2-9、2-11、2-12、2-17~2-19、2-21、2-23、2-24、2-26、2-27及び3-1~3-7の製剤を各々本発明化合物の濃度が500ppmとなるように水で希釈し、希釈液を得た。
Test Example 7
Compounds of the present invention 1-1 to 1-3, 1-5 to 1-10, 1-13, 1-14, 1-16, 1-17, 2-1, 2-2 obtained by Formulation Example 5 2-7 to 2-9, 2-11, 2-12, 2-17 to 2-19, 2-21, 2-23, 2-24, 2-26, 2-27 and 3-1 to 3- Each of the preparations 7 was diluted with water so that the concentration of the compound of the present invention was 500 ppm to obtain a diluted solution.
 ポリエチレンカップに植えた初生葉展開期のツルナシインゲン幼苗に約40頭のナミハダニ(Tetranychus urticae)雌成虫を接種し、接種1日後に該希釈液30mLを散布した。 About 40 adult spider mite (Tetranychus urticae) females were inoculated on the seedling seedlings in the primary leaf development stage planted in a polyethylene cup, and 30 mL of the diluted solution was sprayed one day after the inoculation.
 散布13日後にツルナシインゲンの葉上の生存ダニ数を調査し、次式により防除率を算出した。 After 13 days of spraying, the number of surviving ticks on the leaves of the periwinkle was investigated, and the control rate was calculated by the following formula.
  防除率(%)=100×{1-(処理区の生存ダニ数)/(無処理区の生存ダニ数)}
 その結果、本発明化合物を供試したすべての処理区において、防除率90%以上を示した。
Control rate (%) = 100 × {1− (number of surviving ticks in treated area) / (number of surviving ticks in untreated area)}
As a result, a control rate of 90% or more was exhibited in all the treatment sections where the compounds of the present invention were tested.
試験例8
 製剤例5により得られた本発明化合物1-1~1-18、2-1~2-3、2-7~2-31、3-1~3-3、3-5、3-6、4-1~4-3及び5-1の製剤を、各々本発明化合物の濃度が500ppmとなるように水で希釈し、希釈液を得た。
Test Example 8
Compounds of the present invention 1-1 to 1-18, 2-1 to 2-3, 2-7 to 2-31, 3-1 to 3-3, 3-5, 3-6 obtained by Formulation Example 5 Formulations 4-1 to 4-3 and 5-1 were each diluted with water so that the concentration of the compound of the present invention was 500 ppm to obtain a diluted solution.
 直径5.5cmのポリエチレンカップの底に同大の濾紙を敷き、該希釈液0.7mLを濾紙上に滴下し、餌としてショ糖30mgを均一に入れた。該ポリエチレンカップ内にイエバエ(Musca domestica)雌成虫10頭を放ち、蓋をした。1日後にイエバエの生死を調査し死亡虫数を数え、次式により死虫率を求めた。 A filter paper of the same size was laid on the bottom of a polyethylene cup having a diameter of 5.5 cm, 0.7 mL of the diluted solution was dropped on the filter paper, and 30 mg of sucrose was uniformly added as food. Ten female fly (Musca domestica) females were released into the polyethylene cup and covered. One day later, the life and death of the house fly was investigated, the number of dead insects was counted, and the death rate was calculated by the following formula.
   死虫率(%)=(死亡虫数/供試虫数)×100
 その結果、本発明化合物を供試したすべての処理区において、死虫率100%を示した。
Death rate (%) = (Number of dead insects / number of test insects) × 100
As a result, the death rate was 100% in all the treatment sections where the compound of the present invention was tested.
試験例9
 製剤例5により得られた本発明化合物1-1~1-20、2-1~2-31、3-1~3-7、4-1~4-4、5-1及び6-1の製剤を、各々本発明化合物の濃度が500ppmとなるように水で希釈し、希釈液を得た。
Test Example 9
Compounds of the present invention 1-1 to 1-20, 2-1 to 2-31, 3-1 to 3-7, 4-1 to 4-4, 5-1 and 6-1 obtained by Formulation Example 5 Each preparation was diluted with water so that the concentration of the compound of the present invention was 500 ppm to obtain a diluted solution.
 該希釈液0.7mLをイオン交換水100mLに加えた(有効成分濃度3.5ppm)。該液中にアカイエカ(Culex pipiens pallens)終齢幼虫20頭を放ち、1日後にその生死を調査し死亡虫数を数え、死虫率を求めた。 The diluted solution (0.7 mL) was added to ion-exchanged water (100 mL) (active ingredient concentration: 3.5 ppm). Twenty instar larvae of Culex pipiens pallens were released into the solution, and the number of dead insects was counted one day later, and the death rate was determined.
   死虫率(%)=(死亡虫数/供試虫数)×100
 その結果、本発明化合物を供試したすべての処理区において、死虫率91%以上を示した。
Death rate (%) = (Number of dead insects / number of test insects) × 100
As a result, the mortality rate of 91% or more was shown in all the treatment sections where the compounds of the present invention were tested.
試験例10
 製剤例5により得られた本発明化合物1-2、1-4~1-7、1-9、1-12~1-14、1-18、1-20、2-1~2-3、2-7~2-9、2-11、2-12、2-14~2-16、2-18、2-19、2-21、2-22、2-24~2-27、3-1~3-3、3-5~3-7、4-1及び5-1の製剤を、各々本発明化合物の濃度が500ppmとなるように水で希釈し、希釈液を得た。
Test Example 10
Compound 1-2 of the present invention obtained by Formulation Example 5, 1-4 to 1-7, 1-9, 1-12 to 1-14, 1-18, 1-20, 2-1 to 2-3, 2-7 to 2-9, 2-11, 2-12, 2-14 to 2-16, 2-18, 2-19, 2-21, 2-22, 2-24 to 2-27, 3- The preparations 1 to 3-3, 3-5 to 3-7, 4-1, and 5-1 were each diluted with water so that the concentration of the compound of the present invention was 500 ppm to obtain a diluted solution.
 直径5.5cmのポリエチレンカップの底に同大の濾紙を敷き、該希釈液0.7mLを濾紙上に滴下し、餌としてショ糖30mgを均一に入れた。該ポリエチレンカップ内にチャバネゴキブリ(Blattalla germanica)雄成虫2頭を放ち、蓋をした。1日後に死亡虫数を数え、死虫率を求めた。 A filter paper of the same size was laid on the bottom of a polyethylene cup having a diameter of 5.5 cm, 0.7 mL of the diluted solution was dropped on the filter paper, and 30 mg of sucrose was uniformly added as food. Two adult male cockroaches (Blattalla germanica) were released into the polyethylene cup and covered. One day later, the number of dead insects was counted to determine the death rate.
   死虫率(%)=(死亡虫数/供試虫数)×100
 その結果、本発明化合物を供試したすべての処理区において、死虫率100%を示した。
Death rate (%) = (Number of dead insects / number of test insects) × 100
As a result, the death rate was 100% in all the treatment sections where the compound of the present invention was tested.
 次に本発明化合物と国際公開第2012/164698号に記載の化合物との比較例を以下に示す。 Next, comparative examples of the compounds of the present invention and the compounds described in International Publication No. 2012/164698 are shown below.
比較試験例1
 本発明化合物1-4及び国際公開第2012/164698号に記載の化合物1-22を、上記試験例1に記載の方法に準じて試験したところ、本発明化合物1-4を用いた時の防除価は100%であったのに対し、化合物1-22を用いた時の防除価は29%以下であった。
本発明化合物1-4
Comparative Test Example 1
The compound 1-4 of the present invention and the compound 1-22 described in International Publication No. 2012/164698 were tested in accordance with the method described in Test Example 1 above, and control when the compound 1-4 of the present invention was used was tested. The control value when using compound 1-22 was 29% or less, whereas the value was 100%.
Compound 1-4 of the present invention
Figure JPOXMLDOC01-appb-I000096
Figure JPOXMLDOC01-appb-I000096
国際公開第2012/164698号に記載の化合物1-22
 
Compound 1-22 described in International Publication No. 2012/164698
Figure JPOXMLDOC01-appb-I000097
Figure JPOXMLDOC01-appb-I000097
比較試験例2
 本発明化合物1-7及び国際公開第2012/164698号に記載の化合物1-25を、活性化合物の濃度が50ppmであること以外は上記試験例1に記載の方法に準じて試験したところ、本発明化合物1-7を用いた時の防除価は90%以上であったのに対し、化合物1-25を用いた時の防除価は29%以下であった。
本発明化合物1-7
Comparative test example 2
The compound 1-7 of the present invention and the compound 1-25 described in International Publication No. 2012/164698 were tested according to the method described in Test Example 1 except that the concentration of the active compound was 50 ppm. The control value when using the inventive compound 1-7 was 90% or more, whereas the control value when using the compound 1-25 was 29% or less.
Compound 1-7 of the present invention
Figure JPOXMLDOC01-appb-I000098
Figure JPOXMLDOC01-appb-I000098
国際公開第2012/164698号に記載の化合物1-25 Compound 1-25 described in International Publication No. 2012/164698
Figure JPOXMLDOC01-appb-I000099
Figure JPOXMLDOC01-appb-I000099
 本発明化合物は、有害節足動物に対して優れた防除効果を示す。 The compound of the present invention exhibits an excellent control effect against harmful arthropods.

Claims (10)

  1.  式(1)
    Figure JPOXMLDOC01-appb-I000001
    [式中、
     G及びGはそれぞれ独立して、-CR-又は-C(O)-を表し、
     G、G及びGはそれぞれ独立して、-CR-又は単結合を表し、
     Qは酸素原子、NR、NC(O)R又は無置換を表し、
     R及びRはそれぞれ独立して、水素原子、C1-C6アルキル基、C1-C6アルコキシ基、-S(O)-(C1-C6アルキル)基、C1-C6ハロアルキル基、C1-C6ハロアルコキシ基、-S(O)-(C1-C6ハロアルキル)基、ハロゲン原子、ニトロ基又はシアノ基を表し、
     RはC1-C6ハロアルキル基、C1-C6ハロアルコキシ基又は-S(O)-(C1-C6ハロアルキル)基を表し、
     R及びRはそれぞれ独立して水素原子、C1-C6アルキル基、(C1-C4アルコキシ)C1-C4アルキル基、(C1-C6アルキル)カルボニル基、(C1-C4アルコキシ)カルボニル基、C1-C6ハロアルキル基、(C1-C6ハロアルキル)カルボニル基又は(C1-C4ハロアルコキシ)カルボニル基を表し、
     R及びRはそれぞれ独立して水素原子、C1-C6アルキル基、C1-C6アルコキシ基、-S(O)-(C1-C6アルキル)基、C1-C6ハロアルキル基、C1-C6ハロアルコキシ基、-S(O)-(C1-C6ハロアルキル)基、ハロゲン原子又はシアノ基を表し、
     Rは水素原子、C1-C6アルキル基、C1-C6ハロアルキル基又はシアノ基を表し、
     RはC1-C6アルキル基、又はC1-C6ハロアルキル基を表し、
     Xはそれぞれ独立して、C1-C6アルキル基、C1-C6アルコキシ基、C1-C6ハロアルキル基、C1-C6ハロアルコキシ基、ハロゲン原子又はシアノ基を表し、
     Xはそれぞれ独立して、C1-C6アルキル基、C1-C6アルコキシ基、C1-C6ハロアルキル基、C1-C6ハロアルコキシ基、ハロゲン原子又はシアノ基を表し、
     kは0又は1を表し、
     mは0~4の整数を表し、
     nは0~2の整数を表し、
     pは0~2の整数を表す。]
    で示される3-アミノオキサリルアミノベンズアミド化合物。
    Formula (1)
    Figure JPOXMLDOC01-appb-I000001
    [Where:
    G 1 and G 5 each independently represent —CR 6 R 7 — or —C (O) —,
    G 2 , G 3 and G 4 each independently represent —CR 6 R 7 — or a single bond,
    Q represents an oxygen atom, NR 8 , NC (O) R 9 or unsubstituted,
    R 1 and R 3 are each independently a hydrogen atom, a C1-C6 alkyl group, a C1-C6 alkoxy group, a —S (O) p- (C1-C6 alkyl) group, a C1-C6 haloalkyl group, a C1-C6 A haloalkoxy group, a —S (O) p — (C1-C6 haloalkyl) group, a halogen atom, a nitro group or a cyano group;
    R 2 represents a C1-C6 haloalkyl group, a C1-C6 haloalkoxy group or a —S (O) p — (C1-C6 haloalkyl) group,
    R 4 and R 5 are each independently a hydrogen atom, a C1-C6 alkyl group, a (C1-C4 alkoxy) C1-C4 alkyl group, a (C1-C6 alkyl) carbonyl group, a (C1-C4 alkoxy) carbonyl group, C1 A —C6 haloalkyl group, a (C1-C6 haloalkyl) carbonyl group or a (C1-C4 haloalkoxy) carbonyl group,
    R 6 and R 7 are each independently a hydrogen atom, a C1-C6 alkyl group, a C1-C6 alkoxy group, a —S (O) p- (C1-C6 alkyl) group, a C1-C6 haloalkyl group, a C1-C6 halo. Represents an alkoxy group, —S (O) p — (C1-C6 haloalkyl) group, halogen atom or cyano group,
    R 8 represents a hydrogen atom, a C1-C6 alkyl group, a C1-C6 haloalkyl group or a cyano group,
    R 9 represents a C1-C6 alkyl group or a C1-C6 haloalkyl group,
    Each X a independently represents a C1-C6 alkyl group, a C1-C6 alkoxy group, a C1-C6 haloalkyl group, a C1-C6 haloalkoxy group, a halogen atom or a cyano group;
    Each Xb independently represents a C1-C6 alkyl group, a C1-C6 alkoxy group, a C1-C6 haloalkyl group, a C1-C6 haloalkoxy group, a halogen atom or a cyano group;
    k represents 0 or 1,
    m represents an integer of 0 to 4,
    n represents an integer of 0 to 2,
    p represents an integer of 0-2. ]
    A 3-aminooxalylaminobenzamide compound represented by:
  2.  R及びRがそれぞれ独立して、水素原子、C1-C6アルキル基、C1-C6アルコキシ基、-S(O)-(C1-C6アルキル)基、C1-C6ハロアルキル基、C1-C6ハロアルコキシ基、-S(O)-(C1-C6ハロアルキル)基又はハロゲン原子であり、
     R及びRがそれぞれ独立して水素原子、C1-C6アルキル基、(C1-C6アルキル)カルボニル基、C1-C6ハロアルキル基又は(C1-C6ハロアルキル)カルボニル基であり、
     R及びRがそれぞれ独立して水素原子、C1-C6アルキル基、C1-C6ハロアルキル基、ハロゲン原子又はシアノ基であり、
     Xがそれぞれ独立して、C1-C6アルキル基、C1-C6アルコキシ基、C1-C6ハロアルキル基、C1-C6ハロアルコキシ基又はハロゲン原子であり、
     Xがそれぞれ独立して、C1-C6アルキル基、C1-C6アルコキシ基、C1-C6ハロアルキル基、C1-C6ハロアルコキシ基又はハロゲン原子である請求項1記載の化合物。
    R 1 and R 3 are each independently a hydrogen atom, a C1-C6 alkyl group, a C1-C6 alkoxy group, a —S (O) p- (C1-C6 alkyl) group, a C1-C6 haloalkyl group, a C1-C6 A haloalkoxy group, a —S (O) p — (C1-C6 haloalkyl) group or a halogen atom,
    R 4 and R 5 are each independently a hydrogen atom, a C1-C6 alkyl group, a (C1-C6 alkyl) carbonyl group, a C1-C6 haloalkyl group or a (C1-C6 haloalkyl) carbonyl group,
    R 6 and R 7 are each independently a hydrogen atom, a C1-C6 alkyl group, a C1-C6 haloalkyl group, a halogen atom or a cyano group,
    Each X a is independently a C1-C6 alkyl group, a C1-C6 alkoxy group, a C1-C6 haloalkyl group, a C1-C6 haloalkoxy group or a halogen atom;
    2. The compound according to claim 1, wherein each Xb is independently a C1-C6 alkyl group, a C1-C6 alkoxy group, a C1-C6 haloalkyl group, a C1-C6 haloalkoxy group or a halogen atom.
  3.  G及びGがそれぞれ独立して、-CR-であり、
     R及びRがそれぞれ独立して、水素原子、C1-C3アルキル基、C1-C3アルコキシ基、-S(O)-(C1-C3アルキル)基、C1-C3ハロアルキル基、C1-C3ハロアルコキシ基、-S(O)-(C1-C3ハロアルキル)基又はハロゲン原子であり、
     R及びRがそれぞれ独立して水素原子又はC1-C3アルキル基であり、
     R及びRがそれぞれ独立して水素原子、C1-C3アルキル基又はC1-C3ハロアルキル基であり、
     Rが水素原子、メチル基、エチル基又はシアノ基であり、
     Rがメチル基、エチル基又はトリフルオロメチル基であり、
     Xがそれぞれ独立して、C1-C3アルキル基、C1-C3アルコキシ基、C1-C3ハロアルキル基、C1-C3ハロアルコキシ基又はハロゲン原子であり、
     Xがそれぞれ独立して、C1-C3アルキル基、C1-C3アルコキシ基、C1-C3ハロアルキル基、C1-C3ハロアルコキシ基又はハロゲン原子である請求項1又は請求項2記載の化合物。
    G 1 and G 5 are each independently —CR 6 R 7 —,
    R 1 and R 3 are each independently a hydrogen atom, a C1-C3 alkyl group, a C1-C3 alkoxy group, a —S (O) p — (C1-C3 alkyl) group, a C1-C3 haloalkyl group, a C1-C3 A haloalkoxy group, a —S (O) p — (C1-C3 haloalkyl) group or a halogen atom,
    R 4 and R 5 are each independently a hydrogen atom or a C1-C3 alkyl group,
    R 6 and R 7 are each independently a hydrogen atom, a C1-C3 alkyl group or a C1-C3 haloalkyl group,
    R 8 is a hydrogen atom, a methyl group, an ethyl group or a cyano group,
    R 9 is a methyl group, an ethyl group or a trifluoromethyl group,
    Each X a is independently a C1-C3 alkyl group, a C1-C3 alkoxy group, a C1-C3 haloalkyl group, a C1-C3 haloalkoxy group or a halogen atom;
    The compound according to claim 1 or 2, wherein each Xb is independently a C1-C3 alkyl group, a C1-C3 alkoxy group, a C1-C3 haloalkyl group, a C1-C3 haloalkoxy group or a halogen atom.
  4.  G、G及びGのうち少なくとも1つが-CR-である請求項1~請求項3のいずれかに記載の化合物。 A compound according to any one of the is claims 1 to 3 - G 2, G 3 and at least one of G 4 -CR 6 R 7.
  5.  R及びRのいずれか一方が、臭素原子、ヨウ素原子又はC1-C3アルキル基であり、他方が、C1-C3アルキル基、C1-C3ハロアルキル基、C1-C3ハロアルコキシ基、又は-S(O)-(C1-C3ハロアルキル)基である請求項1~請求項4のいずれかに記載の化合物。 One of R 1 and R 3 is a bromine atom, an iodine atom or a C1-C3 alkyl group, and the other is a C1-C3 alkyl group, a C1-C3 haloalkyl group, a C1-C3 haloalkoxy group, or —S The compound according to any one of claims 1 to 4, which is (O) p- (C1-C3 haloalkyl) group.
  6.  RがC1-C6ハロアルキル基である請求項1~請求項5のいずれかに記載の化合物。 The compound according to any one of claims 1 to 5, wherein R 2 is a C1-C6 haloalkyl group.
  7.  RがC1-C6ハロアルコキシ基である請求項1~請求項5のいずれかに記載の化合物。 The compound according to any one of claims 1 to 5, wherein R 2 is a C1-C6 haloalkoxy group.
  8.  Rが-S(O)-(C1-C6ハロアルキル)基である請求項1~請求項5のいずれかに記載の化合物。 The compound according to any one of claims 1 to 5, wherein R 2 is -S (O) p- (C1-C6 haloalkyl) group.
  9.  請求項1~請求項8のいずれかに記載の化合物と、不活性担体とを含有する有害節足動物防除組成物。 A harmful arthropod control composition comprising the compound according to any one of claims 1 to 8 and an inert carrier.
  10.  請求項1~請求項8のいずれかに記載の化合物の有効量を有害節足動物又は有害節足動物の生息場所に施用する有害節足動物の防除方法。 A method for controlling harmful arthropods, which comprises applying an effective amount of the compound according to any one of claims 1 to 8 to harmful arthropods or habitats of harmful arthropods.
PCT/JP2016/056540 2015-03-06 2016-03-03 3-aminooxalylaminobenzamide compound and use for controlling harmful arthropod WO2016143650A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2015044954 2015-03-06
JP2015-044954 2015-03-06

Publications (1)

Publication Number Publication Date
WO2016143650A1 true WO2016143650A1 (en) 2016-09-15

Family

ID=56879372

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2016/056540 WO2016143650A1 (en) 2015-03-06 2016-03-03 3-aminooxalylaminobenzamide compound and use for controlling harmful arthropod

Country Status (1)

Country Link
WO (1) WO2016143650A1 (en)

Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003011028A1 (en) * 2001-08-01 2003-02-13 Nissan Chemical Industries, Ltd. Substituted amides and pest controllers
RU2247716C2 (en) * 2003-03-27 2005-03-10 Российский химико-технологический университет им. Д.И. Менделеева (РХТУ) Substituted methyl-n-amidooxamoyl-n-phenyl-d,l-alaninates and a method for preparation thereof
JP2006306771A (en) * 2005-04-28 2006-11-09 Mitsui Chemicals Inc Agricultural/horticultural insecticide
WO2010090282A1 (en) * 2009-02-06 2010-08-12 アグロカネショウ株式会社 3-aminoxalylaminobenzamide derivatives, and insecticidal and miticidal agents containing same as active ingredient
WO2010089881A1 (en) * 2009-02-06 2010-08-12 アグロカネショウ株式会社 3-aminooxalylaminobenzamide derivative and pesticide/miticide containing the derivative as active ingredient
JP2011506504A (en) * 2007-12-21 2011-03-03 バイエル・クロツプサイエンス・アクチエンゲゼルシヤフト Aminobenzamide derivatives as useful agents for controlling animal parasites
WO2012020484A1 (en) * 2010-08-11 2012-02-16 アグロカネショウ株式会社 3-aminooxalyl aminobenzanilide derivative, and insecticide and miticide using same as active ingredient
WO2012020483A1 (en) * 2010-08-11 2012-02-16 アグロカネショウ株式会社 3-aminooxalyl aminobenzamide derivative, and insecticide and miticide using same as active ingredient
WO2012042608A1 (en) * 2010-09-29 2012-04-05 アグロカネショウ株式会社 3-aminobenzoic acid derivative and method for producing same
WO2012077221A1 (en) * 2010-12-10 2012-06-14 アグロカネショウ株式会社 3-aminooxalylaminobenzamide derivative, and insecticidal and acaricidal agent containing same as active ingredient
WO2012164698A1 (en) * 2011-06-01 2012-12-06 アグロカネショウ株式会社 3-aminooxalylaminobenzamide derivative, and insecticidal or miticidal agent comprising same as active ingredient
JP2013256522A (en) * 2008-08-13 2013-12-26 Mitsui Chemicals Agro Inc New compound
WO2014069665A1 (en) * 2012-11-05 2014-05-08 三井化学アグロ株式会社 Composition for animal parasite extermination and method for animal parasite extermination

Patent Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003011028A1 (en) * 2001-08-01 2003-02-13 Nissan Chemical Industries, Ltd. Substituted amides and pest controllers
RU2247716C2 (en) * 2003-03-27 2005-03-10 Российский химико-технологический университет им. Д.И. Менделеева (РХТУ) Substituted methyl-n-amidooxamoyl-n-phenyl-d,l-alaninates and a method for preparation thereof
JP2006306771A (en) * 2005-04-28 2006-11-09 Mitsui Chemicals Inc Agricultural/horticultural insecticide
JP2011506504A (en) * 2007-12-21 2011-03-03 バイエル・クロツプサイエンス・アクチエンゲゼルシヤフト Aminobenzamide derivatives as useful agents for controlling animal parasites
JP2013256522A (en) * 2008-08-13 2013-12-26 Mitsui Chemicals Agro Inc New compound
WO2010090282A1 (en) * 2009-02-06 2010-08-12 アグロカネショウ株式会社 3-aminoxalylaminobenzamide derivatives, and insecticidal and miticidal agents containing same as active ingredient
WO2010089881A1 (en) * 2009-02-06 2010-08-12 アグロカネショウ株式会社 3-aminooxalylaminobenzamide derivative and pesticide/miticide containing the derivative as active ingredient
WO2012020484A1 (en) * 2010-08-11 2012-02-16 アグロカネショウ株式会社 3-aminooxalyl aminobenzanilide derivative, and insecticide and miticide using same as active ingredient
WO2012020483A1 (en) * 2010-08-11 2012-02-16 アグロカネショウ株式会社 3-aminooxalyl aminobenzamide derivative, and insecticide and miticide using same as active ingredient
WO2012042608A1 (en) * 2010-09-29 2012-04-05 アグロカネショウ株式会社 3-aminobenzoic acid derivative and method for producing same
WO2012077221A1 (en) * 2010-12-10 2012-06-14 アグロカネショウ株式会社 3-aminooxalylaminobenzamide derivative, and insecticidal and acaricidal agent containing same as active ingredient
WO2012164698A1 (en) * 2011-06-01 2012-12-06 アグロカネショウ株式会社 3-aminooxalylaminobenzamide derivative, and insecticidal or miticidal agent comprising same as active ingredient
WO2014069665A1 (en) * 2012-11-05 2014-05-08 三井化学アグロ株式会社 Composition for animal parasite extermination and method for animal parasite extermination

Similar Documents

Publication Publication Date Title
JP6619364B2 (en) Bipyridine compounds and their use for controlling harmful arthropods
JP6649281B2 (en) Bipyridine compounds and their use for controlling harmful arthropods
EP3202761B1 (en) Pyridazine compound
JP6540708B2 (en) Pyrimidinone compounds
JP6763396B2 (en) Condensed heterocyclic compound
WO2016125621A1 (en) Benzimidazole compound, and use thereof for noxious arthropod control
JP6809478B2 (en) Pyridine compound
WO2016125622A1 (en) Benzoxazole compound, and use thereof for noxious arthropod control
WO2017082132A1 (en) Condensed heterocyclic compound
JP6763380B2 (en) Harmful arthropod control agent
WO2016143650A1 (en) 3-aminooxalylaminobenzamide compound and use for controlling harmful arthropod
WO2017188078A1 (en) Heterocyclic compound
WO2016143652A1 (en) 3-aminooxalylaminobenzamide compound and use for controlling harmful arthropod
WO2016163379A1 (en) Oxalyl amide compound and use thereof for noxious arthropod control
WO2016163383A1 (en) Oxalyl amide compound and use thereof for noxious arthropod control
WO2017026298A1 (en) Oxalyl amide compound and use thereof for controlling harmful arthropods

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16761620

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: JP

122 Ep: pct application non-entry in european phase

Ref document number: 16761620

Country of ref document: EP

Kind code of ref document: A1